
<html lang="en"     class="pb-page"  data-request-id="0a335492-3d28-4ee6-9cd4-5a3a52a59959"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2012.55.issue-19;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm3009234;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy" /></meta><meta name="dc.Creator" content="Denis  Drygin" /></meta><meta name="dc.Creator" content="Mustapha  Haddach" /></meta><meta name="dc.Creator" content="Fabrice  Pierre" /></meta><meta name="dc.Creator" content="David M.  Ryckman" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 4, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3009234" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3009234" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3009234" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3009234" /></link>
        
    
    

<title>Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3009234" /></meta><meta property="og:title" content="Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3009234"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3009234">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3009234&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3009234&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3009234&amp;href=/doi/10.1021/jm3009234" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8199-8208</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm3011993" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis++Drygin">Denis Drygin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mustapha++Haddach">Mustapha Haddach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Pierre">Fabrice Pierre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Ryckman">David M. Ryckman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">HTK Corporation, 5218 Rivergrade Road, Irwindale, California 91706, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">3244 Caminito Eastbluff, Apt 40, La Jolla, California 92037, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1 858 875 5114. E-mail: <a href="/cdn-cgi/l/email-protection#debaaca7bdb5b3bfb09ebda7b2bbb0bbaeb6bfacb3bff0bdb1b3"><span class="__cf_email__" data-cfemail="e286909b81898f838ca2819b8e878c87928a83908f83cc818d8f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3009234&amp;href=/doi/10.1021%2Fjm3009234" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8199–8208</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 27, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 June 2012</li><li><span class="item_label"><b>Published</b> online</span>4 September 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 October 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3009234" title="DOI URL">https://doi.org/10.1021/jm3009234</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8199%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDenis%2BDrygin%252C%2BMustapha%2BHaddach%252C%2BFabrice%2BPierre%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D19%26contentID%3Djm3009234%26title%3DPotential%2BUse%2Bof%2BSelective%2Band%2BNonselective%2BPim%2BKinase%2BInhibitors%2Bfor%2BCancer%2BTherapy%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8208%26publicationDate%3DOctober%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3009234"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2601</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3009234" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;Drygin&quot;},{&quot;first_name&quot;:&quot;Mustapha&quot;,&quot;last_name&quot;:&quot;Haddach&quot;},{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Pierre&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Ryckman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;8199-8208&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3009234&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009234&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009234" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009234&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009234" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009234&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009234" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3009234&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009234&amp;href=/doi/10.1021/jm3009234" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3009234" /></input><a href="/doi/pdf/10.1021/jm3009234" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3009234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3009234%26sid%3Dliteratum%253Aachs%26pmid%3D22924342%26genre%3Darticle%26aulast%3DDrygin%26date%3D2012%26atitle%3DPotential%2BUse%2Bof%2BSelective%2Band%2BNonselective%2BPim%2BKinase%2BInhibitors%2Bfor%2BCancer%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D19%26spage%3D8199%26epage%3D8208%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jmcmar.2012.55.issue-19/production/jmcmar.2012.55.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Targeted agents and personalized medicine for cancer are the topics of much discussion and research in the medical community and pharmaceutical industry. Success in this area began with the first molecular target, the estrogen receptor, and its inhibitors such as tamoxifen (ICI 46474). Subsequently, a number of drugs have been approved that block oncogene induced signal transduction such as imatinib (STI 571)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and others that affect proteins that regulate gene function exemplified by Vorinostat (SAHA). Other classes of targeted agents induce cells to undergo apoptosis like bortezomib (PS-341)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and a number of commercialized agents with function similar to that of sunitinib (SU 11248)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> were designed to block angiogenesis. Clearly, drugs designed to inhibit precise molecular targets or specific signaling pathways represent a valid approach for cancer therapeutics.</div><div class="NLM_p">Particularly, the deregulation of kinase function has emerged as a very active area of research, as it is one of the major mechanisms by which cancer cells avoid normal constraints on growth and proliferation. Additionally, the presence of an ATP-binding pocket makes these proteins easily amenable to medicinal chemistry efforts. In this Miniperspective we will discuss the inhibitors of the Pim kinase family that have been publically disclosed and their potential development as useful therapeutic agents in oncology. The Pim family has also been implicated in inflammation,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and a Pim-1 inhibitor was shown to attenuate of allergen-induced airway hyper-responsiveness and inflammation;<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> however, this is beyond the scope of this Miniperspective.</div><div class="NLM_p">The Pim kinases, Pim-1, -2, and -3, are a class of constitutively active serine/threonine kinases that are highly homologous (60–70%) in their kinase domains and have been implicated in several normal biological process including cell survival, proliferation, differentiation, and apoptosis. However, when these processes become disrupted or hyperactivated, they express several hallmarks of cancer. The name Pim arises from the original <i>pim-1</i> gene as the proviral insertion site of the Moloney murine leukemia virus induced T-cell lymphoma.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Pims are notably involved in signaling mechanisms associated with tumorigenesis. Mechanistic studies have shown that high expression levels of Pims are associated with hematologic and epithelial cancers in humans; thus, they can serve as potential therapeutic targets to address numerous unmet medical needs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Several classes of inhibitors have been described in the literature, and yet only two molecules have progressed to the clinic so far.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> It is noteworthy that for a long time, only inhibitors of Pim-1 were available despite the fact that increasing evidence suggests that all family members should be concurrently inhibited for optimal efficacy. For example, it has been shown that simultaneous inhibition of Pim-1 and Pim-2 is necessary to overcome the oncogenic signaling by protein tyrosine kinases in leukemia.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Only recently have examples of molecules able to modulate all isoforms (pan-Pim kinase inhibitors) been disclosed, representing one of the most interesting developments in the field. It is our desire to provide here a better understanding of the biology associated with Pim-regulated signaling pathway and to promote additional research on these associated inhibitors to discover and develop compounds that have suitable drug properties and the ability to benefit patients.</div><div class="NLM_p last">The concept of simultaneous inhibition of multiple pathways may have its roots in traditional combination chemotherapy but has applicability in targeted or multitargeted drug development as well. In fact, a significant proportion of the kinase inhibitors approved for cancer therapy today are multikinase targeting agents that are able to simultaneously modulate several biological processes of the disease. Although many of these drugs were not deliberately created for their multitargeting profile, a more rational design of molecules with multiple predefined targets has emerged. In this Miniperspective we will provide some discussion on the potential of the development of Pim kinase inhibitors with dialed in activity and selectivity properties to specifically target kinases known to be involved in cross-compensatory signaling for the disruption of cancer networks.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Pim Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Pim kinases isoforms are a three-membered collection of constitutively active enzymes belonging to the CAMK (calmodulin dependent kinase) group.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> They are involved in tumorigenesis, cell survival, and regulation of signaling pathways including proliferation, migration, and metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This kinase family is highly homologous with the kinase domains being very closely related in the linker region and the ATP binding site. Pim-1 and Pim-2 kinases have two and three isoforms, respectively, due to the use of alternative translation initiation sites.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The functional significance of different isoforms is not yet completely understood; however, certain findings, such as the involvement of nucleus- associated p34, but not p44, isoform of Pim-1 in drug resistance, highlight the potential differences in substrate specificity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Pims are constitutively active Ser/Thr kinases that were shown to be dispensable for embryonic development and survival, as mice deficient in all three kinase are viable, albeit display a significant reduction in body size, indicating that Pim kinases are important for growth.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> All three Pim kinases have several common substrates; however, several targets that are unique to a particular member of the Pim family have been identified, as in case of C-X-C chemokine receptor type 4 (CXCR4) for Pim-1.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of Pim kinases in oncogenic signaling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pim kinases have short half-lives for both mRNAs and proteins, indicating that their activity is largely regulated on transcription and translation levels. However, in certain instances, such as in chronic myelocytic leukemia (CML) cell line K562, the half-life of Pim-1 protein was found to be significantly increased pointing at the possible regulatory post-translational modification.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Alternatively, this observation can be potentially explained by the protection from proteosomal degradation through stabilizing interaction with Hsp90,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> as K562 cells were shown to have a higher expression of Hsp90 than normal blood cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> While Pim kinases do not require activation for their function, phosphorylation of Pim-1 on Tyr218 by tyrosine kinase ETK was shown to increase Pim-1 kinase activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The signaling pathways that regulate the expression of Pims are quite diverse and are cell/tissue type dependent, with transcription factors STATs, NF-κB, and HOXA9 being primarily involved in Pim mRNA synthesis (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Numerous lines of evidence denote Pim kinases as proto-oncogenes. Pim-1 is up-regulated in B-cell non-Hodgkin’s lymphoma, and this is generally correlated with poor prognosis. In addition, overexpression of Pim-1 is also noted in acute myeloid leukemia (AML) and nonhematologic cancers such as prostate.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Pim-2 has aberrant overexpression in several types of lymphomas, leukemias, multiple myeloma, and prostate cancer.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Pim-3 is implicated in tumors including those of the liver, pancreas, colon, and stomach.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a></div><div class="NLM_p">The expression of Pim-1 and Pim-2 has been shown to be directly regulated by oncogenes commonly associated with malignant transformation, i.e., Bcr-Abl, Flt3-ITD, JAK2 V617F, MLL-ENL, and MLL-AF9.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, Pim kinases were shown to be crucial mediators of mitogenic and prosurvival signaling by these oncogenes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Transgenic mice overexpressing Pim-1 under the control of the upstream immunoglobulin enhancer with downstream proviral long-term repeat were shown to develop spontaneous lymphomas, albeit with long latency. Moreover, transgenic mice coexpressing both Eμ-Myc and Eμ-Pim-1 succumb to lymphomas in utero or at birth, suggesting a synthetic lethal consequence of co-up-regulated Myc and Pim-1.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> High levels of Myc are known to induce apoptosis. By up-regulating Pim kinases, cancer cells counteract this proapoptotic stimuli, as Pim kinases are known to positively regulate the antiapoptotic machinery, in part by phosphorylating and thus inactivating proapoptotic member of Bcl-2 family, Bad.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Furthermore, Pims were shown to phosphorylate Myc directly, thus inhibiting its degradation.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Recent studies suggest that phosphorylation of histone H3 by Pim-1, which stimulates RNA polymerase II-driven transcription of Myc target genes, can also play an important role in Pim-1/Myc cooperation.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Another interesting discovery came from the report that indicated a potential feedback loop by showing that expression of Pim-3 is directly regulated by Myc.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In line with its role in apoptosis suppression, Pim-1 was also shown to cooperate in tumorigenesis with overexpression of Bcl-2 or loss of Fas ligand.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">In addition, Pim kinases are involved in cell cycle progression facilitating G1/S and G2/M transitions and thus contribute to aberrant cell growth. Accordingly, Pim-1 phosphorylates Cdc25A, which promotes G1/S cell cycle transition.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Furthermore, cyclin-dependent kinase inhibitors p21/CIP1 and p27/KIP1, which inhibit G1/S cell cycle progression, are deactivated by Pim-1, and this in effect removes the braking mechanism to promote uncontrolled proliferation.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Also, the G2/M transition is accelerated by inactivation of Cdc25C and phosphorylation of C-TAK1.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Accompanying increased proliferation, the Pim kinases act as antiapoptotic factors. Increased level of the Pim kinases inactivates the proapoptotic factor Bad, a member of the BH3 family of proteins, predominantly by phosphorylation on Ser 112.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a></div><div class="NLM_p">Genetic manipulations demonstrated that all three members of the Pim family are capable of compensatory function. Deletion of Pim-1 in Eμ-Myc background leads to the activation of Pim-2, while selective induction of Pim-3 was evident in Eμ-Myc/Pim-1<sup>–/–</sup>/Pim-2<sup>–/–</sup> mice.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> These finding should be considered during the design of specific inhibitors of Pim kinases, as these results highlight the necessity to target all three Pim kinases in order to prevent induction of compensatory mechanisms.</div><div class="NLM_p">Cancer cells are known to resist treatment through activation of compensatory signaling pathways. One of the well described compensatory interactions is between Pims and Akt, another kinase that is heavily implicated in suppression of apoptosis and in carcinogenesis and that shares the recognition motif: Arg at 5 and 3 positions with the Pim kinases.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Numerous phosphoproteomics screens identified multiple substrates that are commonly phosphorylated by both Pims and Akt, with the most frequently cited being Ser112 on Bad.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, Pim-2 was shown to regulate translational control in AML by phosphorylating 4E-BP1 on Ser65, a residue traditionally identified as a substrate for mTORC1, a kinase complex that is activated by Akt signaling.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Another kinase that is involved in the regulation of pathways affected by Pims is CK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Like Pims, CK2 is a constitutively active Ser/Thr kinase that is commonly overexpressed in cancer that was also shown to regulate the stability of Myc protein by direct phosphorylation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> While CK2 has a distinct recognition motif compared to Pim kinases and hence does not phosphorylate the same residues as Pims, it has been shown to regulate the same pathways that are known to be linked to carcinogenesis. Like Pim kinases, CK2 plays a prominent role in suppression of apoptosis by increasing the expression and/or stability of antiapoptotic proteins such as Mcl-1 and survivin, as well as through the inhibition of caspase activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> CK2 may also negatively affect the activity of 4E-BP1, potentially through the stimulation of the PI3K-Akt-mTOR pathway,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and like Pims may positively regulate NF-kB-driven transcription.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Both Pim-1 and CK2 were shown to be activated by hypoxia, and such activation can be linked to chemoresistance.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Furthermore, both kinases were shown to promote drug resistance through the activation of members of the ABC transporter family.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> In addition to co-regulating the pathways, CK2 can potentially have an impact on the expression of Pims themselves, as it has been shown to mediate the JAK-STAT signaling transduction<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and be an important player in the activation of Hsp90 machinery,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which is implicated in the stabilization of Pim proteins.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Signaling crosstalk between Pim and CK2 kinases. Solid lines designate direct modulation. Dotted lines designate indirect modulation. Dashed lines designate interaction with unknown function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taking into consideration the potential development of resistance to the inhibition of Pim kinases through activation of compensatory signaling pathways by Akt and/or CK2, one can see a good rationale for combining selective inhibitors that target these pathways individually or a discovery and development of inhibitors with dialed in activity against all of these kinases. While the latter approach is more challenging from the medicinal chemistry perspective, it removes the need for drug–drug interaction studies and allows for a simpler preclinical and clinical development plans.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Structure of the Pim Kinases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several independent groups have reported the crystal structure of Pim-1 in the presence or absence of their inhibitors.<a onclick="showRef(event, 'ref15 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref15 ref28 ref29 ref30 ref31">(15, 28-31)</a> The structural studies revealed several unique features of Pim-1 that differentiate it from other kinases of known structures. Most notably, the presence of a proline at position 123, critical for ATP binding in other kinases, does not allow the formation of the canonical second hydrogen bond between the hinge backbone and the adenine moiety of ATP, making the Pim kinases family unique in the way they interact with ATP and consequently ATP mimetic inhibitors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In addition, the insertion of an additional residue in the Pim-1 hinge results in structural changes in the hinge region due to the unique hinge sequence ERPEPV. Another important difference between Pim-1 and other kinases is the presence of β-hairpin in the N-terminal lobe of the protein. Apart from these features, the Pim-1 kinase structure adopts a classic bilobal protein kinase domain architecture with the two-lobe kinase fold separated by a deep, intervening cleft. The N-terminal lobe is composed primarily of β-sheets, whereas the C-terminal lobe is composed primarily of α-helices. The two domains are connected via the hinge region (residues 121–126). The catalytic domain of the Pim-1 kinase covers the region of amino acid positions 38–290 comprising a conserved glycine loop motif at amino acid positions 45–50, a phosphate binding site at amino acid positions 44–52 and 67, and a proton acceptor site at amino acid 167. The replacement of a lysine at position 67 by a methionine results in a kinase inactive Pim-1 mutant.</div><div class="NLM_p">The crystal structure of Pim-2 has been reported recently and revealed high structural similarity with Pim-1 with several notable changes, such as the absence of the C-terminal αJ helix in Pim-2.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Both Pim-1 and Pim-2 assume an active conformation in the presence or absence of ATP. The crystal structures of Pim showed that this constitutive activity is due to an extensive network of hydrophobic interactions and hydrogen bond between the unphosphorylated activation segment and the catalytic loop keeping the ATP pocket open and maintaining its active conformation.</div><div class="NLM_p">The crystal structure of Pim-3 protein has not yet been reported. However, because of the high sequence similarity between the Pim proteins, it is expected that Pim-3 kinase will have a structure similar to those described for Pim-1 and Pim-2.</div><div class="NLM_p last">While unique architecture of Pim kinases’ ATP-binding site allows identification of highly selective Pim inhibitors, there is enough similarity with other kinases of interest for the creation of inhibitors that target several parallel signaling pathways. For example, a comparison of Pim-1/DAPPA complex structure with a structure of CK2/IQA complex revealed a good overlap in the key residues associated with carboxylic moiety of the ligands between Pim-1 and CK2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In line with that, several classes of compounds capable of inhibiting both Pims and CK2 have been reported.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Inhibitors of the Pim Kinases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The involvement of the Pim kinases in key hallmarks of cancer has triggered a search for small molecule ATP-competitive inhibitors susceptible to lead to new targeted oncology drugs. A large number of these inhibitors (representative structures <b>1</b>–<b>8</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) were discussed in recent, comprehensive reviews.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> Many of the first generation molecules were only inhibitors of the Pim-1 isoform, the Pim-2 isoform being notably more difficult to target likely because of its low <i>K</i><sub>m</sub> for ATP. An effort toward the identification of modulators of the other isoforms has emerged in order to counteract potential compensatory mechanisms arising from the inhibition of only one Pim (vide supra). For example, the dual Pim-1/Pim-2 inhibitor pyrazine <b>6</b> was identified by Pim-2 HTS of the corporate compound collection of Boerhinger Ingelheim.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The SAR revealed that the carboxylic acid was essential for inhibition of the target, and a series of potent analogues bearing different basic amine side chains on the left-hand side were identified. A kinase selectivity assessment of <b>6</b> in a panel of 49 kinases showed that the molecule was remarkably selective, with the notable exception of protein kinase CK2, whereby <b>6</b> inhibited the two isoforms CK2α and CK2α′ with IC<sub>50</sub> values of 663 and 701 nM, respectively. Although the binding mode of <b>6</b> to Pim-1 was studied in detail by crystallography, no cellular activities of any analogues were disclosed, limiting their usefulness.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative structures of different classes of PIM inhibitors discussed in previous reviews.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another promising class of Pim inhibitors is represented by benzo[4,5] thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>7</b>, analogue of a series of potent pan-Pim kinase inhibitors discovered by scientists at Abbott.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Starting from a novel HTS hit, this group used structure-based drug design to optimize the series and carry out extensive SAR studies. This class achieved high potency for the three isoforms concomitant with a remarkable kinase selectivity profile. Several analogues showed cytotoxicity against leukemia cell lines K-562 and MV-4-11 at low micromolar and submicromolar levels. The molecules inhibited the phosphorylation of the Pim target Bad at Ser112 in K562 leukemia and LnCaP prostate cancer cells, strongly indicating that the molecules exerted their antiproliferative effect through the inhibition of the Pim kinases. The PK profile of <b>7</b> was promising in mice with a high oral absorption and a reasonable in vitro ADME profile, making these compounds excellent druglike tools to study the biology of the Pim kinases.</div><div class="NLM_p"><i>N</i>-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-<i>b</i>]pyridazin-6-amine <b>8</b> (SGI-1776) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was the first Pim kinase inhibitor to reach clinical trials, in spite of being a relatively weak inhibitor of Pim-2.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Although its inventors identified the imidazo[1,2-<i>b</i>]pyridazine core by virtual screening of 1.5 million compounds,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> this potent Pim inhibitor scaffold had been discovered earlier by others.<a onclick="showRef(event, 'ref15 ref41'); return false;" href="javascript:void(0);" class="ref ref15 ref41">(15, 41)</a> Further scaffold optimization led to <b>8</b> as a lead compound that showed dose dependent inhibition of Pim-1 (IC<sub>50</sub> = 7 nM), Pim-2 (IC<sub>50</sub> = 363 nM), and Pim-3 (IC<sub>50</sub> = 69 nM). The molecule was selective in a panel of over 300 kinases and was shown to exhibit inhibitory activity against two other kinases: Flt-3 (IC<sub>50</sub> = 44 nM) and haspin (IC<sub>50</sub> = 34 nM).</div><div class="NLM_p">A number of biological studies of the drug in various oncology contexts have been published. Compound <b>8</b> reduced phosphorylation of known Pim substrates involved in cell cycle progression and apoptosis (p21 and Bad), resulting in a cell proliferation inhibition of various prostate cancer cells at low micromolar concentrations.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The same authors reported that the drug was able to reduce cell viability in multidrug resistant prostate cancer cell line and was able to resensitize chemoresistant cells to taxane based therapies. Siu et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> demonstrated that treatment of DU-145 and PC3 prostate cancer cells with <b>8</b> or another specific Pim inhibitor induced up-regulation of the MIG56 gene that encodes a negative regulator of EGFR signaling. These properties resulted in a synergistic effect with gefitinib, suggesting possible combination therapies to increase the efficacy of EFGR kinase inhibitor drugs. In renal cell carcinoma (RCC), <b>8</b> treatment decreased phosphorylated and total c-Myc levels and significantly reduced tumor burden in RCC animal models when used in combination with sunitinib.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">In the context of leukemia, <b>8</b> induced apoptosis in chronic lymphocytic leukemia (CLL) cells in a concentration dependent manner through a mechanism believed to involve Mcl-1 reduction.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The drug also exerted a potent cytotoxicity against AML cells and activity in MV-4-11 xenograft models. Drug treatment reduced the phosphorylation of 4E-BP1 (Thr 36/Thr 37) and c-Myc (Ser62) in AML cell lines, and this was correlated with a significant reduction in Mcl-1 levels.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> However, the increased antiproliferative activity in cells carrying the Flt-3-ITD mutation strongly suggests that the inhibition of Flt-3 by the drug may also play an important role in its cellular effects. In correlation with this hypothesis, a recent publication by Hospital et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> reported the inhibition of Flt-3 autophosphorylation on tyrosine residues in MOLM-14 AML cells treated with <b>8</b>, similar to that observed after treatment with the specific Flt-3 inhibitor AC-220. With Flt-3 being known to regulate the expression of Pim kinases in leukemia,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> potent Flt-3 inhibition by a drug will necessarily create ambiguity in the interpretation of the cellular effect of Pim inhibition and as such should probably be avoided to clearly understand the mechanism of a drug. The recent discovery of structurally close inhibitors 1,2,3-triazolo[4,5-<i>b</i>]pyridines, which are cell-active and devoid of potent Flt-3 inhibition (compound <b>9</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> should provide useful tools for differentiating the effect of Pim and Flt-3 inhibition by <b>8</b>. A paper by Fathi et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> recently suggested that the simultaneous modulation of Flt-3 and Pim might be beneficial in overcoming the emergence of resistance to Flt-3 inhibition, implying that a dual inhibitor of Flt-3 and Pim such as <b>8</b> might still be more beneficial for certain types of cancer. The phase 1 clinical trial of <b>8</b> was discontinued in November 2010 because of dose limiting cardiac QTc prolongation,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> a likely result of the hERG inhibition observed in vivo.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> This unfortunate withdrawal due to off-target activity leaves the floor open for a new generation of molecules with improved properties.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative structures of PIM kinase inhibitors published since 2010.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the past 2 years, several novel inhibitors of the Pim kinases have emerged from the literature, including compound <b>9</b> discussed above (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Benzofuran 2-carboxylic acid <b>10</b> was discovered by fragment based screening followed by X-ray structure guided optimization.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Compound <b>10</b> was found to be selective in a 442 kinase panel, and its binding mode to Pim-1 was elucidated by crystallography. Although the molecule has appealing in vitro PK/ADME properties, no cellular activities of the molecule or its analogues were reported. With the aim of discovering very selective inhibitors, Huber et al.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> prepared several derivatives of a 6,7-dichloroindole scaffold known to bind kinases in an unusual way. Screening of the resulting molecules in a thermal stability shift assay allowed the discovery of 7,8-dichloro-1-oxo-β-carboline <b>11</b> which inhibited Pim-1 and Pim-3 with IC<sub>50</sub> values below 100 nM and displayed good selectivity.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This compound showed antiproliferative activity in the low micromolar range against various cell lines and inhibited the phosphorylation of 4E-BP1 in MV-4-11 cells. Compound <b>12</b>, which was discovered independently by another research group,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> shared some structural similarity with <b>11</b> by also bearing an indole ring. However, no cellular activity of the latter molecule was revealed. Finally, optimization of a screening hit led to the discovery of <b>13</b>,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> which showed great activity against Pim-1 (IC<sub>50</sub> = 3 nM) and Pim-3 (IC<sub>50</sub> = 13 nM). The activity of this molecule against Pim-2 was remarkably low (IC<sub>50</sub> = 1.1 μM), although the potent inhibition of Flt-3 (IC<sub>50</sub> = 47 nM) may account in part for the potent antiproliferative activity of the molecule against MV-4-11 cells, similar to <b>8</b>. This compound, however, was reported to have lower hERG inhibition, addressing a major issue of the former clinical candidate.</div><div class="NLM_p">The molecules discussed below (<b>14</b>–<b>17</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) are recent examples of pan-Pim inhibitors able to potently inhibit the three isoforms of the enzyme. The benzo[4,5] thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-ones (<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) discussed above also belong to this class of molecules. Using structure-based drug design, scientists at Exelixis converged toward a very similar series of molecules in which the sulfur atom of the scaffold was replaced by an oxygen atom. The resulting pan-Pim inhibitors exemplified by <b>14</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) showed good kinase selectivity, cellular potency, and good oral exposure.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Interestingly, the molecule displayed some CK2 inhibition, noted also for other Pim inhibitors in this series (vide infra). Scientists from Novartis reported the discovery of <b>15</b> and its analogues by structure-guided optimization of an HTS hit.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Compound <b>15</b> potently modulated the three Pim isoforms and revealed a good kinase selectivity profile.</div><div class="NLM_p">(<i>E</i>)-5-Chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one <b>16</b> (CX-6258), discovered through the optimization of a screening hit by Haddach et al.,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> is another example of a publically disclosed pan-Pim inhibitor. The molecule inhibited the three Pim isoforms with IC<sub>50</sub> values below 25 nM and showed an excellent selectivity profile in a 107-kinase panel. Although the molecule modulated Flt-3 activity in an enzyme assay, it was inactive against this enzyme in a cellular context. Compound <b>16</b> caused dose dependent inhibition of the phosphorylation of the prosurvival proteins Bad and 4E-BP1 at their respective Pim specific sites. In vitro, the drug produced synergistic cell killing in combination with doxorubicin and paclitaxel in prostate cancer PC3 cells, validating a potential use of pan-Pim kinases inhibitors in combination with chemotherapy. In vivo, <b>16</b> reduced tumor growth in a xenograft model of leukemia (MV-4-11, tumor growth inhibition TGI = 75% at 100 mg/kg) and prostate cancer (PC3, TGI = 51% at 50 mg/kg). A novel class of potent 7-(4<i>H</i>-1,2,4-triazol-3-yl)benzo[<i>c</i>][2,6]naphthyridines exemplified by <b>17</b> was discovered by modifying the potent protein kinase CK2 inhibitor 5-(3-chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic acid (CX-4945).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The resulting compounds were very potent inhibitors of the Pim-1 and Pim-2 isoforms and, to a lesser extent, inhibitors of Pim-3. The molecules inhibited cell proliferation of various cancer cell lines at submicromolar concentrations and modulated the phosphorylation of Bad at Ser 112. A certain level of Flt-3 inhibition was present in enzymological assays of the molecules but absent in a cellular context.</div><div class="NLM_p">Replacing the left pyridine ring in <b>17</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) by various five membered rings such as in thiophene <b>18</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> maintained potent activity against Pim and surprisingly restored inhibition of protein kinase CK2 while suppressing Flt-3 inhibition. The resulting dual inhibitors of CK2 and the Pims displayed antiproliferative activity against several solid and blood cancer cell lines. CK2 and the Pim kinases share a relatively similar ATP binding pocket, allowing the rational design of dual inhibitors of the kinases. This interesting convergence of structure and the signaling crosstalk of the enzymes (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) can be exploited for the rational design of dual inhibitors, an approach that was discussed in detail by Lopez-Ramos et al. in a work describing the discovery of dual CK2/Pim inhibitor <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Unfortunately this compound was not cell-permeable. Multikinase inhibition creates opportunities for a multiprong targeting of the hallmarks of cancer, and dual inhibitors of CK2/Pim may supplement the arsenal of existing therapeutic oncology agents. However, this innovative concept needs more validation and in particular potent dual CK2/Pim inhibitors with good drug properties, which will allow hypothesis testing in vivo.</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of dual Pim/CK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, a number of remarkable inhibitors with undisclosed structures were presented in various conference posters. Array Biopharma described a molecule (structure not disclosed) with potent inhibitory properties for Pim-1 (IC<sub>50</sub> = 0.4 nM) and Pim-3 (IC<sub>50</sub> = 1.7 nM) and moderate inhibition for Pim-2 (IC<sub>50</sub> = 81 nM).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The compound reduced tumor growth of TEL-JAK2/BaF3 subcutaneous tumors in nude mice at 100 mg/kg (TGI = 54%) and 200 mg/kg (TGI = 75%). Scientists at Genentech reported that their pan-Pim inhibitor GNE-652 (structure not disclosed) had picomolar biochemical potency, an excellent selectivity profile, and favorable ADME properties.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The molecule showed excellent in vivo efficacy in combination with the PI3K inhibitor 4-(2-(1<i>H</i>-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)morpholine (GDC-0941). Selvita discovered a novel series of Pim kinase inhibitors of which analogue SEL24-B58 (structure not disclosed; IC<sub>50</sub> of 31 nM (Pim-1), 154 nM (Pim-2), 182 nM (Pim-3)) showed in vitro synergy with inhibitors for PI3K, mTOR, JAK1/2, and Bcl-2.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The molecule was orally efficacious in a xenograft model of AML (MV-4-11) and was well tolerated. Finally, a significant progress in the Pim field was achieved by AstraZeneca scientists who described AZD1208 (structure not disclosed),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> an orally available, potent, and highly selective pan-Pim kinase inhibitor. The compound reduced the phosphorylation of Bad, 4E-BP1, and p70S6K. AZD12078 suppressed the growth of tumors in AML (MOLM-16 and KG-1a) xenograft models of cancer. AZD12078 is currently investigated in a phase 1 clinical trial in AML patients.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is overwhelming evidence that the Pim kinases represent a promising class of drug targets for oncology. Many of the biology and medicinal chemistry studies discussed here strongly suggest that ATP-competitive pan-Pim kinase inhibitors can be used for the treatment of various disorders such as CML, AML, CLL, B-cell non-Hodkin’s lymphoma, multiple myeloma, RCC, and prostate, liver, pancreas, colon, and stomach cancers. Modern understanding of compensatory signaling by different kinases underscores the practical necessity of combining several inhibitors. In that context, some of the studies described above suggest that patients may also benefit from the combination of Pim kinases inhibitors with existing drugs such as modulators of the Akt-PI3K pathways, taxanes, gefitinib, and other inhibitors of the EGFR pathway, sunitinib or doxorubicin among others. As more Pim inhibitors progress into the clinic, the list of possible combination is likely to increase, requiring the design of drugs with profiles with limited potential for drug–drug interactions.</div><div class="NLM_p">An alternative to combination is the discovery of molecules that possess dialed in activity and selectivity against multiple kinases of interest for the complete blockade of the oncogenic signaling. A prime example of this approach is the design of dual inhibitors of CK2 and Pim. Another potentially beneficial strategy is to design the inhibitors that are capable of co-inhibiting Pim and Akt signaling, as these kinases share a substantial amount of common substrates and were shown to be actively involved in compensatory signaling.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The fact that several compounds, such as natural flavonoids or their synthetic derivative LY294002, were shown to have activity against Pim, CK2, and PI3K,<a onclick="showRef(event, 'ref28 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref28 ref62 ref63">(28, 62, 63)</a> a kinase that regulates Akt signaling, demonstrates the feasibility of this approach. However, a multitargeting approach does not come without a price, as promiscuous kinase inhibitors have been associated with unwanted side effects. Indeed, following the discovery that multitargeted inhibitors sunitinib and sorafenib cause cardiotoxicity,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Hasinoff and Patel investigated the connection between the selectivity of kinase inhibitors and their ability to damage cardiomyocytes in vitro. Their findings demonstrated that combined tyrosine kinase and serine–threonine kinase selectivity scores were highly correlative with the myocyte-damaging effects of the kinase inhibitors,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> highlighting a potential drawback of multitargeting approach. While Pim kinases were not among the 12 kinases that were specifically identified in the screen as being linked to the damage of cardiomyocytes, Pim-1 kinase was shown to play a significant role in the preservation of myocardial structure after myocardial infarction.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Pim-3 was also found to be induced by ischemia–reperfusion injury; however, the reports on its ability to protect the myocardial tissue have been mixed.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> In addition to Pim-1, Akt, but interestingly not CK2, was also shown to play an important role in the protection of heart from the injury.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> Because of that, suitable preclinical toxicology studies should be undertaken when administrating agents capable of simultaneous inhibition of Pim and Akt signaling to high-risk cardiovascular patients.</div><div class="NLM_p last">It is surprising that only two Pim inhibitory agents have reached clinical trials and unfortunate that no human proof of concept data were generated because of the early withdrawal of the first drug <b>8</b>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, the pace of discovery of novel Pim inhibitor has dramatically accelerated in the past 2 years, and a new generation of potent molecules without hERG inhibition and appropriate pharmacologic profiles will likely generate Pim kinase inhibitors drugs suitable for human cancer therapy.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm3009234" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Ryckman</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121,
United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e88c9a918b83858986a88b91848d868d9880899a8589c68b8785"><span class="__cf_email__" data-cfemail="1a7e68637971777b745a7963767f747f6a727b68777b34797577">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis Drygin</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mustapha Haddach</span> - <span class="hlFld-Affiliation affiliation">HTK Corporation, 5218 Rivergrade Road, Irwindale, California
91706, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Pierre</span> - <span class="hlFld-Affiliation affiliation">3244
Caminito Eastbluff, Apt 40, La Jolla, California 92037, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Denis Drygin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Denis Drygin</b> received his B.S. and M.S. degrees in Chemistry from Moscow State University, M.S. and Ph.D. degrees in Biochemistry and Molecular Biology from the University of Massachusetts at Amherst, and his postdoctoral training at Isis Pharmaceuticals, where he worked with Dr. Frank Bennett. Dr. Drygin joined Cylene Pharmaceuticals in 2005 as a Research Scientist and has earned increasing responsibilities for the company’s drug mechanism, screening, and in vivo pharmacology operations across all R&D projects, being promoted to Vice President, Biology, in 2012. His discovery and research efforts led to the creation of the first therapeutic agent to directly target RNA polymerase I transcription for the treatment of cancer. Dr. Drygin also played leading roles in Cylene’s CK2 and pan-Pim inhibitors R&D programs.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Mustapha Haddach</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mustapha Haddach</b> received a Ph.D. in Chemistry from the University of Nice-Sophia Antipolis, Nice, France. Most recently, he directed the medicinal chemistry effort in several oncology programs at Cylene Pharmaceuticals. Prior to that he was the Vice President of Chemistry at Parallax Biosystems, a company he cofounded to develop novel molecular detection platforms. Before Parallax he held positions at Neurocrine Biosciences, working to develop therapies for CNS related diseases such as depression and neurodegenerative disorders. He is a named inventor on 17 patents.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Fabrice Pierre</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fabrice Pierre</b> earned his Ph.D. in Chemistry from The University of Rennes, France (1997), with Prof. Claude Moinet. He was awarded a Humboldt Fellowship to pursue postdoctoral studies in asymmetric synthesis with Prof. Dieter Enders in Aachen (RWTH), Germany. After completing a postdoc with Prof. Marco Ciufolini in Lyon, France, he was hired in 2001 by Triad Therapeutics in San Diego, CA, where he worked on multiple drug discovery projects. He joined Cylene Pharmaceuticals in 2004 where he made significant contributions to the creation of the company’s oncology pipeline. Dr. Pierre was involved in the discovery of several clinical candidates and is the coauthor of 40 articles and patent applications. He currently works as a contract medicinal chemist for Vertex Pharmaceuticals in San Diego, CA.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">David M. Ryckman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=bio4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>David M. Ryckman</b> is Senior Vice President of Chemistry and Pharmaceutical Operations at Cylene Pharmaceuticals, Inc. He earned his B.S. and Ph.D. at the University of California at Los Angeles, working for Professors C. S. Foote, R. V. Stevens, and M. E. Jung on the total synthesis of natural products. Subsequently he undertook postdoctoral studies at Harvard University, MA, in the laboratories of Professor Y. Kishi, studying the conformational analysis of carbon glycosides and their relationship to the parent glycosides. He has worked at both large and small pharmaceutical companies including GlaxoSmithKline, Novartis, and Gensia Laboratories, Inc., where he has received several awards in both research and technical operations. His current professional interests include the discovery and development of new targeted agents for oncology.</p></figure></div><div class="ack" id="ACK-d3085e800-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Sean O’Brien for critically reviewing the manuscript. We also thank our former co-workers and colleagues, especially Drs. K. Anderes and H. Skinner, for relevant discussions of Pim biology and for help identifying a desired Pim product profile. In addition, we thank Cylene Pharmaceuticals for support. Finally we acknowledge our colleagues whose work could not be cited because of space constrains.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i11" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i11"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i12" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i12"> Abbreviations Used</h2><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">CAMK</td><td class="NLM_def"><p class="first last">calmodulin dependent kinase</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myelocytic leukemia</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">C-X-C chemokine receptor type 4</p></td></tr><tr><td class="NLM_term">RCC</td><td class="NLM_def"><p class="first last">renal cell carcinoma</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1056%2FNEJM200104053441401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=11287972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1031-1037&issue=14&author=B.+J.+Drukerauthor=M.+Talpazauthor=D.+J.+Restaauthor=B.+Pengauthor=E.+Buchdungerauthor=J.+M.+Fordauthor=N.+B.+Lydonauthor=H.+Kantarjianauthor=R.+Capdevilleauthor=S.+Ohno-Jonesauthor=C.+L.+Sawyers&title=Efficacy+and+safety+of+a+specific+inhibitor+of+the+BCR-ABL+tyrosine+kinase+in+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span></div><div class="casAuthors">Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabeth; Ford, John M.; Lydon, Nicholas B.; Kantarjian, Hagop; Capdeville, Renaud; Ohno-Jones, Sayuri; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML).  Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML.  Methods: We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase.  STI571 was administered orally to 83 patients with CML in the chronic phase in whom treatment with interferon alpha had failed.  Patients were successively assigned to 1 of 14 doses ranging from 25 to 1000 mg per day.  Results: Adverse effects of STI571 were minimal; the most common were nausea, myalgias, edema, and diarrhea.  A maximal tolerated dose was not identified.  Complete hematol. responses were obsd. in 53 of 54 patients treated with daily doses of 300 mg or more and typically occurred in the first four weeks of therapy.  Of the 54 patients treated with doses of 300 mg or more, cytogenetic responses occurred in 29, including 17 (31 percent of the 54 patients who received this dose) with major responses (0 to 35 percent of cells in metaphase pos. for the Philadelphia chromosome); 7 of these patients had complete cytogenetic remissions.  Conclusion: STI571 is well tolerated and has significant antileukemic activity in patients with CML in whom treatment with interferon alpha had failed.  Our results provide evidence of the essential role of BCR-ABL tyrosine kinase activity in CML and demonstrate the potential for the development of anticancer drugs based on the specific mol. abnormality present in a human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrprbDzKoC0ubVg90H21EOLACvtfcHk0lj0nAAy8hX5fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D&md5=1554407678838243a753aa056ffd4f7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441401%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DResta%26aufirst%3DD.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DOhno-Jones%26aufirst%3DS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520BCR-ABL%2520tyrosine%2520kinase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26issue%3D14%26spage%3D1031%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinchcombe, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerciolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depcik-Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soignet, S. L.</span><span> </span><span class="NLM_article-title">Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4420</span><span class="NLM_x">–</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1200%2FJCO.2002.01.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=12431963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=4420-4427&issue=22&author=R.+Z.+Orlowskiauthor=T.+E.+Stinchcombeauthor=B.+S.+Mitchellauthor=T.+C.+Sheaauthor=A.+S.+Baldwinauthor=S.+Stahlauthor=J.+Adamsauthor=D.+L.+Esseltineauthor=P.+J.+Elliottauthor=C.+S.+Pienauthor=R.+Guercioliniauthor=J.+K.+Andersonauthor=N.+D.+Depcik-Smithauthor=R.+Bhagatauthor=M.+J.+Lehmanauthor=S.+C.+Novickauthor=O.+A.+O%E2%80%99Connorauthor=S.+L.+Soignet&title=Phase+I+trial+of+the+proteasome+inhibitor+PS-341+in+patients+with+refractory+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies</span></div><div class="casAuthors">Orlowski, Robert Z.; Stinchcombe, Thomas E.; Mitchell, Beverly S.; Shea, Thomas C.; Baldwin, Albert S.; Stahl, Stephanie; Adams, Julian; Esseltine, Dixie-Lee; Elliott, Peter J.; Pien, Christine S.; Guerciolini, Roberto; Anderson, Jessica K.; Depcik-Smith, Natalie D.; Bhagat, Rita; Lehman, Mary Jo; Novick, Steven C.; O'Connor, Owen A.; Soignet, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4420-4427</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacodynamics (PD) of the proteasome inhibitor bortezomib (previously known as PS-341) in patients with refractory hematol. malignancies.  Patients and Methods: Patients received PS-341 twice weekly for 4 wk at either 0.40,1.04,1.20, or 1.38 mg/m2, followed by a 2-wk rest.  The PD of PS-341 was evaluated by measurement of whole blood 205 proteasome activity.  Results: Twenty-seven patients received 293 doses of PS-341, including 24 complete cycles.  DLTs at doses above the 1.04-mg/m2 MTD attributed to PS-341 included thrombocytopenia, hyponatremia, hypokalemia, fatigue, and malaise.  In three of 10 patients receiving addnl. therapy, serious reversible adverse events appeared during cycle 2, including one episode of postural hypotension, one systemic hypersensitivity reaction, and grade 4 transaminitis in a patient with hepatitis C and a substantial acetaminophen ingestion.  In three of 10 patients receiving addnl. therapy, serious reversible adverse events appeared during cycle 2, including one episode of postural hypotension, one systemic hypersensitivity reaction, and grade 4 transaminitis in a patient with hepatitis C and a substantial acetaminophen ingestion.  Among nine fully assessable patients with heavily pretreated plasma cell dyscrasias completing one cycle of therapy, there was one complete response and a redn. in paraprotein levels and/or marrow plasmacytosis in eight others.  In addn., one patient with mantle cell lymphoma and another with follicular lymphoma had shrinkage of nodal disease.  Conclusion: PS-341 was well tolerated at 1.04 mg/m2 on this dose-intensive schedule, although patients need to be monitored for electrolyte abnormalities and late toxicities.  Addnl. studies are indicated to det. whether incorporation of dose/body surface area yields a superior PD model to dosing without normalization.  PS-341 showed activity against refractory multiple myeloma and possibly non-Hodgkin's lymphoma in this study, and merits further investigation in these populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ7u72jtVj9rVg90H21EOLACvtfcHk0lj0nAAy8hX5fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFCjs70%253D&md5=6992d6ec97624e635a7cdc2aa22a9cd7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.01.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.01.133%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStinchcombe%26aufirst%3DT.%2BE.%26aulast%3DMitchell%26aufirst%3DB.%2BS.%26aulast%3DShea%26aufirst%3DT.%2BC.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DEsseltine%26aufirst%3DD.%2BL.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DGuerciolini%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DJ.%2BK.%26aulast%3DDepcik-Smith%26aufirst%3DN.%2BD.%26aulast%3DBhagat%26aufirst%3DR.%26aulast%3DLehman%26aufirst%3DM.%2BJ.%26aulast%3DNovick%26aufirst%3DS.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DSoignet%26aufirst%3DS.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%2520the%2520proteasome%2520inhibitor%2520PS-341%2520in%2520patients%2520with%2520refractory%2520hematologic%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26issue%3D22%26spage%3D4420%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shaheen, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rini, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R. M.</span><span> </span><span class="NLM_article-title">Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports</span> <span class="citation_source-journal">Clin. Genitourin. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.3816%2FCGC.2006.n.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16859583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A280%3ADC%252BD28vjs1OgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=78-81&author=P.+E.+Shaheenauthor=B.+I.+Riniauthor=R.+M.+Bukowski&title=Clinical+activity+of+sorafenib+and+sunitinib+in+renal+cell+carcinoma+refractory+to+previous+vascular+endothelial+growth+factor-targeted+therapy%3A+two+case+reports"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports</span></div><div class="casAuthors">Shaheen Philip E; Rini Brian I; Bukowski Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genitourinary cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-81</span>
        ISSN:<span class="NLM_cas:issn">1558-7673</span>.
    </div><div class="casAbstract">Sunitinib and sorafenib are multitargeted receptor tyrosine kinase inhibitors of the vascular endothelial growth factor and platelet-derived growth factor receptor families with antiangiogenic and antitumor activity in metastatic renal cell carcinoma.  The utility of these agents in patients refractory to previous treatment with the other agent is unknown.  We report 2 cases highlighting that efficacy of these agents is possible after failure of the other agent.  Further prospective study is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQxIi8h5HcCGgRQsDqrjW_fW6udTcc2eYAC4vQ0wZgX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vjs1OgsQ%253D%253D&md5=e7085da8beac8238743ab41c28824828</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3816%2FCGC.2006.n.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCGC.2006.n.021%26sid%3Dliteratum%253Aachs%26aulast%3DShaheen%26aufirst%3DP.%2BE.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26atitle%3DClinical%2520activity%2520of%2520sorafenib%2520and%2520sunitinib%2520in%2520renal%2520cell%2520carcinoma%2520refractory%2520to%2520previous%2520vascular%2520endothelial%2520growth%2520factor-targeted%2520therapy%253A%2520two%2520case%2520reports%26jtitle%3DClin.%2520Genitourin.%2520Cancer%26date%3D2006%26volume%3D5%26spage%3D78%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jackson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L. L.</span><span> </span><span class="NLM_article-title">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.cellimm.2011.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22078270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2012&pages=200-213&author=L.+J.+Jacksonauthor=J.+A.+Phenegerauthor=T.+J.+Phenegerauthor=G.+Davisauthor=A.+D.+Wrightauthor=J.+E.+Robinsonauthor=S.+Allenauthor=M.+C.+Munsonauthor=L.+L.+Carter&title=The+role+of+PIM+kinases+in+human+and+mouse+CD4%2B+T+cell+activation+and+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span></div><div class="casAuthors">Jackson, Leila J.; Pheneger, Jed A.; Pheneger, Tracy J.; Davis, Gregg; Wright, A. Dale; Robinson, John E.; Allen, Shelley; Munson, Mark C.; Carter, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-213</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PIM kinases are a family of three serine/threonine kinases expressed following T cell activation.  Using potent selective small mol. antagonists of PIM-1/3 kinases, we demonstrate a potential role for these enzymes in naive and effector CD4+ T cell activation.  PIM-1/3 inhibition prevented CD4+ T cell proliferation by inducing a G0/G1 cell cycle arrest without affecting cellular survival.  In the absence of PIM-1/3 kinase activity, naive CD4+ T cells failed to fully differentiate into effector cells both in vitro and in vivo.  Therapeutic dosing of a PIM-1/3 inhibitor was efficacious in a CD4+ T cell-mediated model of inflammatory bowel disease suggesting that PIM-1 and PIM-3 kinase activity contributes to sustained disease severity.  These results demonstrate that PIM-1/3 kinases have an important role in CD4+ T cell responses and inhibition of this activity may provide a therapeutic benefit in T cell-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49-JUG78zSLVg90H21EOLACvtfcHk0lgVG87m4N_b3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP&md5=aa030f7e07e27d4289afdeca873b30a8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BJ.%26aulast%3DPheneger%26aufirst%3DJ.%2BA.%26aulast%3DPheneger%26aufirst%3DT.%2BJ.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DThe%2520role%2520of%2520PIM%2520kinases%2520in%2520human%2520and%2520mouse%2520CD4%252B%2520T%2520cell%2520activation%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2012%26volume%3D272%26spage%3D200%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shin, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicken, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1165%2Frcmb.2011-0190OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22074702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslags7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=488-497&author=Y.+S.+Shinauthor=K.+Takedaauthor=Y.+Shiraishiauthor=Y.+Jiaauthor=M.+Wangauthor=L.+Jacksonauthor=A.+D.+Wrightauthor=L.+Carterauthor=J.+Robinsonauthor=E.+Hickenauthor=E.+W.+Gelfand&title=Inhibition+of+Pim1+kinase+activation+attenuates+allergen-induced+airway+hyperresponsiveness+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation</span></div><div class="casAuthors">Shin, Yoo Seob; Takeda, Katsuyuki; Shiraishi, Yoshiki; Jia, Yi; Wang, Meiqin; Jackson, Leila; Wright, A. Dale; Carter, Laura; Robinson, John; Hicken, Erik; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Pim kinases are a family of serine/threonine kinases whose activity can be induced by cytokines involved in allergy and asthma.  These kinases play a role in cell survival and proliferation, but have not been examd., to the best of our knowledge, in the development of allergic disease.  This study sought to det. the role of Pim1 kinase in the development of allergic airway responses.  Mice were sensitized and challenged with antigen (primary challenge), or were sensitized, challenged, and rechallenged with allergen in a secondary model.  To assess the role of Pim1 kinase, a small mol. inhibitor was administered orally after sensitization and during the challenge phase.  Airway responsiveness to inhaled methacholine, airway and lung inflammation, cell compn., and cytokine concns. were assessed.  Lung Pim1 kinase concns. were increased after ovalbumin sensitization and challenge.  In the primary allergen challenge model, treatment with the Pim1 kinase inhibitor after sensitization and during airway challenges prevented the development of airway hyperresponsiveness, eosinophilic airway inflammation, and goblet cell metaplasia, and increased Th2 cytokine concns. in bronchoalveolar fluid in a dose-dependent manner.  These effects were also demonstrated after a secondary allergen challenge, where lung allergic disease was established before treatment.  After treatment with the inhibitor, a significant redn. was evident in the no. of CD4+ and CD8+ T cells and concns. of cytokines in the airways.  The inhibition of Pim1 kinase was effective in preventing the development of airway hyperresponsiveness, airway inflammation, and cytokine prodn. in allergen-sensitized and allergen-challenged mice.  These data identify the important role of Pim1 kinase in the full development of allergen-induced airway responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5oneDF7UwgrVg90H21EOLACvtfcHk0lgVG87m4N_b3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslags7Y%253D&md5=2af50182a23ff340eb3ed21b18aabac4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0190OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0190OC%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%2BS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DHicken%26aufirst%3DE.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DInhibition%2520of%2520Pim1%2520kinase%2520activation%2520attenuates%2520allergen-induced%2520airway%2520hyperresponsiveness%2520and%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cuypers, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quint, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maandag, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boelens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wezenbeek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melief, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Maandagauthor=W.+Boelensauthor=P.+van+Wezenbeekauthor=C.+Meliefauthor=A.+Berns&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0lhCEh_c-BODYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMaandag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26aulast%3Dvan%2BWezenbeek%26aufirst%3DP.%26aulast%3DMelief%26aufirst%3DC.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Nawijn, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alendar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">For better or for worse: the role of Pim oncogenes in tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+Pim+oncogenes+in+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lhCEh_c-BODYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520Pim%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span>Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects with Relapsed/Refractory Leukemias. <a href="http://clinicaltrials.gov/ct2/show/NCT01239108" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01239108</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+SGI-1776%2C+a+PIM+Kinase+Inhibitor%2C+in+Subjects+with+Relapsed%2FRefractory+Leukemias.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01239108."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span>Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients. <a href="http://clinicaltrials.gov/ct2/show/NCT01489722" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01489722</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Tolerability+of+AZD1208+and+the+Pharmacokinetics+and+Efficacy+of+AZD1208+in+Acute+Myelogenous+Leukemia+%28AML%29+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01489722."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirogane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">Regulation of Pim-1 by Hsp90</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2001&pages=663-669&author=K.+Mizunoauthor=T.+Shiroganeauthor=A.+Shinoharaauthor=A.+Iwamatsuauthor=M.+Hibiauthor=T.+Hirano&title=Regulation+of+Pim-1+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DShirogane%26aufirst%3DT.%26aulast%3DShinohara%26aufirst%3DA.%26aulast%3DIwamatsu%26aufirst%3DA.%26aulast%3DHibi%26aufirst%3DM.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520Pim-1%2520by%2520Hsp90%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D281%26spage%3D663%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Study of heat shock protein HSP90 alpha, HSP70, HSP27 mRNA expression in human acute leukemia cells</span> <span class="citation_source-journal">J. Tongji Med. Univ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1007%2FBF02888109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=9389084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=212-216&issue=4&author=K.+Xiaoauthor=W.+Liuauthor=S.+Quauthor=H.+Sunauthor=J.+Tang&title=Study+of+heat+shock+protein+HSP90+alpha%2C+HSP70%2C+HSP27+mRNA+expression+in+human+acute+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Study of heat shock protein HSP90α, HSP70, HSP27 mRNA expression in human acute leukemia cells</span></div><div class="casAuthors">Xiao, Kanyan; Liu, Wenli; Qu, Shen; Sun, Hanying; Tang, Jinzhi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Tongji Medical University</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">JTMUEI</span>;
        ISSN:<span class="NLM_cas:issn">0257-716X</span>.
    
            (<span class="NLM_cas:orgname">Tongji Medical University</span>)
        </div><div class="casAbstract">The expression of three heat shock proteins (HSPs) - HSP90α, HSP70, HSP27 in cells obtained from 22 patients with leukemia, K562 erythroleukemia cell line, and normal blood cells was obsd. by RNA dot blot anal.  The results showed that the expression of the HSP27 gene was enhanced in 4 cases of acute lymphoid leukemia (ALL), 7 cases of acute nonlymphoid leukemia (ANLL) and 2 cases of myelodysplastic syndrome (MDS) as compared with that of the normal blood cells, yet there was no significant difference in the HSP27 expression between the ALL and ANLL cells.  The expression in HSP70 in all 5 ALL and ANLL patients was much lower than that of the normal subjects, except 1 case of ALL and 1 case of MDS, in which the expression was obviously enhanced.  All the cases including 11 ANLL, 5 ALL and 1 MDS had higher HSP90α expression than the normal subjects.  The enhanced expression of HSP90α in leukemia cells may be assocd. with the active and indefinite proliferation of leukemia cells.  The authors' results also suggest that the high expression of the HSP27 gene may not be confined to a specific type of acute leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDavjXPkXArVg90H21EOLACvtfcHk0lhCEh_c-BODYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFOju7o%253D&md5=ff1ffad4ecf486951af7178b052e2280</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2FBF02888109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02888109%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStudy%2520of%2520heat%2520shock%2520protein%2520HSP90%2520alpha%252C%2520HSP70%252C%2520HSP27%2520mRNA%2520expression%2520in%2520human%2520acute%2520leukemia%2520cells%26jtitle%3DJ.%2520Tongji%2520Med.%2520Univ.%26date%3D1996%26volume%3D16%26issue%3D4%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Forshell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forshell, T. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J.</span><span> </span><span class="NLM_article-title">The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=448-460&author=L.+P.+Forshellauthor=Y.+Liauthor=T.+Z.+Forshellauthor=M.+Rudeliusauthor=L.+Nilssonauthor=U.+Kellerauthor=J.+Nilsson&title=The+direct+Myc+target+Pim3+cooperates+with+other+Pim+kinases+in+supporting+viability+of+Myc-induced+B-cell+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForshell%26aufirst%3DL.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DForshell%26aufirst%3DT.%2BZ.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%26atitle%3DThe%2520direct%2520Myc%2520target%2520Pim3%2520cooperates%2520with%2520other%2520Pim%2520kinases%2520in%2520supporting%2520viability%2520of%2520Myc-induced%2520B-cell%2520lymphomas%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D448%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mikkers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipscheer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeijn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fng950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=12185366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=153-159&author=H.+Mikkersauthor=J.+Allenauthor=P.+Knipscheerauthor=L.+Romeijnauthor=A.+Hartauthor=E.+Vinkauthor=A.+Berns&title=High-throughput+retroviral+tagging+to+identify+components+of+specific+signaling+pathways+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span></div><div class="casAuthors">Mikkers, Harald; Allen, John; Knipscheer, Puck; Romeyn, Lieke; Hart, Augustinus; Vink, Edwin; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genetic screens carried out in lower organisms such as yeast, Drosophila melanogaster and Caenorhabditis elegans have revealed many signaling pathways.  For example, components of the RAS signaling cascade were identified using a mutant eye phenotype in D. melanogaster as a readout.  Screening is usually based on enhancing or suppressing a phenotype by way of a known mutation in a particular signaling pathway.  Such in vivo screens have been difficult to carry out in mammals, however, owing to their relatively long generation times and the limited no. of animals that can be screened.  Here the authors describe an in vivo mammalian genetic screen used to identify components of pathways contributing to oncogenic transformation.  The authors applied retroviral insertional mutagenesis in Myc transgenic (EμMyc) mice lacking expression of Pim1 and Pim2 to search for genes that can substitute for Pim1 and Pim2 in lymphomagenesis.  The authors detd. the chromosomal positions of 477 retroviral insertion sites (RISs) derived from 38 tumors from EμMyc Pim1-/- Pim2-/- mice and 27 tumors from EμMyc control mice using the Ensembl and Celera annotated mouse genome databases.  There were 52 sites occupied by proviruses in more than one tumor.  These common insertion sites (CISs) are likely to contain genes contributing to tumorigenesis.  Comparison of the RISs in tumors of Pim-null mice with the RISs in tumors of EμMyc control mice indicated that 10 of the 52 CISs belong to the Pim complementation group.  In addn., Pim3 is selectively activated in Pim-null tumor cells, which supports the validity of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6i2tPp4vS3rVg90H21EOLACvtfcHk0lienYxkvsHaEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D&md5=fa564ec068d8e70c8aefb533008ad738</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fng950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng950%26sid%3Dliteratum%253Aachs%26aulast%3DMikkers%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DRomeijn%26aufirst%3DL.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DVink%26aufirst%3DE.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DHigh-throughput%2520retroviral%2520tagging%2520to%2520identify%2520components%2520of%2520specific%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span> </span><span class="NLM_article-title">Structure and substrate specificity of the Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">41675</span><span class="NLM_x">–</span> <span class="NLM_lpage">41682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=41675-41682&author=A.+N.+Bullockauthor=J.+Debreczeniauthor=A.+L.+Amosauthor=S.+Knappauthor=B.+E.+Turk&title=Structure+and+substrate+specificity+of+the+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DAmos%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26atitle%3DStructure%2520and%2520substrate%2520specificity%2520of%2520the%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D41675%26epage%3D41682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Amaravadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The survival kinases Akt and Pim as potential pharmacological targets</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1172%2FJCI26273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16200194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2618-2624&issue=10&author=R.+Amaravadiauthor=C.+B.+Thompson&title=The+survival+kinases+Akt+and+Pim+as+potential+pharmacological+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The survival kinases Akt and Pim as potential pharmacological targets</span></div><div class="casAuthors">Amaravadi, Ravi; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2618-2624</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  The Akt and Pim kinases are cytoplasmic protein serine/threonine kinases that control programmed cell death (apoptosis) by phosphorylating substrates that regulate both apoptosis and cellular metab.  The phosphatidylinositol 3-kinase-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways.  Pharmacol. manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUNe0bt5gIJrVg90H21EOLACvtfcHk0lienYxkvsHaEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygt7vL&md5=d501bb9ac92d6d2674d09e6375acb57e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI26273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI26273%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520survival%2520kinases%2520Akt%2520and%2520Pim%2520as%2520potential%2520pharmacological%2520targets%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26issue%3D10%26spage%3D2618%26epage%3D2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzunov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1618-1627&author=J.+Tamburiniauthor=A.+S.+Greenauthor=V.+Bardetauthor=N.+Chapuisauthor=S.+Parkauthor=L.+Willemsauthor=M.+Uzunovauthor=N.+Ifrahauthor=F.+Dreyfusauthor=C.+Lacombeauthor=P.+Mayeuxauthor=D.+Bouscary&title=Protein+synthesis+is+resistant+to+rapamycin+and+constitutes+a+promising+therapeutic+target+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DA.%2BS.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DUzunov%26aufirst%3DM.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DProtein%2520synthesis%2520is%2520resistant%2520to%2520rapamycin%2520and%2520constitutes%2520a%2520promising%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1618%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Channavajhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span> </span><span class="NLM_article-title">Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">34</span><span class="NLM_x">) </span> <span class="NLM_fpage">5280</span><span class="NLM_x">–</span> <span class="NLM_lpage">5288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=5280-5288&issue=34&author=P.+Channavajhalaauthor=D.+C.+Seldin&title=Functional+interaction+of+protein+kinase+CK2+and+c-Myc+in+lymphomagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChannavajhala%26aufirst%3DP.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DFunctional%2520interaction%2520of%2520protein%2520kinase%2520CK2%2520and%2520c-Myc%2520in%2520lymphomagenesis%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26issue%3D34%26spage%3D5280%26epage%3D5288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ahmad, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2—a key suppressor of apoptosis</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=179-187&author=K.+A.+Ahmadauthor=G.+Wangauthor=G.+Ungerauthor=J.+Slatonauthor=K.+Ahmed&title=Protein+kinase+CK2%E2%80%94a+key+suppressor+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%25E2%2580%2594a%2520key%2520suppressor%2520of%2520apoptosis%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2008%26volume%3D48%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bliesath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proffitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span> </span><span class="NLM_article-title">Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.canlet.2012.02.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22387988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2012&pages=113-118&author=J.+Bliesathauthor=N.+Huserauthor=M.+Omoriauthor=D.+Bunagauthor=C.+Proffittauthor=N.+Streinerauthor=C.+Hoauthor=A.+Siddiqui-Jainauthor=S.+E.+O%E2%80%99Brienauthor=J.+K.+Limauthor=D.+M.+Ryckmanauthor=K.+Anderesauthor=W.+G.+Riceauthor=D.+Drygin&title=Combined+inhibition+of+EGFR+and+CK2+augments+the+attenuation+of+PI3K-Akt-mTOR+signaling+and+the+killing+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells</span></div><div class="casAuthors">Bliesath, Joshua; Huser, Nanni; Omori, Mayuko; Bunag, Daniel; Proffitt, Chris; Streiner, Nicole; Ho, Caroline; Siddiqui-Jain, Adam; O'Brien, Sean E.; Lim, John K. C.; Ryckman, David M.; Anderes, Kenna; Rice, William G.; Drygin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ser/Thr protein kinase CK2 regulates multiple processes that play important roles in the sensitivity of cancer to epidermal growth factor receptor targeting therapeutics, including PI3K-Akt-mTOR signaling, Hsp90 activity, and inhibition of apoptosis.  We hypothesized that top-down inhibition of EGFR, combined with lateral suppression of multiple oncogenic pathways by targeting CK2, would create a pharmacol. synthetic lethal event and result in an improved cancer therapy compared to EGFR inhibition alone.  This hypothesis was tested by combining CX-4945, a first-in-class clin. stage inhibitor of CK2, with the EGFR tyrosine kinase inhibitor, erlotinib, in vitro and in vivo in models of non-small cell lung carcinoma, NCI-H2170, and squamous cell carcinoma, A431.  Our results demonstrate that combination of CX-4945 with erlotinib results in enhanced attenuation of the PI3K-Akt-mTOR pathway.  We also obsd. an increase in apoptosis, synergistic killing of cancer cells in vitro, as well as improved antitumor efficacy in vivo.  Taken together, these data position CK2 as a valid pharmacol. target for drug combinations and support further evaluation of CX-4945 in combination with EGFR targeting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzYiiE9A2ALVg90H21EOLACvtfcHk0lhaVuvA8gEXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFynsLg%253D&md5=dcb2f8e5c5b24ead5bbd9bb37b1c5d33</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2012.02.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2012.02.032%26sid%3Dliteratum%253Aachs%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DBunag%26aufirst%3DD.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DDrygin%26aufirst%3DD.%26atitle%3DCombined%2520inhibition%2520of%2520EGFR%2520and%2520CK2%2520augments%2520the%2520attenuation%2520of%2520PI3K-Akt-mTOR%2520signaling%2520and%2520the%2520killing%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2012%26volume%3D322%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Romieu-Mourez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landesman-Bollag, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traish, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G. E.</span><span> </span><span class="NLM_article-title">Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3810</span><span class="NLM_x">–</span> <span class="NLM_lpage">3818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3810-3818&issue=9&author=R.+Romieu-Mourezauthor=E.+Landesman-Bollagauthor=D.+C.+Seldinauthor=A.+M.+Traishauthor=F.+Mercurioauthor=G.+E.+Sonenshein&title=Roles+of+IKK+kinases+and+protein+kinase+CK2+in+activation+of+nuclear+factor-kappaB+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomieu-Mourez%26aufirst%3DR.%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26aulast%3DTraish%26aufirst%3DA.%2BM.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DSonenshein%26aufirst%3DG.%2BE.%26atitle%3DRoles%2520of%2520IKK%2520kinases%2520and%2520protein%2520kinase%2520CK2%2520in%2520activation%2520of%2520nuclear%2520factor-kappaB%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26issue%3D9%26spage%3D3810%26epage%3D3818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. H.</span><span> </span><span class="NLM_article-title">Pim-1 plays a pivotal role in hypoxia-induced chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2581</span><span class="NLM_x">–</span> <span class="NLM_lpage">2592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=2581-2592&author=J.+Chenauthor=M.+Kobayashiauthor=S.+Darmaninauthor=Y.+Qiaoauthor=C.+Gullyauthor=R.+Zhaoauthor=S.+C.+Yeungauthor=M.+H.+Lee&title=Pim-1+plays+a+pivotal+role+in+hypoxia-induced+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DDarmanin%26aufirst%3DS.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DGully%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DYeung%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DM.%2BH.%26atitle%3DPim-1%2520plays%2520a%2520pivotal%2520role%2520in%2520hypoxia-induced%2520chemoresistance%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3D2581%26epage%3D2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mottet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruys, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demazy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, C.</span><span> </span><span class="NLM_article-title">Role for casein kinase 2 in the regulation of HIF-1 activity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1002%2Fijc.21268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=15957168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=764-774&issue=5&author=D.+Mottetauthor=S.+P.+Ruysauthor=C.+Demazyauthor=M.+Raesauthor=C.+Michiels&title=Role+for+casein+kinase+2+in+the+regulation+of+HIF-1+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role for casein kinase 2 in the regulation of HIF-1 activity</span></div><div class="casAuthors">Mottet, Denis; Ruys, Sebastien Pyr Dit; Demazy, Catherine; Raes, Martine; Michiels, Carine</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor that plays a major role in cellular adaptation to hypoxia.  The mechanisms regulating HIF-1 activity occurs at multiple levels in vivo.  The HIF-1α subunit is highly sensible to oxygen and is rapidly degraded by the proteasome 26S in normoxia.  Activation in hypoxia occurs through a multistep process including inhibition of HIF-1α degrdn., but also increase in the transactivation activity of HIF-1.  Several data indicate that phosphorylation could play a role in this regulation.  In this report, we investigated the role of casein kinase 2 (CK2), an ubiquitous serine/threonine kinase, in the regulation of HIF-1 activity.  Hypoxia was capable of increasing the expression of the β subunit of CK2, of inducing a relocalization of this subunit at the plasma membrane, of inducing nuclear translocation of the α subunit and of increasing CK2 activity.  Three inhibitors of this kinase, DRB (5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole), TBB (4,5,6,7-tetrabromotriazole) and apigenin, as well as overexpression of a partial dominant neg. mutant of CK2α, were shown to inhibit HIF-1 activity as measured by a reporter assay and through hypoxia-induced VEGF and aldolase expression.  This does not occur at the stabilization process since they did not affect HIF-1α protein level.  DNA-binding activity was also not inhibited.  We conclude that CK2 is an important regulator of HIF-1 transcriptional activity but the mechanism of this regulation remains to be detd.  Since HIF-1 plays a major role in tumor angiogenesis and since CK2 has been described to be overexpressed in tumor cells, this new pathway of regulation can be one more way for tumor cells to survive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNBUuSy-fVrLVg90H21EOLACvtfcHk0lhUe0odnIj65A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsbbP&md5=3c2c35b3ee77a4bff73e14a34f3fbec0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fijc.21268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21268%26sid%3Dliteratum%253Aachs%26aulast%3DMottet%26aufirst%3DD.%26aulast%3DRuys%26aufirst%3DS.%2BP.%26aulast%3DDemazy%26aufirst%3DC.%26aulast%3DRaes%26aufirst%3DM.%26aulast%3DMichiels%26aufirst%3DC.%26atitle%3DRole%2520for%2520casein%2520kinase%25202%2520in%2520the%2520regulation%2520of%2520HIF-1%2520activity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D117%26issue%3D5%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustolon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertacchini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmiroli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=6915-6926&author=G.+Di+Mairaauthor=F.+Brustolonauthor=J.+Bertacchiniauthor=K.+Tosoniauthor=S.+Marmiroliauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Pharmacological+inhibition+of+protein+kinase+CK2+reverts+the+multidrug+resistance+phenotype+of+a+CEM+cell+line+characterized+by+high+CK2+level"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DBertacchini%26aufirst%3DJ.%26aulast%3DTosoni%26aufirst%3DK.%26aulast%3DMarmiroli%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DPharmacological%2520inhibition%2520of%2520protein%2520kinase%2520CK2%2520reverts%2520the%2520multidrug%2520resistance%2520phenotype%2520of%2520a%2520CEM%2520cell%2520line%2520characterized%2520by%2520high%2520CK2%2520level%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D6915%26epage%3D6926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimelis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">–</span> <span class="NLM_lpage">3356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=3349-3356&author=Y.+Xieauthor=K.+Xuauthor=D.+E.+Linnauthor=X.+Yangauthor=Z.+Guoauthor=H.+Shimelisauthor=T.+Nakanishiauthor=D.+D.+Rossauthor=H.+Chenauthor=L.+Fazliauthor=M.+E.+Gleaveauthor=Y.+Qiu&title=The+44-kDa+Pim-1+kinase+phosphorylates+BCRP%2FABCG2+and+thereby+promotes+its+multimerization+and+drug-resistant+activity+in+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLinn%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DShimelis%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DFazli%26aufirst%3DL.%26aulast%3DGleave%26aufirst%3DM.%2BE.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DThe%252044-kDa%2520Pim-1%2520kinase%2520phosphorylates%2520BCRP%252FABCG2%2520and%2520thereby%2520promotes%2520its%2520multimerization%2520and%2520drug-resistant%2520activity%2520in%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D3349%26epage%3D3356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, E. N.</span><span> </span><span class="NLM_article-title">A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=156-166&author=Y.+Zhengauthor=H.+Qinauthor=S.+J.+Frankauthor=L.+Dengauthor=D.+W.+Litchfieldauthor=A.+Tefferiauthor=A.+Pardananiauthor=F.+T.+Linauthor=J.+Liauthor=B.+Shaauthor=E.+N.+Benveniste&title=A+CK2-dependent+mechanism+for+activation+of+the+JAK-STAT+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSha%26aufirst%3DB.%26aulast%3DBenveniste%26aufirst%3DE.%2BN.%26atitle%3DA%2520CK2-dependent%2520mechanism%2520for%2520activation%2520of%2520the%2520JAK-STAT%2520signaling%2520pathway%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D156%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Miyata, Y.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11–12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1007%2Fs00018-009-9152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19387550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1840-1849&issue=11%E2%80%9312&author=Y.+Miyata&title=Protein+kinase+CK2+in+health+and+disease%3A+CK2%3A+the+kinase+controlling+the+Hsp90+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CK2: the kinase controlling the Hsp90 chaperone machinery</span></div><div class="casAuthors">Miyata, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1840-1849</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells.  Hsp90 is a major mol. chaperone that is required for the folding and function of its client proteins.  A complex contg. Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37.  Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions.  Here, crit. roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described.  CK2 phosphorylates and modulates Hsp90 and its co-chaperones, FKBP52 and Cdc37.  CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases.  The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW2ZhBoll7aLVg90H21EOLACvtfcHk0lhUe0odnIj65A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D&md5=b4447a54564fde9c88ba6ab0b5b22e90</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9152-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520health%2520and%2520disease%253A%2520CK2%253A%2520the%2520kinase%2520controlling%2520the%2520Hsp90%2520chaperone%2520machinery%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2580%259312%26spage%3D1840%26epage%3D1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span> </span><span class="NLM_article-title">Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13728</span><span class="NLM_x">–</span> <span class="NLM_lpage">13734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13728-13734&author=M.+D.+Jacobsauthor=J.+Blackauthor=O.+Futerauthor=L.+Swensonauthor=B.+Hareauthor=M.+Flemingauthor=K.+Saxena&title=Pim-1+ligand-bound+structures+reveal+the+mechanism+of+serine%2Fthreonine+kinase+inhibition+by+LY294002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%26aulast%3DFuter%26aufirst%3DO.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DHare%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26atitle%3DPim-1%2520ligand-bound%2520structures%2520reveal%2520the%2520mechanism%2520of%2520serine%252Fthreonine%2520kinase%2520inhibition%2520by%2520LY294002%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13728%26epage%3D13734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandiyan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span> </span><span class="NLM_article-title">Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2005&pages=183-193&author=A.+Kumarauthor=V.+Mandiyanauthor=Y.+Suzukiauthor=C.+Zhangauthor=J.+Riceauthor=J.+Tsaiauthor=D.+R.+Artisauthor=P.+Ibrahimauthor=R.+Bremer&title=Crystal+structures+of+proto-oncogene+kinase+Pim1%3A+a+target+of+aberrant+somatic+hypermutations+in+diffuse+large+cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DMandiyan%26aufirst%3DV.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DBremer%26aufirst%3DR.%26atitle%3DCrystal%2520structures%2520of%2520proto-oncogene%2520kinase%2520Pim1%253A%2520a%2520target%2520of%2520aberrant%2520somatic%2520hypermutations%2520in%2520diffuse%2520large%2520cell%2520lymphoma%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D348%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptiste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1107%2FS1744309104029963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16508102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=96-99&author=K.+C.+Qianauthor=J.+Studtsauthor=L.+Wangauthor=K.+Barringerauthor=A.+Kronkaitisauthor=C.+Pengauthor=A.+Baptisteauthor=R.+LaFranceauthor=S.+Mischeauthor=B.+Farmer&title=Expression%2C+purification%2C+crystallization+and+preliminary+crystallographic+analysis+of+human+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase</span></div><div class="casAuthors">Qian, Kevin C.; Studts, Joey; Wang, Lian; Barringer, Kevin; Kronkaitis, Anthony; Peng, Charline; Baptiste, Alistair; LaFrance, Roger; Mische, Sheenah; Farmer, Bennett</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">F61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Pim kinases, including Pim-1, Pim-2, and Pim-3, belong to a distinctive serine/threonine protein kinase family.  They are involved in cytokine-induced signal transduction and the development of lymphoid malignancies.  Their kinase domains are highly homologous to one another, but share low sequence identity to other kinases.  Specifically, there are 2 Pro residues in the conserved hinge-region sequence ERPXPX sepd. by a residue that is non-conserved among Pim kinases.  Here, full-length human Pim-1 kinase (1-313) was cloned and expressed in Escherichia coli as a GST-fusion protein and truncated to Pim-1 (14-313) by thrombin digestion during purifn.  The Pim-1 (14-313) protein was purified to high homogeneity and monodispersity.  This protein prepn. yielded small crystals in the initial screening and large crystals after optimization.  The large crystals of apo Pim-1 kinase diffracted to 2.1 Å resoln. and belonged to space group P65, with unit-cell parameters a = b = 95.9, c = 80.0 Å, β = 120° and one mol. per asym. unit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLbLQgcrPUrVg90H21EOLACvtfcHk0liSpO_cqQdaJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVGnsg%253D%253D&md5=4cfe5a9f248a6699287f9a96c627f4ac</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS1744309104029963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309104029963%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DBaptiste%26aufirst%3DA.%26aulast%3DLaFrance%26aufirst%3DR.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DExpression%252C%2520purification%252C%2520crystallization%2520and%2520preliminary%2520crystallographic%2520analysis%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2005%26volume%3D61%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">6130</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6130-6137&author=K.+C.+Qianauthor=L.+Wangauthor=E.+R.+Hickeyauthor=J.+Studtsauthor=K.+Barringerauthor=C.+Pengauthor=A.+Kronkaitisauthor=J.+Liauthor=A.+Whiteauthor=S.+Mischeauthor=B.+Farmer&title=Structural+basis+of+constitutive+activity+and+a+unique+nucleotide+binding+mode+of+human+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520constitutive%2520activity%2520and%2520a%2520unique%2520nucleotide%2520binding%2520mode%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D6130%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Delft, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7112&issue=10&author=A.+N.+Bullockauthor=S.+Russoauthor=A.+Amosauthor=N.+Paganoauthor=H.+Bregmanauthor=J.+E.+Debreczeniauthor=W.+H.+Leeauthor=F.+von+Delftauthor=E.+Meggersauthor=S.+Knapp&title=Crystal+structure+of+the+PIM2+kinase+in+complex+with+an+organoruthenium+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DAmos%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DN.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3Dvon%2BDelft%26aufirst%3DF.%26aulast%3DMeggers%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520PIM2%2520kinase%2520in%2520complex%2520with%2520an%2520organoruthenium%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magboo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1814</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801242y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1814-1827&issue=7&author=K.+Qianauthor=L.+Wangauthor=C.+L.+Cywinauthor=B.+T.+Farmerauthor=E.+Hickeyauthor=C.+Homonauthor=S.+Jakesauthor=M.+A.+Kashemauthor=G.+Leeauthor=S.+Leonardauthor=J.+Liauthor=R.+Magbooauthor=W.+Maoauthor=E.+Packauthor=C.+Pengauthor=A.+Prokopowiczauthor=M.+Welzelauthor=J.+Wolakauthor=T.+Morwick&title=Hit+to+lead+account+of+the+discovery+of+a+new+class+of+inhibitors+of+Pim+kinases+and+crystallographic+studies+revealing+an+unusual+kinase+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm801242y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801242y%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DFarmer%26aufirst%3DB.%2BT.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DHomon%26aufirst%3DC.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMagboo%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DProkopowicz%26aufirst%3DA.%26aulast%3DWelzel%26aufirst%3DM.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DHit%2520to%2520lead%2520account%2520of%2520the%2520discovery%2520of%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520Pim%2520kinases%2520and%2520crystallographic%2520studies%2520revealing%2520an%2520unusual%2520kinase%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D7%26spage%3D1814%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3171-3185&author=M.+Lopez-Ramosauthor=R.+Prudentauthor=V.+Moucadelauthor=C.+F.+Sautelauthor=C.+Baretteauthor=L.+Lafanechereauthor=L.+Mouawadauthor=D.+Griersonauthor=F.+Schmidtauthor=J.+C.+Florentauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=S.+Knappauthor=J.+B.+Reiserauthor=C.+Cochet&title=New+potent+dual+inhibitors+of+CK2+and+Pim+kinases%3A+discovery+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DJ.%2BB.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%253A%2520discovery%2520and%2520structural%2520insights%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3171%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3327-3331&author=F.+Pierreauthor=C.+F.+Reganauthor=M.+C.+Chevrelauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=W.+G.+Riceauthor=D.+M.+Ryckman&title=Novel+potent+dual+inhibitors+of+CK2+and+Pim+kinases+with+antiproliferative+activity+against+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DChevrel%26aufirst%3DM.%2BC.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3DNovel%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%2520with%2520antiproliferative%2520activity%2520against%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3327%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danilenko, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.2174%2F092986710793348554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20939820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=4114-4133&author=F.+Anizonauthor=A.+A.+Shtilauthor=V.+N.+Danilenkoauthor=P.+Moreau&title=Fighting+tumor+cell+survival%3A+advances+in+the+design+and+evaluation+of+Pim+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fighting tumor cell survival: advances in the design and evaluation of pim inhibitors</span></div><div class="casAuthors">Anizon, F.; Shtil, A. A.; Danilenko, V. N.; Moreau, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">4114-4133</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Pim (provirus insertion site of Moloney murine leukemia virus) family of serine/threonine protein kinases possesses the fundamental characteristics crit. for the biol. of eukaryotes, in particular, survival and malignant transformation of cells.  The members of this protein family (Pim-1 to Pim-3) are aberrantly expressed in human tumors, most frequently in prostate cancer and hematol. malignancies.  Therefore, Pim proteins are widely considered as attractive targets in cancer chemotherapy.  Growing knowledge of mechanisms of Pim-mediated anti-apoptosis and transformation, as well as rapid progress in the design of Pim-modulating compds. dictate the need for an in-depth anal. of the chem. of inhibitors and the modes of their interaction with these protein kinases.  This review summarizes recent advances in understanding the mol. events regulated by Pim proteins.  In addn., we focus on the non-patent literature (mostly since 2005) that demonstrates a diversity of chem. classes of small mol. wt. Pim inhibitors.  The X-ray co-crystal structures of complexes Pim:inhibitor provide evidence for SAR data important for the choice of synthetic routes, optimization of lead compds. and testing chem. libraries.  We also discuss a cell-based test system useful for rapid and inexpensive pre-screening of compds. capable of preventing Pim-mediated phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiicnOer8gErVg90H21EOLACvtfcHk0lihP7Ap1oajfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgtbbK&md5=7d05b928cf825cfa54b00ba2f015e85d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F092986710793348554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793348554%26sid%3Dliteratum%253Aachs%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DShtil%26aufirst%3DA.%2BA.%26aulast%3DDanilenko%26aufirst%3DV.%2BN.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DFighting%2520tumor%2520cell%2520survival%253A%2520advances%2520in%2520the%2520design%2520and%2520evaluation%2520of%2520Pim%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D4114%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">Pim kinase inhibitors: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1517%2F13543770903496442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20100002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=193-212&issue=2&author=T.+Morwick&title=Pim+kinase+inhibitors%3A+a+survey+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinase inhibitors: a survey of the patent literature</span></div><div class="casAuthors">Morwick, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Pim kinases have recently emerged as targets of interest in oncol. and immune regulation.  Ongoing studies have identified a role for these proteins in cell survival and proliferation, both functionally and mechanistically, and overexpression has been obsd. in a no. of human cancers and inflammatory states.  Areas covered in this review: This report reviews the patent literature for Pim kinase inhibitors identified from a search of the Thomson patent databases from 1970 through July 2009.  Full analyses are provided for publications reporting Pim kinases as primary targets, and a cursory description is given for those disclosing Pim as one of a limited no. of secondary targets.  What the reader will gain: Readers will gain an overview of the various inhibitor series including coverage, potency, selectivity, protein binding features and therapeutic focus, and an appreciation for which scaffolds and structural features have been most highly exploited.  Take home message: A greater understanding of pathol. mechanisms for Pim kinases has stimulated the recent development of a variety of inhibitor classes with one compd. advancing into the clinic earlier this year.  Ongoing studies will help define applications for these inhibitors in the treatment of Pim-assocd. human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qJ9wz2Tau7Vg90H21EOLACvtfcHk0lgQ0oCqe7oiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D&md5=21d9c3c31b2af04e63bef9ac5adaf549</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F13543770903496442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903496442%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DPim%2520kinase%2520inhibitors%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D193%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tao, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span> </span><span class="NLM_article-title">Discovery of 3<i>H</i>-benzo[4,5]thieno[3,2-<i>d</i>]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900943h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6621-6636&issue=21&author=Z.+F.+Taoauthor=L.+A.+Hasvoldauthor=J.+D.+Leversonauthor=E.+K.+Hanauthor=R.+Guanauthor=E.+F.+Johnsonauthor=V.+S.+Stollauthor=K.+D.+Stewartauthor=G.+Stamperauthor=N.+Soniauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=T.+J.+Sowinauthor=N.+H.+Linauthor=V.+S.+Girandaauthor=S.+H.+Rosenbergauthor=T.+D.+Penning&title=Discovery+of+3H-benzo%5B4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-ones+as+potent%2C+highly+selective%2C+and+orally+bioavailable+inhibitors+of+the+human+protooncogene+proviral+insertion+site+in+moloney+murine+leukemia+virus+%28PIM%29+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm900943h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900943h%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStamper%26aufirst%3DG.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DGiranda%26aufirst%3DV.%2BS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520of%25203H-benzo%255B4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-ones%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520human%2520protooncogene%2520proviral%2520insertion%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520%2528PIM%2529%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D21%26spage%3D6621%26epage%3D6636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V.</span><span> </span><span class="NLM_article-title">Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=4150-4157&author=L.+S.+Chenauthor=S.+Redkarauthor=D.+Bearssauthor=W.+G.+Wierdaauthor=V.+Gandhi&title=Pim+kinase+inhibitor%2C+SGI-1776%2C+induces+apoptosis+in+chronic+lymphocytic+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DPim%2520kinase%2520inhibitor%252C%2520SGI-1776%252C%2520induces%2520apoptosis%2520in%2520chronic%2520lymphocytic%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D4150%26epage%3D4157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mumenthaler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanekal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1158%2F1535-7163.MCT-09-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19825806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2882-2893&author=S.+M.+Mumenthalerauthor=P.+Y.+Ngauthor=A.+Hodgeauthor=D.+Bearssauthor=G.+Berkauthor=S.+Kanekalauthor=S.+Redkarauthor=P.+Tavernaauthor=D.+B.+Agusauthor=A.+Jain&title=Pharmacologic+inhibition+of+Pim+kinases+alters+prostate+cancer+cell+growth+and+resensitizes+chemoresistant+cells+to+taxanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span></div><div class="casAuthors">Mumenthaler, Shannon M.; Ng, Patricia Y. B.; Hodge, Amanda; Bearss, David; Berk, Gregory; Kanekal, Sarath; Redkar, Sanjeev; Taverna, Pietro; Agus, David B.; Jain, Anjali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2882-2893</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine family of Pim kinases function as oncogenes and have been implicated in prostate cancer progression, particularly in hormone-refractory prostate disease, as a result of their antiapoptotic function.  In this study, we used a pharmacol. inhibitor targeting the Pim family members, SGI-1776, to det. whether modulation of Pim kinase activity could alter prostate cancer cell survival and modulate chemotherapy resistance.  Extensive biochem. characterization of SGI-1776 confirmed its specificity for the three isoforms of the Pim family.  Treatment of prostate cancer cells with SGI-1776 resulted in a dose-dependent redn. in phosphorylation of known Pim kinase substrates that are involved in cell cycle progression and apoptosis (p21Cip1/WAF1 and Bad).  Consequently, SGI-1776 compromised overall cell viability by inducing G1 cell cycle arrest and triggering apoptosis.  Overexpression of recombinant Pim-1 markedly increased sensitivity of SGI-1776-mediated prostate cancer cell apoptosis and p21Cip1/WAF1 phosphorylation inhibition, reinforcing the specificity of SGI-1776.  An addnl. cytotoxic effect was obsd. when SGI-1776 was combined with taxane-based chemotherapy agents.  SGI-1776 was able to reduce cell viability in a multidrug resistance 1 protein-based taxane-refractory prostate cancer cell line.  In addn., SGI-1776 treatment was able to resensitize chemoresistant cells to taxane-based therapies by inhibiting multidrug resistance 1 activity and inducing apoptosis.  These findings support the idea that inhibiting Pim kinases, in combination with a chemotherapeutic agent, could play an important role in prostate cancer treatment by targeting the clin. problem of chemoresistance. [Mol Cancer Ther 2009;8(10):2882-93].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGQXKbXm4Y7Vg90H21EOLACvtfcHk0lgQ0oCqe7oiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E&md5=b6353cdc3b367e336a707147e5c99a4c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0293%26sid%3Dliteratum%253Aachs%26aulast%3DMumenthaler%26aufirst%3DS.%2BM.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DHodge%26aufirst%3DA.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DBerk%26aufirst%3DG.%26aulast%3DKanekal%26aufirst%3DS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DJain%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520Pim%2520kinases%2520alters%2520prostate%2520cancer%2520cell%2520growth%2520and%2520resensitizes%2520chemoresistant%2520cells%2520to%2520taxanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2882%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Pogacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Monard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">Structural analysis identifies imidazo[1,2-<i>b</i>]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6916</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6916-6924&author=V.+Pogacicauthor=A.+N.+Bullockauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=C.+Gasserauthor=A.+Biondiauthor=S.+Meyer-Monardauthor=S.+Knappauthor=J.+Schwaller&title=Structural+analysis+identifies+imidazo%5B1%2C2-b%5Dpyridazines+as+PIM+kinase+inhibitors+with+in+vitro+antileukemic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPogacic%26aufirst%3DV.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBiondi%26aufirst%3DA.%26aulast%3DMeyer-Monard%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DStructural%2520analysis%2520identifies%2520imidazo%255B1%252C2-b%255Dpyridazines%2520as%2520PIM%2520kinase%2520inhibitors%2520with%2520in%2520vitro%2520antileukemic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6916%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Siu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongstra, J.</span><span> </span><span class="NLM_article-title">PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1134-1144&author=A.+Siuauthor=C.+Virtanenauthor=J.+Jongstra&title=PIM+kinase+isoform+specific+regulation+of+MIG6+expression+and+EGFR+signaling+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DA.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DJongstra%26aufirst%3DJ.%26atitle%3DPIM%2520kinase%2520isoform%2520specific%2520regulation%2520of%2520MIG6%2520expression%2520and%2520EGFR%2520signaling%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1134%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mahalingam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivel, J. A.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawrocki, S. T.</span><span> </span><span class="NLM_article-title">Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fbjc.2011.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22015557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=1563-1573&author=D.+Mahalingamauthor=C.+M.+Espitiaauthor=E.+C.+Medinaauthor=J.+A.+Esquivelauthor=K.+R.+Kellyauthor=D.+Bearssauthor=G.+Choyauthor=P.+Tavernaauthor=J.+S.+Carewauthor=F.+J.+Gilesauthor=S.+T.+Nawrocki&title=Targeting+PIM+kinase+enhances+the+activity+of+sunitinib+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma</span></div><div class="casAuthors">Mahalingam, D.; Espitia, C. M.; Medina, E. C.; Esquivel, J. A., II; Kelly, K. R.; Bearss, D.; Choy, G.; Taverna, P.; Carew, J. S.; Giles, F. J.; Nawrocki, S. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1563-1573</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Upregulation of PIM kinase expression has been reported in many malignancies, suggesting that inhibition of PIM kinase activity may be an attractive therapeutic strategy.  We hypothesised that inhibition of PIM kinase activity with SGI-1776, a novel small mol. inhibitor of PIM kinase activity, would reduce the viability of renal cell carcinoma (RCC) cells and enhance the activity of sunitinib.  Methods: Immunoblotting, qRT-PCR, and gene expression arrays were carried out to identify genes modulated by SGI-1776 treatment.  The anticancer activity of SGI-1776 and sunitinib was detd. by viability and apoptosis assays and in tumor xenografts in vivo.  Results: Treatment with SGI-1776 led to a decrease in phosphorylated and total c-Myc levels, which resulted in the modulation of c-Myc target genes.  SGI-1776 in combination with sunitinib induced a further redn. in c-Myc levels, which was assocd. with enhanced anticancer activity. siRNA-mediated knockdown of c-Myc demonstrated that its expression has a key role in regulating the sensitivity to the combination of SGI-1776 and sunitinib.  Importantly, the combination significantly reduced tumor burden in two RCC xenograft models compared with single-agent therapy and was very well tolerated.  Conclusion: These data indicate that targeting PIM kinase signalling is a promising treatment strategy for RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHfOk11dbA8rVg90H21EOLACvtfcHk0lifHW8rmHlCjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrzO&md5=822d95590ce777e0e17efb7615344352</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.426%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DEspitia%26aufirst%3DC.%2BM.%26aulast%3DMedina%26aufirst%3DE.%2BC.%26aulast%3DEsquivel%26aufirst%3DJ.%2BA.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DChoy%26aufirst%3DG.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DNawrocki%26aufirst%3DS.%2BT.%26atitle%3DTargeting%2520PIM%2520kinase%2520enhances%2520the%2520activity%2520of%2520sunitinib%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D1563%26epage%3D1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Chen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V.</span><span> </span><span class="NLM_article-title">Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=693-702&author=L.+S.+Chenauthor=S.+Redkarauthor=P.+Tavernaauthor=J.+E.+Cortesauthor=V.+Gandhi&title=Mechanisms+of+cytotoxicity+to+Pim+kinase+inhibitor%2C+SGI-1776%2C+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520cytotoxicity%2520to%2520Pim%2520kinase%2520inhibitor%252C%2520SGI-1776%252C%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D693%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hospital, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span> </span><span class="NLM_article-title">The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1791-1792&author=M.+A.+Hospitalauthor=A.+S.+Greenauthor=C.+Lacombeauthor=P.+Mayeuxauthor=D.+Bouscaryauthor=J.+Tamburini&title=The+FLT3+and+Pim+kinases+inhibitor+SGI-1776+preferentially+target+FLT3-ITD+AML+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHospital%26aufirst%3DM.%2BA.%26aulast%3DGreen%26aufirst%3DA.%2BS.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DBouscary%26aufirst%3DD.%26aulast%3DTamburini%26aufirst%3DJ.%26atitle%3DThe%2520FLT3%2520and%2520Pim%2520kinases%2520inhibitor%2520SGI-1776%2520preferentially%2520target%2520FLT3-ITD%2520AML%2520cells%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D1791%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1759-1767&author=K.+T.+Kimauthor=K.+Bairdauthor=J.+Y.+Ahnauthor=P.+Meltzerauthor=M.+Lillyauthor=M.+Levisauthor=D.+Small&title=Pim-1+is+up-regulated+by+constitutively+activated+FLT3+and+plays+a+role+in+FLT3-mediated+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DBaird%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BY.%26aulast%3DMeltzer%26aufirst%3DP.%26aulast%3DLilly%26aufirst%3DM.%26aulast%3DLevis%26aufirst%3DM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DPim-1%2520is%2520up-regulated%2520by%2520constitutively%2520activated%2520FLT3%2520and%2520plays%2520a%2520role%2520in%2520FLT3-mediated%2520cell%2520survival%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D1759%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Constitutively activated FLT3 phosphorylates BAD partially through pim-1</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1111%2Fj.1365-2141.2006.06225.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16869825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWlu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2006&pages=500-509&author=K.+T.+Kimauthor=M.+Levisauthor=D.+Small&title=Constitutively+activated+FLT3+phosphorylates+BAD+partially+through+pim-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutively activated FLT3 phosphorylates BAD partially through Pim-1</span></div><div class="casAuthors">Kim, Kyu-Tae; Levis, Mark; Small, Donald</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-509</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Constitutively activating internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) play an important role in leukemogenesis and their presence is assocd. with a poor prognosis in acute myeloid leukemia (AML).  Examg. the anti- and pro-apoptotic proteins in constitutively activated FLT3 signaling in BaF3/ITD and MV4-11 cells, we found that the level of Bcl-2 antagonist of cell death (BAD) phosphorylation was greatly decreased in response to FLT3 inhibition.  Both Ser-112 and Ser-136 of BAD are rapidly dephosphorylated after treatment with the FLT3 inhibitor CEP-701 in BaF3/ITD and MV4-11 cells.  In confirmation of the cell line data, BAD was highly phosphorylated in both constitutively activated wild-type and mutant FLT3 primary AML samples, and rapidly dephosphorylated after treatment of the primary samples with CEP-701.  Upstream proteins known to phosphorylate BAD include Akt, extracellular signal-regulated kinase/mitogen-activated protein kinase (Erk/MAPK), Pim-1 and Pim-2.  We and other groups have shown that constitutively activated FLT3 induces multiple signaling pathways, including phosphatidylinositol 3-kinase (PI3K)/Akt, Erk/MAPK and Janus kinase/signal transducers and activators of transcription (Jak/STAT).  Thus, BAD may be a nexus point upon which these multiple signaling pathways converge in FLT3-mediated cell survival.  In support of this, siRNA knockdown of BAD expression in MV4-11 cells conferred resistance to CEP-701-mediated apoptosis.  Our data suggests that Pim-1 is one of the principal kinases mediating the anti-apoptotic function of FLT3/ITD signaling via the phosphorylation of BAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonz5rNZxqqDrVg90H21EOLACvtfcHk0ljgJe3oovqOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWlu7vO&md5=013ab27ae219a6cf4659e48b1acdc45e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.06225.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.06225.x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DLevis%26aufirst%3DM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DConstitutively%2520activated%2520FLT3%2520phosphorylates%2520BAD%2520partially%2520through%2520pim-1%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2006%26volume%3D134%26spage%3D500%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Pastor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajenjo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarran, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebrian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrionero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fominaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span> </span><span class="NLM_article-title">Hit to lead evaluation of 1,2,3-triazolo[4,5-<i>b</i>]pyridines as PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1591-1597&author=J.+Pastorauthor=J.+Oyarzabalauthor=G.+Salusteauthor=R.+M.+Alvarezauthor=V.+Riveroauthor=F.+Ramosauthor=E.+Cendonauthor=C.+Blanco-Aparicioauthor=N.+Ajenjoauthor=A.+Cebriaauthor=M.+I.+Albarranauthor=D.+Cebrianauthor=A.+Corrioneroauthor=J.+Fominayaauthor=G.+Montoyaauthor=M.+Mazzorana&title=Hit+to+lead+evaluation+of+1%2C2%2C3-triazolo%5B4%2C5-b%5Dpyridines+as+PIM+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DSaluste%26aufirst%3DG.%26aulast%3DAlvarez%26aufirst%3DR.%2BM.%26aulast%3DRivero%26aufirst%3DV.%26aulast%3DRamos%26aufirst%3DF.%26aulast%3DCendon%26aufirst%3DE.%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DAjenjo%26aufirst%3DN.%26aulast%3DCebria%26aufirst%3DA.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DCebrian%26aufirst%3DD.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DMontoya%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26atitle%3DHit%2520to%2520lead%2520evaluation%2520of%25201%252C2%252C3-triazolo%255B4%252C5-b%255Dpyridines%2520as%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1591%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Fathi, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arowojolu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkhowa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmsater, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span> </span><span class="NLM_article-title">A potential therapeutic target for FLT3-ITD AML: PIM1 kinase</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.leukres.2011.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21802138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=224-231&author=A.+T.+Fathiauthor=O.+Arowojoluauthor=I.+Swinnenauthor=T.+Satoauthor=T.+Rajkhowaauthor=D.+Smallauthor=F.+Marmsaterauthor=J.+E.+Robinsonauthor=S.+D.+Grossauthor=M.+Martinsonauthor=S.+Allenauthor=N.+C.+Kallanauthor=M.+Levis&title=A+potential+therapeutic+target+for+FLT3-ITD+AML%3A+PIM1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A potential therapeutic target for FLT3-ITD AML: PIM1 kinase</span></div><div class="casAuthors">Fathi, Amir T.; Arowojolu, Omotayo; Swinnen, Ian; Sato, Takashi; Rajkhowa, Trivikram; Small, Donald; Marmsater, Fredrik; Robinson, John E.; Gross, Stefan David; Martinson, Matthew; Allen, Shelley; Kallan, Nicholas C.; Levis, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-231</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Patients with acute myeloid leukemia (AML) and a FLT3 internal tandem duplication (ITD) mutation have a poor prognosis, and FLT3 inhibitors are now under clin. investigation.  PIM1, a serine/threonine kinase, is up-regulated in FLT3-ITD AML and may be involved in FLT3-mediated leukemogenesis.  We employed a PIM1 inhibitor, AR00459339 (Array Biopharma Inc.), to investigate the effect of PIM1 inhibition in FLT3-mutant AML.  Like FLT3 inhibitors, AR00459339 was preferentially cytotoxic to FLT3-ITD cells, as demonstrated in the MV4-11, Molm-14, and TF/ITD cell lines, as well as 12 FLT3-ITD primary samples.  Unlike FLT3 inhibitors, AR00459339 did not suppress phosphorylation of FLT3, but did promote the de-phosphorylation of downstream FLT3 targets, STAT5, AKT, and BAD.  Combining AR00459339 with a FLT3 inhibitor resulted in additive to mildly synergistic cytotoxic effects.  AR00459339 was cytotoxic to FLT3-ITD samples from patients with secondary resistance to FLT3 inhibitors, suggesting a novel benefit to combining these agents.  We conclude that PIM1 appears to be closely assocd. with FLT3 signaling, and that inhibition of PIM1 may hold therapeutic promise, either as monotherapy, or by overcoming resistance to FLT3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBBVHeB4yqFbVg90H21EOLACvtfcHk0ljgJe3oovqOeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVemtQ%253D%253D&md5=e7430db23fe996d45fe6a0a55ec040b3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2011.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2011.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DArowojolu%26aufirst%3DO.%26aulast%3DSwinnen%26aufirst%3DI.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DRajkhowa%26aufirst%3DT.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DMarmsater%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DS.%2BD.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DA%2520potential%2520therapeutic%2520target%2520for%2520FLT3-ITD%2520AML%253A%2520PIM1%2520kinase%26jtitle%3DLeuk.%2520Res.%26date%3D2012%26volume%3D36%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmussen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemann, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jancsics, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoulis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepp, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R. R.</span><span> </span><span class="NLM_article-title">The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3050-3056&author=Y.+Xiangauthor=B.+Hirthauthor=G.+Asmussenauthor=H.+P.+Biemannauthor=K.+A.+Bishopauthor=A.+Goodauthor=M.+Fitzgeraldauthor=T.+Gladyshevaauthor=A.+Jainauthor=K.+Jancsicsauthor=J.+Liuauthor=M.+Metzauthor=A.+Papoulisauthor=R.+Skerljauthor=J.+D.+Steppauthor=R.+R.+Wei&title=The+discovery+of+novel+benzofuran-2-carboxylic+acids+as+potent+Pim-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DAsmussen%26aufirst%3DG.%26aulast%3DBiemann%26aufirst%3DH.%2BP.%26aulast%3DBishop%26aufirst%3DK.%2BA.%26aulast%3DGood%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DJancsics%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DPapoulis%26aufirst%3DA.%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DStepp%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DR.%2BR.%26atitle%3DThe%2520discovery%2520of%2520novel%2520benzofuran-2-carboxylic%2520acids%2520as%2520potent%2520Pim-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3050%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span> </span><span class="NLM_article-title">7,8-Dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201286z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=403-413&issue=1&author=K.+Huberauthor=L.+Braultauthor=O.+Fedorovauthor=C.+Gasserauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=D.+Fabbroauthor=J.+Trappeauthor=J.+Schwallerauthor=S.+Knappauthor=F.+Bracher&title=7%2C8-Dichloro-1-oxo-beta-carbolines+as+a+versatile+scaffold+for+the+development+of+potent+and+selective+kinase+inhibitors+with+unusual+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm201286z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201286z%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBracher%26aufirst%3DF.%26atitle%3D7%252C8-Dichloro-1-oxo-beta-carbolines%2520as%2520a%2520versatile%2520scaffold%2520for%2520the%2520development%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520with%2520unusual%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D1%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Akue-Gedu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letribot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saugues, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-<i>a</i>]carbazole derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3807</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3807-3809&author=R.+Akue-Geduauthor=B.+Letribotauthor=E.+Sauguesauthor=E.+Debitonauthor=F.+Anizonauthor=P.+Moreau&title=Kinase+inhibitory+potencies+and+in+vitro+antiproliferative+activities+of+N-10+substituted+pyrrolo%5B2%2C3-a%5Dcarbazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkue-Gedu%26aufirst%3DR.%26aulast%3DLetribot%26aufirst%3DB.%26aulast%3DSaugues%26aufirst%3DE.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DKinase%2520inhibitory%2520potencies%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520N-10%2520substituted%2520pyrrolo%255B2%252C3-a%255Dcarbazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3807%26epage%3D3809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Nakano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuganezawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Rational evolution of a novel type of potent and selective proviral integration site in moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3001289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5151-5164&issue=11&author=H.+Nakanoauthor=N.+Saitoauthor=L.+Parkerauthor=Y.+Tadaauthor=M.+Abeauthor=K.+Tsuganezawaauthor=S.+Yokoyamaauthor=A.+Tanakaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Rational+evolution+of+a+novel+type+of+potent+and+selective+proviral+integration+site+in+moloney+murine+leukemia+virus+kinase+1+%28PIM1%29+inhibitor+from+a+screening-hit+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm3001289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001289%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DN.%26aulast%3DParker%26aufirst%3DL.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DTsuganezawa%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DRational%2520evolution%2520of%2520a%2520novel%2520type%2520of%2520potent%2520and%2520selective%2520proviral%2520integration%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520kinase%25201%2520%2528PIM1%2529%2520inhibitor%2520from%2520a%2520screening-hit%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D5151%26epage%3D5164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Tsuhako, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcalas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">The design, synthesis, and biological evaluation of PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3732-3738&author=A.+L.+Tsuhakoauthor=D.+S.+Brownauthor=E.+S.+Koltunauthor=N.+Aayauthor=A.+Arcalasauthor=V.+Chanauthor=H.+Duauthor=S.+Engstauthor=M.+Franziniauthor=A.+Galanauthor=P.+Huangauthor=S.+Johnstonauthor=B.+Kaneauthor=M.+H.+Kimauthor=A.+D.+Lairdauthor=R.+Linauthor=L.+Mockauthor=I.+Nganauthor=M.+Packauthor=G.+Stottauthor=T.+J.+Stoutauthor=P.+Yuauthor=C.+Zahariaauthor=W.+Zhangauthor=P.+Zhouauthor=J.+M.+Nussauthor=P.+C.+Kearneyauthor=W.+Xu&title=The+design%2C+synthesis%2C+and+biological+evaluation+of+PIM+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuhako%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGalan%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DS.%26aulast%3DKane%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DNgan%26aufirst%3DI.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DStott%26aufirst%3DG.%26aulast%3DStout%26aufirst%3DT.%2BJ.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZaharia%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DKearney%26aufirst%3DP.%2BC.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3732%26epage%3D3738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lgl9NgSedEXLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaebe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafaelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darjania, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proffitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliesath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">Discovery of CX-6258. A potent, selective, and orally efficacious pan-Pim kinases inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200259q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=135-139&author=M.+Haddachauthor=J.+Michauxauthor=M.+K.+Schwaebeauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=C.+Borsanauthor=J.+Tranauthor=N.+Rafaelleauthor=S.+Ravulaauthor=D.+Dryginauthor=A.+Siddiqui-Jainauthor=L.+Darjaniaauthor=R.+Stansfieldauthor=C.+Proffittauthor=D.+Macalinoauthor=N.+Streinerauthor=J.+Bliesathauthor=M.+Omoriauthor=J.+P.+Whittenauthor=K.+Anderesauthor=W.+G.+Riceauthor=D.+M.+Ryckman&title=Discovery+of+CX-6258.+A+potent%2C+selective%2C+and+orally+efficacious+pan-Pim+kinases+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fml200259q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200259q%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBorsan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DRafaelle%26aufirst%3DN.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520of%2520CX-6258.%2520A%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520pan-Pim%2520kinases%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedellec, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">7-(4<i>H</i>-1,2,4-Triazol-3-yl)benzo[<i>c</i>][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6687</span><span class="NLM_x">–</span> <span class="NLM_lpage">6692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6687-6692&author=F.+Pierreauthor=E.+Stefanauthor=A.+S.+Nedellecauthor=M.+C.+Chevrelauthor=C.+F.+Reganauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=K.+Anderesauthor=D.+M.+Ryckman&title=7-%284H-1%2C2%2C4-Triazol-3-yl%29benzo%5Bc%5D%5B2%2C6%5Dnaphthyridines%3A+a+novel+class+of+Pim+kinase+inhibitors+with+potent+cell+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DNedellec%26aufirst%3DA.%2BS.%26aulast%3DChevrel%26aufirst%3DM.%2BC.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3D7-%25284H-1%252C2%252C4-Triazol-3-yl%2529benzo%255Bc%255D%255B2%252C6%255Dnaphthyridines%253A%2520a%2520novel%2520class%2520of%2520Pim%2520kinase%2520inhibitors%2520with%2520potent%2520cell%2520antiproliferative%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6687%26epage%3D6692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gross, S. D.; Robinson, J. E.; Allen, S.; Cox, A.; DeWolf, W. E.; Galbraith, S.; Lee, P.; Lemieux, C.; Lyssikatos, J. P.; Marmsater, F.; Martinson, M.; Munson, M. C.; Wallace, R. D.; Woessner, R.; Zuzack, J.; Winkler, J.; Koch, K.</span><span> </span><span class="NLM_article-title">Characterization of the Effects of Pim Kinase Inhibition on Multiple Oncogene-Driven Cell Lines</span>. Presented at the 50th Annual Meeting of the American Society of Hematology, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Gross&author=J.+E.+Robinson&author=S.+Allen&author=A.+Cox&author=W.+E.+DeWolf&author=S.+Galbraith&author=P.+Lee&author=C.+Lemieux&author=J.+P.+Lyssikatos&author=F.+Marmsater&author=M.+Martinson&author=M.+C.+Munson&author=R.+D.+Wallace&author=R.+Woessner&author=J.+Zuzack&author=J.+Winkler&author=K.+Koch&title=Characterization+of+the+Effects+of+Pim+Kinase+Inhibition+on+Multiple+Oncogene-Driven+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%2BD.%26atitle%3DCharacterization%2520of%2520the%2520Effects%2520of%2520Pim%2520Kinase%2520Inhibition%2520on%2520Multiple%2520Oncogene-Driven%2520Cell%2520Lines%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ebens, A. J.; Berry, L.; Chen, Y.-H.; Deshumkh, G.; Drummond, G.; Du, C.; Eby, M.; Fitzgerald, K.; Friedman, L. S.; Gould, S. E.; Kenny, J. R.; Maecker, H.; Moffat, J.; Moskalenko, M.; Pacheco, P.; Saadat, A.; Slaga, D.; Sun, L.; Wang, G.; Yang, Y.; Munugalavdla, V.</span><span> </span><span class="NLM_article-title">A Selective PIM Kinase Inhibitor Is Highly Active in Multiple Myeloma: The Biology of Single Agent and PI3K/AKT/mTOR Combination Activity</span>. Presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology, San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+J.+Ebens&author=L.+Berry&author=Y.-H.+Chen&author=G.+Deshumkh&author=G.+Drummond&author=C.+Du&author=M.+Eby&author=K.+Fitzgerald&author=L.+S.+Friedman&author=S.+E.+Gould&author=J.+R.+Kenny&author=H.+Maecker&author=J.+Moffat&author=M.+Moskalenko&author=P.+Pacheco&author=A.+Saadat&author=D.+Slaga&author=L.+Sun&author=G.+Wang&author=Y.+Yang&author=V.+Munugalavdla&title=A+Selective+PIM+Kinase+Inhibitor+Is+Highly+Active+in+Multiple+Myeloma%3A+The+Biology+of+Single+Agent+and+PI3K%2FAKT%2FmTOR+Combination+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26atitle%3DA%2520Selective%2520PIM%2520Kinase%2520Inhibitor%2520Is%2520Highly%2520Active%2520in%2520Multiple%2520Myeloma%253A%2520The%2520Biology%2520of%2520Single%2520Agent%2520and%2520PI3K%252FAKT%252FmTOR%2520Combination%2520Activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Czardybon, W.; Windak, R.; Krawczynska, K.; Zarebski, A.; Dolata, I.; Salwinska, M.; Surawska, M.; Sabiniarz, A.; Szamborska-Gbur, A.; Prymula, K.; Milik, M.; Kosowska-Wardega, A.; Trebacz, E.; Rsymski, T.; Kowalczyk, P.; Brzozka, K.</span><span> </span><span class="NLM_article-title">Development of Selective Pim Kinase Inhibitors for Cancer Treatment</span>. Presented at the 2012 Annual Meeting of the American Association for Cancer Research, Chicago, IL,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+Czardybon&author=R.+Windak&author=K.+Krawczynska&author=A.+Zarebski&author=I.+Dolata&author=M.+Salwinska&author=M.+Surawska&author=A.+Sabiniarz&author=A.+Szamborska-Gbur&author=K.+Prymula&author=M.+Milik&author=A.+Kosowska-Wardega&author=E.+Trebacz&author=T.+Rsymski&author=P.+Kowalczyk&author=K.+Brzozka&title=Development+of+Selective+Pim+Kinase+Inhibitors+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCzardybon%26aufirst%3DW.%26atitle%3DDevelopment%2520of%2520Selective%2520Pim%2520Kinase%2520Inhibitors%2520for%2520Cancer%2520Treatment%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Keeton, E.; McEachem, K.; Alimzhanov, M.; Wang, S.; Cao, Y.; Bao, L.; Palakurthi, S.; Grondine, M.; Chen, Y.; Dillman, K.; Chinnappan, D.; Shen, M.; Dakin, L.; Zheng, X.; Lamb, M.; Wu, A.; Chen, H.; Lyne, P.; Huszar, D.</span><span> </span><span class="NLM_article-title">Efficacy and Biomarker Modulation by AZD1208, a Novel, Potent and Selective Pan-Pim Kinase Inhibitor, in Models of Acute Meloid Leukemia</span>. Presented at the 2012 Annual Meeting of the American Association for Cancer Research, Chicaogo, IL,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=E.+Keeton&author=K.+McEachem&author=M.+Alimzhanov&author=S.+Wang&author=Y.+Cao&author=L.+Bao&author=S.+Palakurthi&author=M.+Grondine&author=Y.+Chen&author=K.+Dillman&author=D.+Chinnappan&author=M.+Shen&author=L.+Dakin&author=X.+Zheng&author=M.+Lamb&author=A.+Wu&author=H.+Chen&author=P.+Lyne&author=D.+Huszar&title=Efficacy+and+Biomarker+Modulation+by+AZD1208%2C+a+Novel%2C+Potent+and+Selective+Pan-Pim+Kinase+Inhibitor%2C+in+Models+of+Acute+Meloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKeeton%26aufirst%3DE.%26atitle%3DEfficacy%2520and%2520Biomarker%2520Modulation%2520by%2520AZD1208%252C%2520a%2520Novel%252C%2520Potent%2520and%2520Selective%2520Pan-Pim%2520Kinase%2520Inhibitor%252C%2520in%2520Models%2520of%2520Acute%2520Meloid%2520Leukemia%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=95-105&issue=Part+1&author=S.+P.+Daviesauthor=H.+Reddyauthor=M.+Caivanoauthor=P.+Cohen&title=Specificity+and+mechanism+of+action+of+some+commonly+used+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DH.%26aulast%3DCaivano%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DSpecificity%2520and%2520mechanism%2520of%2520action%2520of%2520some%2520commonly%2520used%2520protein%2520kinase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26issue%3DPart%25201%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&issue=7&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26issue%3D7%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Why do kinase inhibitors cause cardiotoxicity and what can be done about it?</span> <span class="citation_source-journal">Prog. Cardiovasc. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=114-120&author=H.+Chengauthor=T.+Force&title=Why+do+kinase+inhibitors+cause+cardiotoxicity+and+what+can+be+done+about+it%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DWhy%2520do%2520kinase%2520inhibitors%2520cause%2520cardiotoxicity%2520and%2520what%2520can%2520be%2520done%2520about%2520it%253F%26jtitle%3DProg.%2520Cardiovasc.%2520Dis.%26date%3D2010%26volume%3D53%26spage%3D114%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Hasinoff, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span> </span><span class="NLM_article-title">The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.taap.2010.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20832415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlentLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=2010&pages=132-139&author=B.+B.+Hasinoffauthor=D.+Patel&title=The+lack+of+target+specificity+of+small+molecule+anticancer+kinase+inhibitors+is+correlated+with+their+ability+to+damage+myocytes+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro</span></div><div class="casAuthors">Hasinoff, Brian B.; Patel, Daywin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Many new targeted small mol. anticancer kinase inhibitors are actively being developed.  However, the clin. use of some kinase inhibitors has been shown to result in cardiotoxicity.  In most cases the mechanisms by which they exert their cardiotoxicity are not well understood.  We have used large scale profiling data on 8 FDA-approved tyrosine kinase inhibitors and 10 other kinase inhibitors to a panel of 317 kinases in order to correlate binding consts. and kinase inhibitor binding selectivity scores with kinase inhibitor-induced damage to neonatal rat cardiac myocytes.  The 18 kinase inhibitors that were the subject of this study were: canertinib, dasatinib, dovitinib, erlotinib, flavopiridol, gefitinib, imatinib, lapatinib, midostaurin, motesanib, pazopanib, sorafenib, staurosporine, sunitinib, tandutinib, tozasertib, vandetanib and vatalanib.  The combined tyrosine kinase and serine-threonine kinase selectivity scores were highly correlated with the myocyte-damaging effects of the kinase inhibitors.  This result suggests that myocyte damage was due to a lack of target selectivity to binding of both tyrosine kinases and serine-threonine kinases, and was not due to binding to either group specifically.  Finally, the strength of kinase inhibitor binding for 290 kinases was examd. for correlations with myocyte damage.  Kinase inhibitor binding was significantly correlated with myocyte damage for 12 kinases.  Thus, myocyte damage may be multifactorial in nature with the inhibition of a no. of kinases involved in producing kinase inhibitor-induced myocyte damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLMB7MMhLiLVg90H21EOLACvtfcHk0lishfAo5GNhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlentLvE&md5=7d79b5cbb2ddf05a33d64235a4bfe37f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2010.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2010.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26aulast%3DPatel%26aufirst%3DD.%26atitle%3DThe%2520lack%2520of%2520target%2520specificity%2520of%2520small%2520molecule%2520anticancer%2520kinase%2520inhibitors%2520is%2520correlated%2520with%2520their%2520ability%2520to%2520damage%2520myocytes%2520in%2520vitro%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2010%26volume%3D249%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Fischer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottage, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Din, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransioli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, M. A.</span><span> </span><span class="NLM_article-title">Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2009&pages=2077-2087&author=K.+M.+Fischerauthor=C.+T.+Cottageauthor=W.+Wuauthor=S.+Dinauthor=N.+A.+Gudeauthor=D.+Avitabileauthor=P.+Quijadaauthor=B.+L.+Collinsauthor=J.+Fransioliauthor=M.+A.+Sussman&title=Enhancement+of+myocardial+regeneration+through+genetic+engineering+of+cardiac+progenitor+cells+expressing+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DK.%2BM.%26aulast%3DCottage%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DDin%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DN.%2BA.%26aulast%3DAvitabile%26aufirst%3DD.%26aulast%3DQuijada%26aufirst%3DP.%26aulast%3DCollins%26aufirst%3DB.%2BL.%26aulast%3DFransioli%26aufirst%3DJ.%26aulast%3DSussman%26aufirst%3DM.%2BA.%26atitle%3DEnhancement%2520of%2520myocardial%2520regeneration%2520through%2520genetic%2520engineering%2520of%2520cardiac%2520progenitor%2520cells%2520expressing%2520Pim-1%2520kinase%26jtitle%3DCirculation%26date%3D2009%26volume%3D120%26spage%3D2077%26epage%3D2087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. X.</span><span> </span><span class="NLM_article-title">Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.biocel.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19505587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyntLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=2315-2322&author=D.+Liuauthor=M.+Heauthor=B.+Yiauthor=W.+H.+Guoauthor=A.+L.+Queauthor=J.+X.+Zhang&title=Pim-3+protects+against+cardiomyocyte+apoptosis+in+anoxia%2Freoxygenation+injury+via+p38-mediated+signal+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway</span></div><div class="casAuthors">Liu, Dan; He, Ming; Yi, Bo; Guo, Wu-hua; Que, Ai-ling; Zhang, Ji-xiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2315-2322</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although anoxic preconditioning (APC) in the myocardium has been investigated for many years, its physiol. mechanism is still not completely understood.  Increasing evidence indicates that transiently increased resistance to ischemic damage following APC is dependent on de novo proteins synthesis.  However, the key effector pathway(s) assocd. with APC still remains unclear.  The proto-oncogene Pim kinase belongs to a serine/threonine protein kinase family, consists of Pim-1, Pim-2 and Pim-3 and has been implicated in stimulating cell growth and inhibiting cell apoptosis.  Therefore we assumed that Pim-3 expression might be aberrantly induced in cardiomyocytes that were subjected to anoxia/reoxygenation (A/R) injury and that Pim-3 might also contribute to cardio-protection after APC.  To address this hypothesis, we cloned a Pim-3 expression vector, transfected it into rat cardiomyocytes, and examd. Pim-3 expression in rat cardiomyocytes that were subjected to A/R injury.  Moreover, we studied the role of three major MAPK pathways, e.g. p38 MAPK, JNK, and ERK1/2, in order to evaluate the mol. mechanism underlying Pim-3 up-regulation and A/R induced cardiomyocyte injury.  Our expts. showed that APC induced an up-regulation of Pim-3 and the transfection of Pim-3 gene into the cardiomyocytes attenuated A/R injury.  The inhibition of p38 MAPK by SB203580 abolished both the Pim-3 up-regulation and the cardio-protection provided by APC.  Overall, these results suggest that APC could act to protect the heart from A/R injury with cooperation from the proto-oncogene Pim-3; in addn., it up-regulates Pim-3 expression through a p38 MAPK signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB9h-Mg4eYQbVg90H21EOLACvtfcHk0lhQn5lFlky6ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyntLvP&md5=84181dc44aac3a4c75f476272160174f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DW.%2BH.%26aulast%3DQue%26aufirst%3DA.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%2BX.%26atitle%3DPim-3%2520protects%2520against%2520cardiomyocyte%2520apoptosis%2520in%2520anoxia%252Freoxygenation%2520injury%2520via%2520p38-mediated%2520signal%2520pathway%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D2315%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span> </span><span class="NLM_article-title">Ischemia–reperfusion injury up-regulates Pim-3 gene expression in myocardial tissue</span> <span class="citation_source-journal">J. Huazhong Univ. Sci. Technol., Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=704-708&issue=6&author=L.+Zhaoauthor=Y.+Wangauthor=X.+Minauthor=H.+Yangauthor=P.+Zhangauthor=Q.+Zeng&title=Ischemia%E2%80%93reperfusion+injury+up-regulates+Pim-3+gene+expression+in+myocardial+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DQ.%26atitle%3DIschemia%25E2%2580%2593reperfusion%2520injury%2520up-regulates%2520Pim-3%2520gene%2520expression%2520in%2520myocardial%2520tissue%26jtitle%3DJ.%2520Huazhong%2520Univ.%2520Sci.%2520Technol.%252C%2520Med.%2520Sci.%26date%3D2010%26volume%3D30%26issue%3D6%26spage%3D704%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Kim, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critz, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelech, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. V.</span><span> </span><span class="NLM_article-title">Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1139%2Fo99-065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=10668633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1alsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=559-567&issue=6&author=S.+O.+Kimauthor=C.+P.+Bainesauthor=S.+D.+Critzauthor=S.+L.+Pelechauthor=S.+Katzauthor=J.+M.+Downeyauthor=M.+V.+Cohen&title=Ischemia+induced+activation+of+heat+shock+protein+27+kinases+and+casein+kinase+2+in+the+preconditioned+rabbit+heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart</span></div><div class="casAuthors">Kim, Sung O.; Baines, Christopher P.; Critz, Stuart D.; Pelech, Steven L.; Katz, Sidney; Downey, James M.; Cohen, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">559-567</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">Protein kinase C (PKC), p38 MAP kinase, and mitogen-activated protein kinase-activated kinases 2 and 3 (MAPKAPK2 and MAPKAPK3) have been implicated in ischemic preconditioning (PC) of the heart to reduce damage following a myocardial infarct.  This study examd. whether extracellular signal-regulated kinase (Erk) 1, p70 ribosomal S6 kinase (p70 S6K), casein kinase 2 (CK2), and other hsp27 kinases are also activated by PC, and if they are required for protection in rabbit hearts.  CK2 and hsp27 kinase activities declined during global ischemia in control hearts, whereas PC with 5 min ischemia and 10 min reperfusion increased their activities during global ischemia.  Resource Q chromatog. resolved two distinct peaks of hsp27 phosphotransferase activities; the first peak (at 0.36 M NaCl) appeared to correspond to the 55-kDa MAPKAPK2.  Erk1 activity was elevated in both control and PC hearts after post-ischemic reperfusion, but no change was obsd. in p70 S6K activity.  Infarct size (measured by triphenyltetrazolium staining) in isolated rabbit hearts subjected to 30 min regional ischemia and 2 h reperfusion was 31.0% of the risk zone in controls and was 10.3% in PC hearts.  Neither the CK2 inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) nor the Mek1/2 inhibitor PD 98059 infused during ischemia blocked protection by PC.  The activation of CK2 and Erk1 in ischemic preconditioned hearts appear to be epiphenomena and not required for the redn. of infarction from myocardial ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdAYhd9o9SLVg90H21EOLACvtfcHk0lhQn5lFlky6ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1alsQ%253D%253D&md5=05a155c6be8d96c498db910f7e6c5103</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1139%2Fo99-065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo99-065%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BO.%26aulast%3DBaines%26aufirst%3DC.%2BP.%26aulast%3DCritz%26aufirst%3DS.%2BD.%26aulast%3DPelech%26aufirst%3DS.%2BL.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DDowney%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DM.%2BV.%26atitle%3DIschemia%2520induced%2520activation%2520of%2520heat%2520shock%2520protein%252027%2520kinases%2520and%2520casein%2520kinase%25202%2520in%2520the%2520preconditioned%2520rabbit%2520heart%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D1999%26volume%3D77%26issue%3D6%26spage%3D559%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Sussman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottage, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Din, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundararaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstandin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, M.</span><span> </span><span class="NLM_article-title">Myocardial AKT: the omnipresent nexus</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1023-1070&author=M.+A.+Sussmanauthor=M.+Volkersauthor=K.+Fischerauthor=B.+Baileyauthor=C.+T.+Cottageauthor=S.+Dinauthor=N.+Gudeauthor=D.+Avitabileauthor=R.+Alvarezauthor=B.+Sundararamanauthor=P.+Quijadaauthor=M.+Masonauthor=M.+H.+Konstandinauthor=A.+Malhowskiauthor=Z.+Chengauthor=M.+Khanauthor=M.+McGregor&title=Myocardial+AKT%3A+the+omnipresent+nexus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSussman%26aufirst%3DM.%2BA.%26aulast%3DVolkers%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DB.%26aulast%3DCottage%26aufirst%3DC.%2BT.%26aulast%3DDin%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DN.%26aulast%3DAvitabile%26aufirst%3DD.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DSundararaman%26aufirst%3DB.%26aulast%3DQuijada%26aufirst%3DP.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DKonstandin%26aufirst%3DM.%2BH.%26aulast%3DMalhowski%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%26atitle%3DMyocardial%2520AKT%253A%2520the%2520omnipresent%2520nexus%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D1023%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hirofumi  Nakano</span>, <span class="hlFld-ContribAuthor ">Tsukasa  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Hirotatsu  Kojima</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Okabe</span>, and <span class="hlFld-ContribAuthor ">Tetsuo  Nagano</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 504-509. <a href="https://doi.org/10.1021/acsmedchemlett.6b00518" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPotent%252Band%252BSelective%252BPIM%252BKinase%252BInhibitors%252Bby%252BTargeting%252BUnique%252BStructure%252Bof%252BATP-Binding%252BPocket%26aulast%3DNakano%26aufirst%3DHirofumi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23122016%26date%3D02042017%26date%3D10042017%26date%3D11052017%26date%3D03042017%26volume%3D8%26issue%3D5%26spage%3D504%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez, Jr.</span>, <span class="hlFld-ContribAuthor ">Yuping  Chen</span>, <span class="hlFld-ContribAuthor ">Heather  Eastwood</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">Bradley  Herberich</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Jimmy  Laszlo, III</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Bethany  Mattson</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">David  Powers</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Winston</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, and <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6407-6430. <a href="https://doi.org/10.1021/acs.jmedchem.6b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BQuinazolinone-pyrrolopyrrolones%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BPan-Pim%252BKinase%252BInhibitors%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D22062016%26date%3D14072016%26date%3D10062016%26volume%3D59%26issue%3D13%26spage%3D6407%26epage%3D6430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez, Jr.</span>, <span class="hlFld-ContribAuthor ">Bradley  Herberich</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Jimmy  Laszlo, III</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">Bethany K.  Mattson</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Christine E.  Sastri</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Qiong  Wu</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Winston</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, and <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 408-412. <a href="https://doi.org/10.1021/acsmedchemlett.5b00403" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00403%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BMacrocyclic%252BQuinoxaline-pyrrolo-dihydropiperidinones%252Bas%252BPotent%252BPim-1%25252F2%252BKinase%252BInhibitors%26aulast%3DCee%26aufirst%3DVictor%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14102015%26date%3D08022016%26date%3D12022016%26date%3D14042016%26volume%3D7%26issue%3D4%26spage%3D408%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. A.  Maryasov</span>, <span class="hlFld-ContribAuthor ">N. P.  Romashov</span>, <span class="hlFld-ContribAuthor ">V. V.  Davydova</span>, <span class="hlFld-ContribAuthor ">O. E.  Nasakin</span>, <span class="hlFld-ContribAuthor ">M. P.  Osipova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Aryl-6-oxo-5-cyano-1,6-dihydropyridine-2-carboxylic Acids and Their Methyl Esters by Reacting Methyl Acylpyruvates with Malononitrile and Cyanoacetamide. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2021,</strong> <em>91 </em>
                                    (5)
                                     , 947-950. <a href="https://doi.org/10.1134/S1070363221050261" title="DOI URL">https://doi.org/10.1134/S1070363221050261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363221050261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363221050261%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-Aryl-6-oxo-5-cyano-1%25252C6-dihydropyridine-2-carboxylic%252BAcids%252Band%252BTheir%252BMethyl%252BEsters%252Bby%252BReacting%252BMethyl%252BAcylpyruvates%252Bwith%252BMalononitrile%252Band%252BCyanoacetamide%26aulast%3DMaryasov%26aufirst%3DM.%2BA.%26date%3D2021%26date%3D2021%26volume%3D91%26issue%3D5%26spage%3D947%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amel M.  Farrag</span>, <span class="hlFld-ContribAuthor ">Mona H.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>, <span class="hlFld-ContribAuthor ">Magda M.F.  Ismail</span>. </span><span class="cited-content_cbyCitation_article-title">New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104378. <a href="https://doi.org/10.1016/j.bioorg.2020.104378" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104378%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252Bcyanopyridine-based%252Bscaffold%252Bas%252BPIM-1%252Binhibitors%252Band%252Bapoptotic%252Binducers%25253A%252BSynthesis%252Band%252BSARs%252Bstudy%26aulast%3DFarrag%26aufirst%3DAmel%2BM.%26date%3D2020%26volume%3D105%26spage%3D104378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Mark  Czekaj</span>, <span class="hlFld-ContribAuthor ">Luke  Fire</span>, <span class="hlFld-ContribAuthor ">James  Pribish</span>, <span class="hlFld-ContribAuthor ">Elina  Tserlin</span>, <span class="hlFld-ContribAuthor ">Sachin  Maniar</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Batchelor</span>, <span class="hlFld-ContribAuthor ">Jinyu  Liu</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Andrew  Hebert</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Shih-Min A.  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (23)
                                     , 127625. <a href="https://doi.org/10.1016/j.bmcl.2020.127625" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127625%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSARxxxx92%25252C%252Ba%252Bpan-PIM%252Bkinase%252Binhibitor%25252C%252Befficacious%252Bin%252Ba%252BKG1%252Btumor%252Bmodel%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2020%26volume%3D30%26issue%3D23%26spage%3D127625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed E. M.  Mekky</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>, <span class="hlFld-ContribAuthor ">Ahmed Y.  Said</span>, <span class="hlFld-ContribAuthor ">Mohamed A. A.  Elneairy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxicity,
              in-vitro
              antibacterial screening and
              in-silico
              study of novel thieno[2,3-
              b
              ]pyridines as potential pim-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2020,</strong> <em>50 </em>
                                    (15)
                                     , 2376-2389. <a href="https://doi.org/10.1080/00397911.2020.1778033" title="DOI URL">https://doi.org/10.1080/00397911.2020.1778033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1778033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1778033%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%25252C%252Bcytotoxicity%25252C%252Bin-vitro%252Bantibacterial%252Bscreening%252Band%252Bin-silico%252Bstudy%252Bof%252Bnovel%252Bthieno%25255B2%25252C3-%252Bb%252B%25255Dpyridines%252Bas%252Bpotential%252Bpim-1%252Binhibitors%26aulast%3DMekky%26aufirst%3DAhmed%2BE.%2BM.%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D15%26spage%3D2376%26epage%3D2389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magda M. F.  Ismail</span>, <span class="hlFld-ContribAuthor ">Amel M.  Farrag</span>, <span class="hlFld-ContribAuthor ">Dalal  Abou‐El‐Ela</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anticancer screening, and in silico
              ADME
              prediction of novel
              2‐pyridones
              as Pim inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>102 </em><a href="https://doi.org/10.1002/jhet.4064" title="DOI URL">https://doi.org/10.1002/jhet.4064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%25252C%252Banticancer%252Bscreening%25252C%252Band%252Bin%252Bsilico%252BADME%252Bprediction%252Bof%252Bnovel%252B2%2525E2%252580%252590pyridones%252Bas%252BPim%252Binhibitors%26aulast%3DIsmail%26aufirst%3DMagda%2BM.%2BF.%26date%3D2020%26date%3D2020%26volume%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asmaa M.  AboulMagd</span>, <span class="hlFld-ContribAuthor ">Hossam M.  Hassan</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Usama Ramadan  Abdelmohsen</span>, <span class="hlFld-ContribAuthor ">Hamdy M.  Abdel-Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (12)
                                     , 6752-6762. <a href="https://doi.org/10.1039/C9RA10216G" title="DOI URL">https://doi.org/10.1039/C9RA10216G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA10216G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA10216G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSaccharomonosporine%252BA%252Binspiration%25253B%252Bsynthesis%252Bof%252Bpotent%252Banalogues%252Bas%252Bpotential%252BPIM%252Bkinase%252Binhibitors%26aulast%3DAboulMagd%26aufirst%3DAsmaa%2BM.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D12%26spage%3D6752%26epage%3D6762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magda M.F.  Ismail</span>, <span class="hlFld-ContribAuthor ">Amel M.  Farrag</span>, <span class="hlFld-ContribAuthor ">Marwa F.  Harras</span>, <span class="hlFld-ContribAuthor ">Mona H.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>. </span><span class="cited-content_cbyCitation_article-title">Apoptosis: A target for anticancer therapy with novel cyanopyridines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103481. <a href="https://doi.org/10.1016/j.bioorg.2019.103481" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103481%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DApoptosis%25253A%252BA%252Btarget%252Bfor%252Banticancer%252Btherapy%252Bwith%252Bnovel%252Bcyanopyridines%26aulast%3DIsmail%26aufirst%3DMagda%2BM.F.%26date%3D2020%26volume%3D94%26spage%3D103481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abd El-Galil E.  Amr</span>, <span class="hlFld-ContribAuthor ">Alhussein A.  Ibrahimd</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  El-Shehry</span>, <span class="hlFld-ContribAuthor ">Hanaa M.  Hosni</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  Fayed</span>, <span class="hlFld-ContribAuthor ">Elsayed A.  Elsayed</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and In Vivo Anti-Breast Cancer Activities of Some Newly Synthesized 5-(thiophen-2-yl)thieno-[2,3-d]pyrimidin-4-one Candidates. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2255. <a href="https://doi.org/10.3390/molecules24122255" title="DOI URL">https://doi.org/10.3390/molecules24122255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122255%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIn%252BVitro%252Band%252BIn%252BVivo%252BAnti-Breast%252BCancer%252BActivities%252Bof%252BSome%252BNewly%252BSynthesized%252B5-%252528thiophen-2-yl%252529thieno-%25255B2%25252C3-d%25255Dpyrimidin-4-one%252BCandidates%26aulast%3DAmr%26aufirst%3DAbd%2BEl-Galil%2BE.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">James  Pribish</span>, <span class="hlFld-ContribAuthor ">Elina  Tserlin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gross</span>, <span class="hlFld-ContribAuthor ">Mark  Czekaj</span>, <span class="hlFld-ContribAuthor ">Matthieu  Barragué</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Sachin  Maniar</span>, <span class="hlFld-ContribAuthor ">John  Jiang</span>, <span class="hlFld-ContribAuthor ">Luke  Fire</span>, <span class="hlFld-ContribAuthor ">Vinod  Patel</span>, <span class="hlFld-ContribAuthor ">Andrew  Hebert</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Shih-Min A.  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (3)
                                     , 491-495. <a href="https://doi.org/10.1016/j.bmcl.2018.12.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-substituted%252B7-azaindoles%252Bas%252BPan-PIM%252Bkinases%252Binhibitors%252B%2525E2%252580%252593%252BLead%252Boptimization%252B%2525E2%252580%252593%252BPart%252BIII%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2019%26volume%3D29%26issue%3D3%26spage%3D491%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Tingyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Weisi  Wang</span>, <span class="hlFld-ContribAuthor ">Junmin  Yao</span>, <span class="hlFld-ContribAuthor ">Shaomin  Han</span>, <span class="hlFld-ContribAuthor ">Yi  Tao</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Carbazole Aminoalcohols as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (44)
                                     , 12630-12638. <a href="https://doi.org/10.1002/slct.201803029" title="DOI URL">https://doi.org/10.1002/slct.201803029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803029%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BCarbazole%252BAminoalcohols%252Bas%252BAntitumor%252BAgents%26aulast%3DChen%26aufirst%3DZhuo%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D44%26spage%3D12630%26epage%3D12638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hannah J.  Winfield</span>, <span class="hlFld-ContribAuthor ">Michael M.  Cahill</span>, <span class="hlFld-ContribAuthor ">Kevin D.  O'Shea</span>, <span class="hlFld-ContribAuthor ">Larry T.  Pierce</span>, <span class="hlFld-ContribAuthor ">Thomas  Robert</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>, <span class="hlFld-ContribAuthor ">Florence O.  McCarthy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 4209-4224. <a href="https://doi.org/10.1016/j.bmc.2018.07.012" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.07.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.07.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252Bbisindolylhydroxymaleimide%252Bderivatives%252Bwith%252Bpotent%252BGSK-3%252Bkinase%252Binhibition%26aulast%3DWinfield%26aufirst%3DHannah%2BJ.%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D4209%26epage%3D4224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  You</span>, <span class="hlFld-ContribAuthor ">Daqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Wenhua  Lu</span>, <span class="hlFld-ContribAuthor ">Yichen  Sun</span>, <span class="hlFld-ContribAuthor ">Shuang  Qiao</span>, <span class="hlFld-ContribAuthor ">Bingling  Luo</span>, <span class="hlFld-ContribAuthor ">Yongliang  Du</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Yumin  Hu</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Shijun  Wen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of
              N
              -arylsulfonyl carbazoles as novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (31)
                                     , 17183-17190. <a href="https://doi.org/10.1039/C8RA02939C" title="DOI URL">https://doi.org/10.1039/C8RA02939C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02939C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02939C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN%252B-arylsulfonyl%252Bcarbazoles%252Bas%252Bnovel%252Banticancer%252Bagents%26aulast%3DYou%26aufirst%3DXin%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D31%26spage%3D17183%26epage%3D17190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Neil  Moorcroft</span>, <span class="hlFld-ContribAuthor ">James  Pribish</span>, <span class="hlFld-ContribAuthor ">Elina  Tserlin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gross</span>, <span class="hlFld-ContribAuthor ">Mark  Czekaj</span>, <span class="hlFld-ContribAuthor ">Matthieu  Barrague</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Tahir  Majid</span>, <span class="hlFld-ContribAuthor ">Joseph  Batchelor</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Andrew  Hebert</span>, <span class="hlFld-ContribAuthor ">Liduo  Shen</span>, <span class="hlFld-ContribAuthor ">Sandra  Moreno-Mazza</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4735-4740. <a href="https://doi.org/10.1016/j.bmcl.2017.08.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-substituted%252B7-azaindoles%252Bas%252BPan-PIM%252Bkinase%252Binhibitors%252B%2525E2%252580%252593%252BLead%252Bseries%252Bidentification%252B%2525E2%252580%252593%252BPart%252BII%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4735%26epage%3D4740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Neil  Moorcroft</span>, <span class="hlFld-ContribAuthor ">Chris  Arendt</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Sandra  Moreno-Mazza</span>, <span class="hlFld-ContribAuthor ">Joseph  Batchelor</span>, <span class="hlFld-ContribAuthor ">Ingrid  Mechin</span>, <span class="hlFld-ContribAuthor ">Tahir  Majid</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -substituted 7-azaindoles as PIM1 kinase inhibitors – Part I. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4730-4734. <a href="https://doi.org/10.1016/j.bmcl.2017.08.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-substituted%252B7-azaindoles%252Bas%252BPIM1%252Bkinase%252Binhibitors%252B%2525E2%252580%252593%252BPart%252BI%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4730%26epage%3D4734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carole J.R.  Bataille</span>, <span class="hlFld-ContribAuthor ">Méabh B.  Brennan</span>, <span class="hlFld-ContribAuthor ">Simon  Byrne</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Davies</span>, <span class="hlFld-ContribAuthor ">Matthew  Durbin</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Kilian V.M.  Huber</span>, <span class="hlFld-ContribAuthor ">Alan M.  Jones</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Gu  Liu</span>, <span class="hlFld-ContribAuthor ">Anna  Nadali</span>, <span class="hlFld-ContribAuthor ">Camilo E.  Quevedo</span>, <span class="hlFld-ContribAuthor ">Angela J.  Russell</span>, <span class="hlFld-ContribAuthor ">Roderick G.  Walker</span>, <span class="hlFld-ContribAuthor ">Robert  Westwood</span>, <span class="hlFld-ContribAuthor ">Graham M.  Wynne</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (9)
                                     , 2657-2665. <a href="https://doi.org/10.1016/j.bmc.2017.02.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.02.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.02.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.02.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThiazolidine%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Binhibitors%252Bof%252Bthe%252BPIM%252Bkinase%252Bfamily%26aulast%3DBataille%26aufirst%3DCarole%2BJ.R.%26date%3D2017%26volume%3D25%26issue%3D9%26spage%3D2657%26epage%3D2665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassem H.  Naguib</span>, <span class="hlFld-ContribAuthor ">Hala B.  El-Nassan</span>, <span class="hlFld-ContribAuthor ">Tamer M.  Abdelghany</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 457-467. <a href="https://doi.org/10.1080/14756366.2016.1261130" title="DOI URL">https://doi.org/10.1080/14756366.2016.1261130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1261130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1261130%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnew%252Bpyridothienopyrimidinone%252Bderivatives%252Bas%252BPim-1%252Binhibitors%26aulast%3DNaguib%26aufirst%3DBassem%2BH.%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Derin C.  D’Amico</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Claire L.M.  Jackson</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Winston</span>, <span class="hlFld-ContribAuthor ">Yajing  Yang</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">J.D.  Zhang</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (22)
                                     , 5580-5590. <a href="https://doi.org/10.1016/j.bmcl.2016.09.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.09.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.09.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.09.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bimidazopyridazines%252Bas%252Bpotent%252BPim-1%25252F2%252Bkinase%252Binhibitors%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2016%26volume%3D26%26issue%3D22%26spage%3D5580%26epage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassem H.  Naguib</span>, <span class="hlFld-ContribAuthor ">Hala B.  El-Nassan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new thieno[2,3-
              b
              ]pyridine derivatives as pim-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (6)
                                     , 1718-1725. <a href="https://doi.org/10.3109/14756366.2016.1158711" title="DOI URL">https://doi.org/10.3109/14756366.2016.1158711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2016.1158711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2016.1158711%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnew%252Bthieno%25255B2%25252C3-%252Bb%252B%25255Dpyridine%252Bderivatives%252Bas%252Bpim-1%252Binhibitors%26aulast%3DNaguib%26aufirst%3DBassem%2BH.%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3D6%26spage%3D1718%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makaram M.  Said</span>, <span class="hlFld-ContribAuthor ">Azza T.  Taher</span>, <span class="hlFld-ContribAuthor ">Hala B.  El-Nassan</span>, <span class="hlFld-ContribAuthor ">Eman A.  El-Khouly</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (8)
                                     , 6643-6662. <a href="https://doi.org/10.1007/s11164-016-2487-x" title="DOI URL">https://doi.org/10.1007/s11164-016-2487-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2487-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2487-x%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSynthesis%252Bof%252Bnovel%252BS-acyl%252Band%252BS-alkylpyrimidinone%252Bderivatives%252Bas%252Bpotential%252Bcytotoxic%252Bagents%26aulast%3DSaid%26aufirst%3DMakaram%2BM.%26date%3D2016%26date%3D2016%26volume%3D42%26issue%3D8%26spage%3D6643%26epage%3D6662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Di  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinbo  Fan</span>, <span class="hlFld-ContribAuthor ">Hongye  Guo</span>, <span class="hlFld-ContribAuthor ">Tianyi  Ma</span>, <span class="hlFld-ContribAuthor ">Jiachen  Wen</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1889-1897. <a href="https://doi.org/10.1016/j.bmc.2016.03.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bquinoline%252Bderivatives%252Bas%252Bpotential%252Banti-prostate%252Bcancer%252Bagents%252Band%252BPim-1%252Bkinase%252Binhibitors%26aulast%3DLi%26aufirst%3DKun%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1889%26epage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin-Bo  Fan</span>, <span class="hlFld-ContribAuthor ">Kun  Li</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Yu  Cao</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Shu-Yu  Jin</span>, <span class="hlFld-ContribAuthor ">Wen-Bing  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Chen  Wen</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Lin-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (4)
                                     , 1224-1228. <a href="https://doi.org/10.1016/j.bmcl.2016.01.032" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.01.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.01.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bsubstituted%252Bpyrido%25255B3%25252C2-d%25255D-1%25252C2%25252C3-triazines%252Bas%252Bpotential%252BPim-1%252Binhibitors%26aulast%3DFan%26aufirst%3DYin-Bo%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1224%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Koroleva</span>, <span class="hlFld-ContribAuthor ">Zh. I.  Ignatovich</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Sinyutich</span>, <span class="hlFld-ContribAuthor ">K. N.  Gusak</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidine derivatives as protein kinases inhibitors. Molecular design, synthesis, and biologic activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>52 </em>
                                    (2)
                                     , 139-177. <a href="https://doi.org/10.1134/S1070428016020019" title="DOI URL">https://doi.org/10.1134/S1070428016020019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428016020019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428016020019%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAminopyrimidine%252Bderivatives%252Bas%252Bprotein%252Bkinases%252Binhibitors.%252BMolecular%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiologic%252Bactivity%26aulast%3DKoroleva%26aufirst%3DE.%2BV.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D2%26spage%3D139%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maud  Antoine</span>, <span class="hlFld-ContribAuthor ">Tilmann  Schuster</span>, <span class="hlFld-ContribAuthor ">Irene  Seipelt</span>, <span class="hlFld-ContribAuthor ">Babette  Aicher</span>, <span class="hlFld-ContribAuthor ">Michael  Teifel</span>, <span class="hlFld-ContribAuthor ">Eckhard  Günther</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 224-229. <a href="https://doi.org/10.1039/C5MD00424A" title="DOI URL">https://doi.org/10.1039/C5MD00424A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00424A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00424A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnovel%252Bdisubstituted%252Bpyrido%25255B3%25252C4-b%25255Dpyrazines%252Bfor%252Bthe%252Bdesign%252Bof%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DAntoine%26aufirst%3DMaud%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D224%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiyong  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>, <span class="hlFld-ContribAuthor ">Grace Ka Yan  Chan</span>, <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Jake  Drummond</span>, <span class="hlFld-ContribAuthor ">Allen  Ebens</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Qi  Chao</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Heidi  Wallweber</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5258-5264. <a href="https://doi.org/10.1016/j.bmcl.2015.09.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C5-substituted%252B6-azaindazoles%252Bas%252Bpotent%252Bpan-Pim%252Binhibitors%26aulast%3DHu%26aufirst%3DHuiyong%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5258%26epage%3D5264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Claire  Jackson</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Victor  Cee</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez</span>, <span class="hlFld-ContribAuthor ">Thomas  Nixey</span>, <span class="hlFld-ContribAuthor ">Jimmy  Laszlo</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">Jeff  Winston</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 847-855. <a href="https://doi.org/10.1016/j.bmcl.2014.12.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Baminooxadiazoles%252Bas%252Bpotent%252BPim%252Bkinase%252Binhibitors%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D847%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Jeff  Winston</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 834-840. <a href="https://doi.org/10.1016/j.bmcl.2014.12.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bnovel%252B3-%252528pyrazin-2-yl%252529-1H-indazoles%252Bas%252Bpotent%252Bpan-Pim%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DHui-Ling%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D834%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Thomas  Nixey</span>, <span class="hlFld-ContribAuthor ">Liping  Pettus</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Jeff  Winston</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 775-780. <a href="https://doi.org/10.1016/j.bmcl.2014.12.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-%2525281H-indol-5-yl%252529-1%25252C3%25252C4-thiadiazol-2-amines%252Bas%252Bpotent%252BPIM%252Binhibitors%26aulast%3DWu%26aufirst%3DBin%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D775%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen'kii</span>, <span class="hlFld-ContribAuthor ">Yu B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 193-363. <a href="https://doi.org/10.1016/bs.aihch.2015.04.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXIII%25252C%252B2012%2525E2%252580%2525932013%26aulast%3DBelen%2527kii%26aufirst%3DLeonid%2BI.%26date%3D2015%26spage%3D193%26epage%3D363%26pub%3DElsevier%26date%3D2015%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bich Thuy  Le</span>, <span class="hlFld-ContribAuthor ">Malika  Kumarasiri</span>, <span class="hlFld-ContribAuthor ">Julian RJ  Adams</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Robert  Milne</span>, <span class="hlFld-ContribAuthor ">Matthew J  Sykes</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Pim kinases for cancer treatment: opportunities and challenges. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (1)
                                     , 35-53. <a href="https://doi.org/10.4155/fmc.14.145" title="DOI URL">https://doi.org/10.4155/fmc.14.145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.145%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BPim%252Bkinases%252Bfor%252Bcancer%252Btreatment%25253A%252Bopportunities%252Band%252Bchallenges%26aulast%3DLe%26aufirst%3DBich%2BThuy%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D35%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esperanza  Martín-Sánchez</span>, <span class="hlFld-ContribAuthor ">Lina  Odqvist</span>, <span class="hlFld-ContribAuthor ">Socorro M.  Rodríguez-Pinilla</span>, <span class="hlFld-ContribAuthor ">Margarita  Sánchez-Beato</span>, <span class="hlFld-ContribAuthor ">Giovanna  Roncador</span>, <span class="hlFld-ContribAuthor ">Beatriz  Domínguez-González</span>, <span class="hlFld-ContribAuthor ">Carmen  Blanco-Aparicio</span>, <span class="hlFld-ContribAuthor ">Ana M.  García Collazo</span>, <span class="hlFld-ContribAuthor ">Esther González  Cantalapiedra</span>, <span class="hlFld-ContribAuthor ">Joaquín Pastor  Fernández</span>, <span class="hlFld-ContribAuthor ">Soraya Curiel del  Olmo</span>, <span class="hlFld-ContribAuthor ">Helena  Pisonero</span>, <span class="hlFld-ContribAuthor ">Rebeca  Madureira</span>, <span class="hlFld-ContribAuthor ">Carmen  Almaraz</span>, <span class="hlFld-ContribAuthor ">Manuela  Mollejo</span>, <span class="hlFld-ContribAuthor ">F. Javier  Alves</span>, <span class="hlFld-ContribAuthor ">Javier  Menárguez</span>, <span class="hlFld-ContribAuthor ">Fernando  González-Palacios</span>, <span class="hlFld-ContribAuthor ">José Luis  Rodríguez-Peralto</span>, <span class="hlFld-ContribAuthor ">Pablo L.  Ortiz-Romero</span>, <span class="hlFld-ContribAuthor ">Francisco X.  Real</span>, <span class="hlFld-ContribAuthor ">Juan F.  García</span>, <span class="hlFld-ContribAuthor ">James R.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Miguel A.  Piris</span>, . </span><span class="cited-content_cbyCitation_article-title">PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , e112148. <a href="https://doi.org/10.1371/journal.pone.0112148" title="DOI URL">https://doi.org/10.1371/journal.pone.0112148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0112148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0112148%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DPIM%252BKinases%252Bas%252BPotential%252BTherapeutic%252BTargets%252Bin%252Ba%252BSubset%252Bof%252BPeripheral%252BT%252BCell%252BLymphoma%252BCases%26aulast%3DMart%25C3%25ADn-S%25C3%25A1nchez%26aufirst%3DEsperanza%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3De112148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koremu  Meja</span>, <span class="hlFld-ContribAuthor ">Chloe  Stengel</span>, <span class="hlFld-ContribAuthor ">Rob  Sellar</span>, <span class="hlFld-ContribAuthor ">Dennis  Huszar</span>, <span class="hlFld-ContribAuthor ">Barry R.  Davies</span>, <span class="hlFld-ContribAuthor ">Rosemary E.  Gale</span>, <span class="hlFld-ContribAuthor ">David C.  Linch</span>, <span class="hlFld-ContribAuthor ">Asim  Khwaja</span>. </span><span class="cited-content_cbyCitation_article-title">PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Haematology</span><span> <strong>2014,</strong> <em>167 </em>
                                    (1)
                                     , 69-79. <a href="https://doi.org/10.1111/bjh.13013" title="DOI URL">https://doi.org/10.1111/bjh.13013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bjh.13013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbjh.13013%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Haematology%26atitle%3DPIM%252Band%252BAKT%252Bkinase%252Binhibitors%252Bshow%252Bsynergistic%252Bcytotoxicity%252Bin%252Bacute%252Bmyeloid%252Bleukaemia%252Bthat%252Bis%252Bassociated%252Bwith%252Bconvergence%252Bon%252BmTOR%252Band%252BMCL1%252Bpathways%26aulast%3DMeja%26aufirst%3DKoremu%26date%3D2014%26date%3D2014%26volume%3D167%26issue%3D1%26spage%3D69%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Qiang  Gao</span>, <span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Michel  Tabart</span>, <span class="hlFld-ContribAuthor ">Jingxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dietmar  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Dmitri  Wiederschain</span>, <span class="hlFld-ContribAuthor ">Jennifer  Rocnik</span>, <span class="hlFld-ContribAuthor ">Fangxian  Sun</span>, <span class="hlFld-ContribAuthor ">Josh  Murtie</span>, <span class="hlFld-ContribAuthor ">Christoph  Lengauer</span>, <span class="hlFld-ContribAuthor ">Stefan  Gross</span>, <span class="hlFld-ContribAuthor ">Bailin  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Cheng</span>, <span class="hlFld-ContribAuthor ">Vinod  Patel</span>, <span class="hlFld-ContribAuthor ">Laurent  Schio</span>, <span class="hlFld-ContribAuthor ">Francisco  Adrian</span>, <span class="hlFld-ContribAuthor ">Marion  Dorsch</span>, <span class="hlFld-ContribAuthor ">Carlos  Garcia-Echeverria</span>, <span class="hlFld-ContribAuthor ">Shih-Min A.  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2014,</strong> <em>124 </em>
                                    (11)
                                     , 1777-1789. <a href="https://doi.org/10.1182/blood-2014-01-551234" title="DOI URL">https://doi.org/10.1182/blood-2014-01-551234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2014-01-551234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2014-01-551234%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DPIM%252Binhibitors%252Btarget%252BCD25-positive%252BAML%252Bcells%252Bthrough%252Bconcomitant%252Bsuppression%252Bof%252BSTAT5%252Bactivation%252Band%252Bdegradation%252Bof%252BMYC%252Boncogene%26aulast%3DGuo%26aufirst%3DZhuyan%26date%3D2014%26volume%3D124%26issue%3D11%26spage%3D1777%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginie  Suchaud</span>, <span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Francis  Giraud</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Vincent  Théry</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4704-4710. <a href="https://doi.org/10.1016/j.bmc.2014.07.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrazolo%25255B4%25252C3-a%25255Dphenanthridines%25252C%252Ba%252Bnew%252Bscaffold%252Bfor%252BPim%252Bkinase%252Binhibition%26aulast%3DSuchaud%26aufirst%3DVirginie%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4704%26epage%3D4710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Defaux</span>, <span class="hlFld-ContribAuthor ">Maud  Antoine</span>, <span class="hlFld-ContribAuthor ">Cédric  Logé</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>, <span class="hlFld-ContribAuthor ">Tilmann  Schuster</span>, <span class="hlFld-ContribAuthor ">Irene  Seipelt</span>, <span class="hlFld-ContribAuthor ">Babette  Aicher</span>, <span class="hlFld-ContribAuthor ">Michael  Teifel</span>, <span class="hlFld-ContribAuthor ">Eckhard  Günther</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3748-3752. <a href="https://doi.org/10.1016/j.bmcl.2014.06.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%2525287-aryl-1%25252C5-naphthyridin-2-yl%252529ureas%252Bas%252Bdual%252Binhibitors%252Bof%252BERK2%252Band%252BAurora%252BB%252Bkinases%252Bwith%252Bantiproliferative%252Bactivity%252Bagainst%252Bcancer%252Bcells%26aulast%3DDefaux%26aufirst%3DJulien%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3748%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinho  Lee</span>, <span class="hlFld-ContribAuthor ">Kunal N.  More</span>, <span class="hlFld-ContribAuthor ">Seun-Ah  Yang</span>, <span class="hlFld-ContribAuthor ">Victor S.  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">3,5-Bis(aminopyrimidinyl)indole Derivatives: Synthesis and Evaluation of Pim Kinase Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (7)
                                     , 2123-2129. <a href="https://doi.org/10.5012/bkcs.2014.35.7.2123" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.7.2123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.7.2123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.7.2123%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3D3%25252C5-Bis%252528aminopyrimidinyl%252529indole%252BDerivatives%25253A%252BSynthesis%252Band%252BEvaluation%252Bof%252BPim%252BKinase%252BInhibitory%252BActivities%26aulast%3DLee%26aufirst%3DJinho%26date%3D2014%26volume%3D35%26issue%3D7%26spage%3D2123%26epage%3D2129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Defaux</span>, <span class="hlFld-ContribAuthor ">Maud  Antoine</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>, <span class="hlFld-ContribAuthor ">Tilmann  Schuster</span>, <span class="hlFld-ContribAuthor ">Irene  Seipelt</span>, <span class="hlFld-ContribAuthor ">Babette  Aicher</span>, <span class="hlFld-ContribAuthor ">Michael  Teifel</span>, <span class="hlFld-ContribAuthor ">Eckhard  Günther</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , 217-232. <a href="https://doi.org/10.1002/cmdc.201300384" title="DOI URL">https://doi.org/10.1002/cmdc.201300384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300384%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252B7-Aryl-Substituted%252B%2525281%25252C5-Naphthyridin-4-yl%252529ureas%252Bas%252BAurora%252BKinase%252BInhibitors%26aulast%3DDefaux%26aufirst%3DJulien%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D1%26spage%3D217%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denis  Drygin</span>. </span><span class="cited-content_cbyCitation_article-title">PIM Protein Kinase Family. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-5. <a href="https://doi.org/10.1007/978-3-642-27841-9_7141-4" title="DOI URL">https://doi.org/10.1007/978-3-642-27841-9_7141-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27841-9_7141-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27841-9_7141-4%26sid%3Dliteratum%253Aachs%26atitle%3DPIM%252BProtein%252BKinase%252BFamily%26aulast%3DDrygin%26aufirst%3DDenis%26date%3D2014%26date%3D2015%26spage%3D1%26epage%3D5%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DEncyclopedia%252Bof%252BCancer%26aulast%3DSchwab%26aufirst%3DManfred%26date%3D2014%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denis  Drygin</span>. </span><span class="cited-content_cbyCitation_article-title">PIM Protein Kinase Family. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 3586-3590. <a href="https://doi.org/10.1007/978-3-662-46875-3_7141" title="DOI URL">https://doi.org/10.1007/978-3-662-46875-3_7141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-662-46875-3_7141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-662-46875-3_7141%26sid%3Dliteratum%253Aachs%26atitle%3DPIM%252BProtein%252BKinase%252BFamily%26aulast%3DDrygin%26aufirst%3DDenis%26date%3D2014%26date%3D2017%26spage%3D3586%26epage%3D3590%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DEncyclopedia%252Bof%252BCancer%26aulast%3DSchwab%26aufirst%3DManfred%26date%3D2017%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Zhizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Linlin  Lv</span>, <span class="hlFld-ContribAuthor ">Shanshan  Song</span>, <span class="hlFld-ContribAuthor ">Zehong  Miao</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free synthesis of benzofuran-fused pyrido[4,3-d]pyrimidines from 2-(2-hydroxyaryl)acetonitrile and 4,6-dichloropyrimidine-5-carbaldehyde through domino condensation reactions. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (1)
                                     , 358-364. <a href="https://doi.org/10.1039/C3RA44828B" title="DOI URL">https://doi.org/10.1039/C3RA44828B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3RA44828B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3RA44828B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DCatalyst-free%252Bsynthesis%252Bof%252Bbenzofuran-fused%252Bpyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bfrom%252B2-%2525282-hydroxyaryl%252529acetonitrile%252Band%252B4%25252C6-dichloropyrimidine-5-carbaldehyde%252Bthrough%252Bdomino%252Bcondensation%252Breactions%26aulast%3DLi%26aufirst%3DBo%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D1%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muthusamy  Boominathan</span>, <span class="hlFld-ContribAuthor ">Muthupandi  Nagaraj</span>, <span class="hlFld-ContribAuthor ">Shanmugam  Muthusubramanian</span>, <span class="hlFld-ContribAuthor ">Nattamai  Bhuvanesh</span>. </span><span class="cited-content_cbyCitation_article-title">Three component synthesis of 2-oxindole via sequential Michael addition, intramolecular cyclization and aromatization. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (36)
                                     , 18549. <a href="https://doi.org/10.1039/c4ra02091j" title="DOI URL">https://doi.org/10.1039/c4ra02091j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c4ra02091j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc4ra02091j%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DThree%252Bcomponent%252Bsynthesis%252Bof%252B2-oxindole%252Bvia%252Bsequential%252BMichael%252Baddition%25252C%252Bintramolecular%252Bcyclization%252Band%252Baromatization%26aulast%3DBoominathan%26aufirst%3DMuthusamy%26date%3D2014%26volume%3D4%26issue%3D36%26spage%3D18549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Casuscelli</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Giovanni  Cervi</span>, <span class="hlFld-ContribAuthor ">Matteo  D’Anello</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Daniela  Faiardi</span>, <span class="hlFld-ContribAuthor ">Ronald D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Gianpaolo  Fogliatto</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Aurelio  Marsiglio</span>, <span class="hlFld-ContribAuthor ">Danilo G.  Mirizzi</span>, <span class="hlFld-ContribAuthor ">Marisa  Montemartini</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Gianluca  Papeo</span>, <span class="hlFld-ContribAuthor ">Claudia  Piutti</span>, <span class="hlFld-ContribAuthor ">Barbara  Salom</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (23)
                                     , 7364-7380. <a href="https://doi.org/10.1016/j.bmc.2013.09.054" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bpyrrolo%25255B1%25252C2-a%25255Dpyrazinones%252Bleads%252Bto%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252BPIM%252Bkinases%26aulast%3DCasuscelli%26aufirst%3DFrancesco%26date%3D2013%26volume%3D21%26issue%3D23%26spage%3D7364%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Harrington</span>, <span class="hlFld-ContribAuthor ">S.  Cheley</span>, <span class="hlFld-ContribAuthor ">L. T.  Alexander</span>, <span class="hlFld-ContribAuthor ">S.  Knapp</span>, <span class="hlFld-ContribAuthor ">H.  Bayley</span>. </span><span class="cited-content_cbyCitation_article-title">Stochastic detection of Pim protein kinases reveals electrostatically enhanced association of a peptide substrate. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2013,</strong> <em>110 </em>
                                    (47)
                                     , E4417-E4426. <a href="https://doi.org/10.1073/pnas.1312739110" title="DOI URL">https://doi.org/10.1073/pnas.1312739110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1312739110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1312739110%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DStochastic%252Bdetection%252Bof%252BPim%252Bprotein%252Bkinases%252Breveals%252Belectrostatically%252Benhanced%252Bassociation%252Bof%252Ba%252Bpeptide%252Bsubstrate%26aulast%3DHarrington%26aufirst%3DL.%26date%3D2013%26date%3D2013%26volume%3D110%26issue%3D47%26spage%3DE4417%26epage%3DE4426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Dwyer</span>, <span class="hlFld-ContribAuthor ">Kartik  Keertikar</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez</span>, <span class="hlFld-ContribAuthor ">Marc  Labroli</span>, <span class="hlFld-ContribAuthor ">Cory  Poker</span>, <span class="hlFld-ContribAuthor ">Thierry O.  Fischmann</span>, <span class="hlFld-ContribAuthor ">Rosemary  Mayer-Ezell</span>, <span class="hlFld-ContribAuthor ">Richard  Bond</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Rita  Azevedo</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Guzi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (22)
                                     , 6178-6182. <a href="https://doi.org/10.1016/j.bmcl.2013.08.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine-based%252BPim%252Binhibitors%25253A%252BA%252Btemplate-based%252Bapproach%26aulast%3DDwyer%26aufirst%3DMichael%2BP.%26date%3D2013%26volume%3D23%26issue%3D22%26spage%3D6178%26epage%3D6182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginie  Suchaud</span>, <span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Saugues</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Vincent  Théry</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (14)
                                     , 4102-4111. <a href="https://doi.org/10.1016/j.bmc.2013.05.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B1%25252C6-dihydropyrazolo%25255B4%25252C3-c%25255Dcarbazoles%252Band%252B3%25252C6-dihydropyrazolo%25255B3%25252C4-c%25255Dcarbazoles%252Bas%252Bnew%252BPim%252Bkinase%252Binhibitors%26aulast%3DSuchaud%26aufirst%3DVirginie%26date%3D2013%26volume%3D21%26issue%3D14%26spage%3D4102%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Ekambaram</span>, <span class="hlFld-ContribAuthor ">Erki  Enkvist</span>, <span class="hlFld-ContribAuthor ">Angela  Vaasa</span>, <span class="hlFld-ContribAuthor ">Marje  Kasari</span>, <span class="hlFld-ContribAuthor ">Gerda  Raidaru</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Asko  Uri</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Bisubstrate Inhibitors with Sub-nanomolar Affinity for Protein Kinase Pim-1. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 909-913. <a href="https://doi.org/10.1002/cmdc.201300042" title="DOI URL">https://doi.org/10.1002/cmdc.201300042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300042%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSelective%252BBisubstrate%252BInhibitors%252Bwith%252BSub-nanomolar%252BAffinity%252Bfor%252BProtein%252BKinase%252BPim-1%26aulast%3DEkambaram%26aufirst%3DRamesh%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D909%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>, <span class="hlFld-ContribAuthor ">Rich  Pastor</span>, <span class="hlFld-ContribAuthor ">Eric  Fan</span>, <span class="hlFld-ContribAuthor ">Huiyong  Hu</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Wei  Deng</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Heidi  Wallweber</span>, <span class="hlFld-ContribAuthor ">John  Moffat</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Grace  Chan</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Allen J.  Ebens</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3149-3153. <a href="https://doi.org/10.1016/j.bmcl.2013.04.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Bas%252Bpotent%252Bpan-Pim%252Binhibitors%252Bby%252Bstructure-%252Band%252Bproperty-based%252Bdrug%252Bdesign%26aulast%3DWang%26aufirst%3DXiaojing%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3149%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wanyeon  Kim</span>, <span class="hlFld-ContribAuthor ">HyeSook  Youn</span>, <span class="hlFld-ContribAuthor ">TaeWoo  Kwon</span>, <span class="hlFld-ContribAuthor ">JiHoon  Kang</span>, <span class="hlFld-ContribAuthor ">EunGi  Kim</span>, <span class="hlFld-ContribAuthor ">Beomseok  Son</span>, <span class="hlFld-ContribAuthor ">Hee Jung  Yang</span>, <span class="hlFld-ContribAuthor ">Youngmi  Jung</span>, <span class="hlFld-ContribAuthor ">BuHyun  Youn</span>. </span><span class="cited-content_cbyCitation_article-title">PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2013,</strong> <em>70 </em>
                                    (1)
                                     , 90-101. <a href="https://doi.org/10.1016/j.phrs.2013.01.005" title="DOI URL">https://doi.org/10.1016/j.phrs.2013.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2013.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2013.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPIM1%252Bkinase%252Binhibitors%252Binduce%252Bradiosensitization%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bcells%26aulast%3DKim%26aufirst%3DWanyeon%26date%3D2013%26volume%3D70%26issue%3D1%26spage%3D90%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of Pim kinases in oncogenic signaling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Signaling crosstalk between Pim and CK2 kinases. Solid lines designate direct modulation. Dotted lines designate indirect modulation. Dashed lines designate interaction with unknown function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative structures of different classes of PIM inhibitors discussed in previous reviews.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative structures of PIM kinase inhibitors published since 2010.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/medium/jm-2012-009234_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of dual Pim/CK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-19/jm3009234/production/images/large/jm-2012-009234_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009234&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i13">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resta, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno-Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1056%2FNEJM200104053441401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=11287972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1031-1037&issue=14&author=B.+J.+Drukerauthor=M.+Talpazauthor=D.+J.+Restaauthor=B.+Pengauthor=E.+Buchdungerauthor=J.+M.+Fordauthor=N.+B.+Lydonauthor=H.+Kantarjianauthor=R.+Capdevilleauthor=S.+Ohno-Jonesauthor=C.+L.+Sawyers&title=Efficacy+and+safety+of+a+specific+inhibitor+of+the+BCR-ABL+tyrosine+kinase+in+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia</span></div><div class="casAuthors">Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabeth; Ford, John M.; Lydon, Nicholas B.; Kantarjian, Hagop; Capdeville, Renaud; Ohno-Jones, Sayuri; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML).  Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML.  Methods: We conducted a phase 1, dose-escalating trial of STI571 (formerly known as CGP 57148B), a specific inhibitor of the BCR-ABL tyrosine kinase.  STI571 was administered orally to 83 patients with CML in the chronic phase in whom treatment with interferon alpha had failed.  Patients were successively assigned to 1 of 14 doses ranging from 25 to 1000 mg per day.  Results: Adverse effects of STI571 were minimal; the most common were nausea, myalgias, edema, and diarrhea.  A maximal tolerated dose was not identified.  Complete hematol. responses were obsd. in 53 of 54 patients treated with daily doses of 300 mg or more and typically occurred in the first four weeks of therapy.  Of the 54 patients treated with doses of 300 mg or more, cytogenetic responses occurred in 29, including 17 (31 percent of the 54 patients who received this dose) with major responses (0 to 35 percent of cells in metaphase pos. for the Philadelphia chromosome); 7 of these patients had complete cytogenetic remissions.  Conclusion: STI571 is well tolerated and has significant antileukemic activity in patients with CML in whom treatment with interferon alpha had failed.  Our results provide evidence of the essential role of BCR-ABL tyrosine kinase activity in CML and demonstrate the potential for the development of anticancer drugs based on the specific mol. abnormality present in a human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrprbDzKoC0ubVg90H21EOLACvtfcHk0lgDD87BB4ETlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGnu70%253D&md5=1554407678838243a753aa056ffd4f7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441401%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DResta%26aufirst%3DD.%2BJ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DOhno-Jones%26aufirst%3DS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520a%2520specific%2520inhibitor%2520of%2520the%2520BCR-ABL%2520tyrosine%2520kinase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26issue%3D14%26spage%3D1031%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stinchcombe, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerciolini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depcik-Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soignet, S. L.</span><span> </span><span class="NLM_article-title">Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4420</span><span class="NLM_x">–</span> <span class="NLM_lpage">4427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1200%2FJCO.2002.01.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=12431963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFCjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=4420-4427&issue=22&author=R.+Z.+Orlowskiauthor=T.+E.+Stinchcombeauthor=B.+S.+Mitchellauthor=T.+C.+Sheaauthor=A.+S.+Baldwinauthor=S.+Stahlauthor=J.+Adamsauthor=D.+L.+Esseltineauthor=P.+J.+Elliottauthor=C.+S.+Pienauthor=R.+Guercioliniauthor=J.+K.+Andersonauthor=N.+D.+Depcik-Smithauthor=R.+Bhagatauthor=M.+J.+Lehmanauthor=S.+C.+Novickauthor=O.+A.+O%E2%80%99Connorauthor=S.+L.+Soignet&title=Phase+I+trial+of+the+proteasome+inhibitor+PS-341+in+patients+with+refractory+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies</span></div><div class="casAuthors">Orlowski, Robert Z.; Stinchcombe, Thomas E.; Mitchell, Beverly S.; Shea, Thomas C.; Baldwin, Albert S.; Stahl, Stephanie; Adams, Julian; Esseltine, Dixie-Lee; Elliott, Peter J.; Pien, Christine S.; Guerciolini, Roberto; Anderson, Jessica K.; Depcik-Smith, Natalie D.; Bhagat, Rita; Lehman, Mary Jo; Novick, Steven C.; O'Connor, Owen A.; Soignet, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4420-4427</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacodynamics (PD) of the proteasome inhibitor bortezomib (previously known as PS-341) in patients with refractory hematol. malignancies.  Patients and Methods: Patients received PS-341 twice weekly for 4 wk at either 0.40,1.04,1.20, or 1.38 mg/m2, followed by a 2-wk rest.  The PD of PS-341 was evaluated by measurement of whole blood 205 proteasome activity.  Results: Twenty-seven patients received 293 doses of PS-341, including 24 complete cycles.  DLTs at doses above the 1.04-mg/m2 MTD attributed to PS-341 included thrombocytopenia, hyponatremia, hypokalemia, fatigue, and malaise.  In three of 10 patients receiving addnl. therapy, serious reversible adverse events appeared during cycle 2, including one episode of postural hypotension, one systemic hypersensitivity reaction, and grade 4 transaminitis in a patient with hepatitis C and a substantial acetaminophen ingestion.  In three of 10 patients receiving addnl. therapy, serious reversible adverse events appeared during cycle 2, including one episode of postural hypotension, one systemic hypersensitivity reaction, and grade 4 transaminitis in a patient with hepatitis C and a substantial acetaminophen ingestion.  Among nine fully assessable patients with heavily pretreated plasma cell dyscrasias completing one cycle of therapy, there was one complete response and a redn. in paraprotein levels and/or marrow plasmacytosis in eight others.  In addn., one patient with mantle cell lymphoma and another with follicular lymphoma had shrinkage of nodal disease.  Conclusion: PS-341 was well tolerated at 1.04 mg/m2 on this dose-intensive schedule, although patients need to be monitored for electrolyte abnormalities and late toxicities.  Addnl. studies are indicated to det. whether incorporation of dose/body surface area yields a superior PD model to dosing without normalization.  PS-341 showed activity against refractory multiple myeloma and possibly non-Hodgkin's lymphoma in this study, and merits further investigation in these populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ7u72jtVj9rVg90H21EOLACvtfcHk0ljDOX8hB-zfjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFCjs70%253D&md5=6992d6ec97624e635a7cdc2aa22a9cd7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.01.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.01.133%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStinchcombe%26aufirst%3DT.%2BE.%26aulast%3DMitchell%26aufirst%3DB.%2BS.%26aulast%3DShea%26aufirst%3DT.%2BC.%26aulast%3DBaldwin%26aufirst%3DA.%2BS.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DEsseltine%26aufirst%3DD.%2BL.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DGuerciolini%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DJ.%2BK.%26aulast%3DDepcik-Smith%26aufirst%3DN.%2BD.%26aulast%3DBhagat%26aufirst%3DR.%26aulast%3DLehman%26aufirst%3DM.%2BJ.%26aulast%3DNovick%26aufirst%3DS.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DSoignet%26aufirst%3DS.%2BL.%26atitle%3DPhase%2520I%2520trial%2520of%2520the%2520proteasome%2520inhibitor%2520PS-341%2520in%2520patients%2520with%2520refractory%2520hematologic%2520malignancies%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26issue%3D22%26spage%3D4420%26epage%3D4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shaheen, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rini, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R. M.</span><span> </span><span class="NLM_article-title">Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports</span> <span class="citation_source-journal">Clin. Genitourin. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.3816%2FCGC.2006.n.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16859583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A280%3ADC%252BD28vjs1OgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=78-81&author=P.+E.+Shaheenauthor=B.+I.+Riniauthor=R.+M.+Bukowski&title=Clinical+activity+of+sorafenib+and+sunitinib+in+renal+cell+carcinoma+refractory+to+previous+vascular+endothelial+growth+factor-targeted+therapy%3A+two+case+reports"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports</span></div><div class="casAuthors">Shaheen Philip E; Rini Brian I; Bukowski Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genitourinary cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-81</span>
        ISSN:<span class="NLM_cas:issn">1558-7673</span>.
    </div><div class="casAbstract">Sunitinib and sorafenib are multitargeted receptor tyrosine kinase inhibitors of the vascular endothelial growth factor and platelet-derived growth factor receptor families with antiangiogenic and antitumor activity in metastatic renal cell carcinoma.  The utility of these agents in patients refractory to previous treatment with the other agent is unknown.  We report 2 cases highlighting that efficacy of these agents is possible after failure of the other agent.  Further prospective study is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQxIi8h5HcCGgRQsDqrjW_fW6udTcc2ead542X1mdV2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vjs1OgsQ%253D%253D&md5=e7085da8beac8238743ab41c28824828</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3816%2FCGC.2006.n.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCGC.2006.n.021%26sid%3Dliteratum%253Aachs%26aulast%3DShaheen%26aufirst%3DP.%2BE.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DBukowski%26aufirst%3DR.%2BM.%26atitle%3DClinical%2520activity%2520of%2520sorafenib%2520and%2520sunitinib%2520in%2520renal%2520cell%2520carcinoma%2520refractory%2520to%2520previous%2520vascular%2520endothelial%2520growth%2520factor-targeted%2520therapy%253A%2520two%2520case%2520reports%26jtitle%3DClin.%2520Genitourin.%2520Cancer%26date%3D2006%26volume%3D5%26spage%3D78%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jackson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L. L.</span><span> </span><span class="NLM_article-title">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.cellimm.2011.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22078270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2012&pages=200-213&author=L.+J.+Jacksonauthor=J.+A.+Phenegerauthor=T.+J.+Phenegerauthor=G.+Davisauthor=A.+D.+Wrightauthor=J.+E.+Robinsonauthor=S.+Allenauthor=M.+C.+Munsonauthor=L.+L.+Carter&title=The+role+of+PIM+kinases+in+human+and+mouse+CD4%2B+T+cell+activation+and+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span></div><div class="casAuthors">Jackson, Leila J.; Pheneger, Jed A.; Pheneger, Tracy J.; Davis, Gregg; Wright, A. Dale; Robinson, John E.; Allen, Shelley; Munson, Mark C.; Carter, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-213</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PIM kinases are a family of three serine/threonine kinases expressed following T cell activation.  Using potent selective small mol. antagonists of PIM-1/3 kinases, we demonstrate a potential role for these enzymes in naive and effector CD4+ T cell activation.  PIM-1/3 inhibition prevented CD4+ T cell proliferation by inducing a G0/G1 cell cycle arrest without affecting cellular survival.  In the absence of PIM-1/3 kinase activity, naive CD4+ T cells failed to fully differentiate into effector cells both in vitro and in vivo.  Therapeutic dosing of a PIM-1/3 inhibitor was efficacious in a CD4+ T cell-mediated model of inflammatory bowel disease suggesting that PIM-1 and PIM-3 kinase activity contributes to sustained disease severity.  These results demonstrate that PIM-1/3 kinases have an important role in CD4+ T cell responses and inhibition of this activity may provide a therapeutic benefit in T cell-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49-JUG78zSLVg90H21EOLACvtfcHk0lj3hEYZaPEG6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP&md5=aa030f7e07e27d4289afdeca873b30a8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BJ.%26aulast%3DPheneger%26aufirst%3DJ.%2BA.%26aulast%3DPheneger%26aufirst%3DT.%2BJ.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DThe%2520role%2520of%2520PIM%2520kinases%2520in%2520human%2520and%2520mouse%2520CD4%252B%2520T%2520cell%2520activation%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2012%26volume%3D272%26spage%3D200%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shin, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicken, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1165%2Frcmb.2011-0190OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22074702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslags7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=488-497&author=Y.+S.+Shinauthor=K.+Takedaauthor=Y.+Shiraishiauthor=Y.+Jiaauthor=M.+Wangauthor=L.+Jacksonauthor=A.+D.+Wrightauthor=L.+Carterauthor=J.+Robinsonauthor=E.+Hickenauthor=E.+W.+Gelfand&title=Inhibition+of+Pim1+kinase+activation+attenuates+allergen-induced+airway+hyperresponsiveness+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation</span></div><div class="casAuthors">Shin, Yoo Seob; Takeda, Katsuyuki; Shiraishi, Yoshiki; Jia, Yi; Wang, Meiqin; Jackson, Leila; Wright, A. Dale; Carter, Laura; Robinson, John; Hicken, Erik; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-497</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Pim kinases are a family of serine/threonine kinases whose activity can be induced by cytokines involved in allergy and asthma.  These kinases play a role in cell survival and proliferation, but have not been examd., to the best of our knowledge, in the development of allergic disease.  This study sought to det. the role of Pim1 kinase in the development of allergic airway responses.  Mice were sensitized and challenged with antigen (primary challenge), or were sensitized, challenged, and rechallenged with allergen in a secondary model.  To assess the role of Pim1 kinase, a small mol. inhibitor was administered orally after sensitization and during the challenge phase.  Airway responsiveness to inhaled methacholine, airway and lung inflammation, cell compn., and cytokine concns. were assessed.  Lung Pim1 kinase concns. were increased after ovalbumin sensitization and challenge.  In the primary allergen challenge model, treatment with the Pim1 kinase inhibitor after sensitization and during airway challenges prevented the development of airway hyperresponsiveness, eosinophilic airway inflammation, and goblet cell metaplasia, and increased Th2 cytokine concns. in bronchoalveolar fluid in a dose-dependent manner.  These effects were also demonstrated after a secondary allergen challenge, where lung allergic disease was established before treatment.  After treatment with the inhibitor, a significant redn. was evident in the no. of CD4+ and CD8+ T cells and concns. of cytokines in the airways.  The inhibition of Pim1 kinase was effective in preventing the development of airway hyperresponsiveness, airway inflammation, and cytokine prodn. in allergen-sensitized and allergen-challenged mice.  These data identify the important role of Pim1 kinase in the full development of allergen-induced airway responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5oneDF7UwgrVg90H21EOLACvtfcHk0lj3hEYZaPEG6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslags7Y%253D&md5=2af50182a23ff340eb3ed21b18aabac4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2011-0190OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2011-0190OC%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%2BS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DHicken%26aufirst%3DE.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DInhibition%2520of%2520Pim1%2520kinase%2520activation%2520attenuates%2520allergen-induced%2520airway%2520hyperresponsiveness%2520and%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26spage%3D488%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cuypers, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quint, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maandag, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boelens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wezenbeek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melief, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Maandagauthor=W.+Boelensauthor=P.+van+Wezenbeekauthor=C.+Meliefauthor=A.+Berns&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0lhOZAgPJribxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMaandag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26aulast%3Dvan%2BWezenbeek%26aufirst%3DP.%26aulast%3DMelief%26aufirst%3DC.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Nawijn, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alendar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">For better or for worse: the role of Pim oncogenes in tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+Pim+oncogenes+in+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lhOZAgPJribxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520Pim%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span>Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects with Relapsed/Refractory Leukemias. <a href="http://clinicaltrials.gov/ct2/show/NCT01239108" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01239108</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+SGI-1776%2C+a+PIM+Kinase+Inhibitor%2C+in+Subjects+with+Relapsed%2FRefractory+Leukemias.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01239108."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span>Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients. <a href="http://clinicaltrials.gov/ct2/show/NCT01489722" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01489722</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Tolerability+of+AZD1208+and+the+Pharmacokinetics+and+Efficacy+of+AZD1208+in+Acute+Myelogenous+Leukemia+%28AML%29+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01489722."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirogane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">Regulation of Pim-1 by Hsp90</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2001&pages=663-669&author=K.+Mizunoauthor=T.+Shiroganeauthor=A.+Shinoharaauthor=A.+Iwamatsuauthor=M.+Hibiauthor=T.+Hirano&title=Regulation+of+Pim-1+by+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DShirogane%26aufirst%3DT.%26aulast%3DShinohara%26aufirst%3DA.%26aulast%3DIwamatsu%26aufirst%3DA.%26aulast%3DHibi%26aufirst%3DM.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520Pim-1%2520by%2520Hsp90%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D281%26spage%3D663%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Study of heat shock protein HSP90 alpha, HSP70, HSP27 mRNA expression in human acute leukemia cells</span> <span class="citation_source-journal">J. Tongji Med. Univ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1007%2FBF02888109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=9389084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=212-216&issue=4&author=K.+Xiaoauthor=W.+Liuauthor=S.+Quauthor=H.+Sunauthor=J.+Tang&title=Study+of+heat+shock+protein+HSP90+alpha%2C+HSP70%2C+HSP27+mRNA+expression+in+human+acute+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Study of heat shock protein HSP90α, HSP70, HSP27 mRNA expression in human acute leukemia cells</span></div><div class="casAuthors">Xiao, Kanyan; Liu, Wenli; Qu, Shen; Sun, Hanying; Tang, Jinzhi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Tongji Medical University</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">JTMUEI</span>;
        ISSN:<span class="NLM_cas:issn">0257-716X</span>.
    
            (<span class="NLM_cas:orgname">Tongji Medical University</span>)
        </div><div class="casAbstract">The expression of three heat shock proteins (HSPs) - HSP90α, HSP70, HSP27 in cells obtained from 22 patients with leukemia, K562 erythroleukemia cell line, and normal blood cells was obsd. by RNA dot blot anal.  The results showed that the expression of the HSP27 gene was enhanced in 4 cases of acute lymphoid leukemia (ALL), 7 cases of acute nonlymphoid leukemia (ANLL) and 2 cases of myelodysplastic syndrome (MDS) as compared with that of the normal blood cells, yet there was no significant difference in the HSP27 expression between the ALL and ANLL cells.  The expression in HSP70 in all 5 ALL and ANLL patients was much lower than that of the normal subjects, except 1 case of ALL and 1 case of MDS, in which the expression was obviously enhanced.  All the cases including 11 ANLL, 5 ALL and 1 MDS had higher HSP90α expression than the normal subjects.  The enhanced expression of HSP90α in leukemia cells may be assocd. with the active and indefinite proliferation of leukemia cells.  The authors' results also suggest that the high expression of the HSP27 gene may not be confined to a specific type of acute leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDavjXPkXArVg90H21EOLACvtfcHk0lh3ANS4Ndgtjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFOju7o%253D&md5=ff1ffad4ecf486951af7178b052e2280</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2FBF02888109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02888109%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStudy%2520of%2520heat%2520shock%2520protein%2520HSP90%2520alpha%252C%2520HSP70%252C%2520HSP27%2520mRNA%2520expression%2520in%2520human%2520acute%2520leukemia%2520cells%26jtitle%3DJ.%2520Tongji%2520Med.%2520Univ.%26date%3D1996%26volume%3D16%26issue%3D4%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Forshell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forshell, T. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudelius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J.</span><span> </span><span class="NLM_article-title">The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=448-460&author=L.+P.+Forshellauthor=Y.+Liauthor=T.+Z.+Forshellauthor=M.+Rudeliusauthor=L.+Nilssonauthor=U.+Kellerauthor=J.+Nilsson&title=The+direct+Myc+target+Pim3+cooperates+with+other+Pim+kinases+in+supporting+viability+of+Myc-induced+B-cell+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForshell%26aufirst%3DL.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DForshell%26aufirst%3DT.%2BZ.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%26atitle%3DThe%2520direct%2520Myc%2520target%2520Pim3%2520cooperates%2520with%2520other%2520Pim%2520kinases%2520in%2520supporting%2520viability%2520of%2520Myc-induced%2520B-cell%2520lymphomas%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D448%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mikkers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipscheer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeijn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fng950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=12185366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=153-159&author=H.+Mikkersauthor=J.+Allenauthor=P.+Knipscheerauthor=L.+Romeijnauthor=A.+Hartauthor=E.+Vinkauthor=A.+Berns&title=High-throughput+retroviral+tagging+to+identify+components+of+specific+signaling+pathways+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span></div><div class="casAuthors">Mikkers, Harald; Allen, John; Knipscheer, Puck; Romeyn, Lieke; Hart, Augustinus; Vink, Edwin; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genetic screens carried out in lower organisms such as yeast, Drosophila melanogaster and Caenorhabditis elegans have revealed many signaling pathways.  For example, components of the RAS signaling cascade were identified using a mutant eye phenotype in D. melanogaster as a readout.  Screening is usually based on enhancing or suppressing a phenotype by way of a known mutation in a particular signaling pathway.  Such in vivo screens have been difficult to carry out in mammals, however, owing to their relatively long generation times and the limited no. of animals that can be screened.  Here the authors describe an in vivo mammalian genetic screen used to identify components of pathways contributing to oncogenic transformation.  The authors applied retroviral insertional mutagenesis in Myc transgenic (EμMyc) mice lacking expression of Pim1 and Pim2 to search for genes that can substitute for Pim1 and Pim2 in lymphomagenesis.  The authors detd. the chromosomal positions of 477 retroviral insertion sites (RISs) derived from 38 tumors from EμMyc Pim1-/- Pim2-/- mice and 27 tumors from EμMyc control mice using the Ensembl and Celera annotated mouse genome databases.  There were 52 sites occupied by proviruses in more than one tumor.  These common insertion sites (CISs) are likely to contain genes contributing to tumorigenesis.  Comparison of the RISs in tumors of Pim-null mice with the RISs in tumors of EμMyc control mice indicated that 10 of the 52 CISs belong to the Pim complementation group.  In addn., Pim3 is selectively activated in Pim-null tumor cells, which supports the validity of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6i2tPp4vS3rVg90H21EOLACvtfcHk0lh3ANS4Ndgtjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D&md5=fa564ec068d8e70c8aefb533008ad738</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fng950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng950%26sid%3Dliteratum%253Aachs%26aulast%3DMikkers%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DRomeijn%26aufirst%3DL.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DVink%26aufirst%3DE.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DHigh-throughput%2520retroviral%2520tagging%2520to%2520identify%2520components%2520of%2520specific%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D153%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span> </span><span class="NLM_article-title">Structure and substrate specificity of the Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">41675</span><span class="NLM_x">–</span> <span class="NLM_lpage">41682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=41675-41682&author=A.+N.+Bullockauthor=J.+Debreczeniauthor=A.+L.+Amosauthor=S.+Knappauthor=B.+E.+Turk&title=Structure+and+substrate+specificity+of+the+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DAmos%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26atitle%3DStructure%2520and%2520substrate%2520specificity%2520of%2520the%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D41675%26epage%3D41682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Amaravadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The survival kinases Akt and Pim as potential pharmacological targets</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1172%2FJCI26273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16200194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=2618-2624&issue=10&author=R.+Amaravadiauthor=C.+B.+Thompson&title=The+survival+kinases+Akt+and+Pim+as+potential+pharmacological+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The survival kinases Akt and Pim as potential pharmacological targets</span></div><div class="casAuthors">Amaravadi, Ravi; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2618-2624</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  The Akt and Pim kinases are cytoplasmic protein serine/threonine kinases that control programmed cell death (apoptosis) by phosphorylating substrates that regulate both apoptosis and cellular metab.  The phosphatidylinositol 3-kinase-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways.  Pharmacol. manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUNe0bt5gIJrVg90H21EOLACvtfcHk0ljt9ax3wHY5uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygt7vL&md5=d501bb9ac92d6d2674d09e6375acb57e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI26273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI26273%26sid%3Dliteratum%253Aachs%26aulast%3DAmaravadi%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520survival%2520kinases%2520Akt%2520and%2520Pim%2520as%2520potential%2520pharmacological%2520targets%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26issue%3D10%26spage%3D2618%26epage%3D2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tamburini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzunov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifrah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span> </span><span class="NLM_article-title">Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1618-1627&author=J.+Tamburiniauthor=A.+S.+Greenauthor=V.+Bardetauthor=N.+Chapuisauthor=S.+Parkauthor=L.+Willemsauthor=M.+Uzunovauthor=N.+Ifrahauthor=F.+Dreyfusauthor=C.+Lacombeauthor=P.+Mayeuxauthor=D.+Bouscary&title=Protein+synthesis+is+resistant+to+rapamycin+and+constitutes+a+promising+therapeutic+target+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamburini%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DA.%2BS.%26aulast%3DBardet%26aufirst%3DV.%26aulast%3DChapuis%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DWillems%26aufirst%3DL.%26aulast%3DUzunov%26aufirst%3DM.%26aulast%3DIfrah%26aufirst%3DN.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DBouscary%26aufirst%3DD.%26atitle%3DProtein%2520synthesis%2520is%2520resistant%2520to%2520rapamycin%2520and%2520constitutes%2520a%2520promising%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1618%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Channavajhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span> </span><span class="NLM_article-title">Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">34</span><span class="NLM_x">) </span> <span class="NLM_fpage">5280</span><span class="NLM_x">–</span> <span class="NLM_lpage">5288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=5280-5288&issue=34&author=P.+Channavajhalaauthor=D.+C.+Seldin&title=Functional+interaction+of+protein+kinase+CK2+and+c-Myc+in+lymphomagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChannavajhala%26aufirst%3DP.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DFunctional%2520interaction%2520of%2520protein%2520kinase%2520CK2%2520and%2520c-Myc%2520in%2520lymphomagenesis%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26issue%3D34%26spage%3D5280%26epage%3D5288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ahmad, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2—a key suppressor of apoptosis</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=179-187&author=K.+A.+Ahmadauthor=G.+Wangauthor=G.+Ungerauthor=J.+Slatonauthor=K.+Ahmed&title=Protein+kinase+CK2%E2%80%94a+key+suppressor+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%25E2%2580%2594a%2520key%2520suppressor%2520of%2520apoptosis%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2008%26volume%3D48%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bliesath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proffitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span> </span><span class="NLM_article-title">Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.canlet.2012.02.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22387988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2012&pages=113-118&author=J.+Bliesathauthor=N.+Huserauthor=M.+Omoriauthor=D.+Bunagauthor=C.+Proffittauthor=N.+Streinerauthor=C.+Hoauthor=A.+Siddiqui-Jainauthor=S.+E.+O%E2%80%99Brienauthor=J.+K.+Limauthor=D.+M.+Ryckmanauthor=K.+Anderesauthor=W.+G.+Riceauthor=D.+Drygin&title=Combined+inhibition+of+EGFR+and+CK2+augments+the+attenuation+of+PI3K-Akt-mTOR+signaling+and+the+killing+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells</span></div><div class="casAuthors">Bliesath, Joshua; Huser, Nanni; Omori, Mayuko; Bunag, Daniel; Proffitt, Chris; Streiner, Nicole; Ho, Caroline; Siddiqui-Jain, Adam; O'Brien, Sean E.; Lim, John K. C.; Ryckman, David M.; Anderes, Kenna; Rice, William G.; Drygin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-118</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ser/Thr protein kinase CK2 regulates multiple processes that play important roles in the sensitivity of cancer to epidermal growth factor receptor targeting therapeutics, including PI3K-Akt-mTOR signaling, Hsp90 activity, and inhibition of apoptosis.  We hypothesized that top-down inhibition of EGFR, combined with lateral suppression of multiple oncogenic pathways by targeting CK2, would create a pharmacol. synthetic lethal event and result in an improved cancer therapy compared to EGFR inhibition alone.  This hypothesis was tested by combining CX-4945, a first-in-class clin. stage inhibitor of CK2, with the EGFR tyrosine kinase inhibitor, erlotinib, in vitro and in vivo in models of non-small cell lung carcinoma, NCI-H2170, and squamous cell carcinoma, A431.  Our results demonstrate that combination of CX-4945 with erlotinib results in enhanced attenuation of the PI3K-Akt-mTOR pathway.  We also obsd. an increase in apoptosis, synergistic killing of cancer cells in vitro, as well as improved antitumor efficacy in vivo.  Taken together, these data position CK2 as a valid pharmacol. target for drug combinations and support further evaluation of CX-4945 in combination with EGFR targeting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzYiiE9A2ALVg90H21EOLACvtfcHk0lg1E188lIvM9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFynsLg%253D&md5=dcb2f8e5c5b24ead5bbd9bb37b1c5d33</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2012.02.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2012.02.032%26sid%3Dliteratum%253Aachs%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DBunag%26aufirst%3DD.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DDrygin%26aufirst%3DD.%26atitle%3DCombined%2520inhibition%2520of%2520EGFR%2520and%2520CK2%2520augments%2520the%2520attenuation%2520of%2520PI3K-Akt-mTOR%2520signaling%2520and%2520the%2520killing%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2012%26volume%3D322%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Romieu-Mourez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landesman-Bollag, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traish, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G. E.</span><span> </span><span class="NLM_article-title">Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3810</span><span class="NLM_x">–</span> <span class="NLM_lpage">3818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3810-3818&issue=9&author=R.+Romieu-Mourezauthor=E.+Landesman-Bollagauthor=D.+C.+Seldinauthor=A.+M.+Traishauthor=F.+Mercurioauthor=G.+E.+Sonenshein&title=Roles+of+IKK+kinases+and+protein+kinase+CK2+in+activation+of+nuclear+factor-kappaB+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomieu-Mourez%26aufirst%3DR.%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26aulast%3DTraish%26aufirst%3DA.%2BM.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DSonenshein%26aufirst%3DG.%2BE.%26atitle%3DRoles%2520of%2520IKK%2520kinases%2520and%2520protein%2520kinase%2520CK2%2520in%2520activation%2520of%2520nuclear%2520factor-kappaB%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26issue%3D9%26spage%3D3810%26epage%3D3818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. H.</span><span> </span><span class="NLM_article-title">Pim-1 plays a pivotal role in hypoxia-induced chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2581</span><span class="NLM_x">–</span> <span class="NLM_lpage">2592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=2581-2592&author=J.+Chenauthor=M.+Kobayashiauthor=S.+Darmaninauthor=Y.+Qiaoauthor=C.+Gullyauthor=R.+Zhaoauthor=S.+C.+Yeungauthor=M.+H.+Lee&title=Pim-1+plays+a+pivotal+role+in+hypoxia-induced+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DDarmanin%26aufirst%3DS.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DGully%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DYeung%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DM.%2BH.%26atitle%3DPim-1%2520plays%2520a%2520pivotal%2520role%2520in%2520hypoxia-induced%2520chemoresistance%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3D2581%26epage%3D2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mottet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruys, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demazy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, C.</span><span> </span><span class="NLM_article-title">Role for casein kinase 2 in the regulation of HIF-1 activity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1002%2Fijc.21268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=15957168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=764-774&issue=5&author=D.+Mottetauthor=S.+P.+Ruysauthor=C.+Demazyauthor=M.+Raesauthor=C.+Michiels&title=Role+for+casein+kinase+2+in+the+regulation+of+HIF-1+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role for casein kinase 2 in the regulation of HIF-1 activity</span></div><div class="casAuthors">Mottet, Denis; Ruys, Sebastien Pyr Dit; Demazy, Catherine; Raes, Martine; Michiels, Carine</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor that plays a major role in cellular adaptation to hypoxia.  The mechanisms regulating HIF-1 activity occurs at multiple levels in vivo.  The HIF-1α subunit is highly sensible to oxygen and is rapidly degraded by the proteasome 26S in normoxia.  Activation in hypoxia occurs through a multistep process including inhibition of HIF-1α degrdn., but also increase in the transactivation activity of HIF-1.  Several data indicate that phosphorylation could play a role in this regulation.  In this report, we investigated the role of casein kinase 2 (CK2), an ubiquitous serine/threonine kinase, in the regulation of HIF-1 activity.  Hypoxia was capable of increasing the expression of the β subunit of CK2, of inducing a relocalization of this subunit at the plasma membrane, of inducing nuclear translocation of the α subunit and of increasing CK2 activity.  Three inhibitors of this kinase, DRB (5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole), TBB (4,5,6,7-tetrabromotriazole) and apigenin, as well as overexpression of a partial dominant neg. mutant of CK2α, were shown to inhibit HIF-1 activity as measured by a reporter assay and through hypoxia-induced VEGF and aldolase expression.  This does not occur at the stabilization process since they did not affect HIF-1α protein level.  DNA-binding activity was also not inhibited.  We conclude that CK2 is an important regulator of HIF-1 transcriptional activity but the mechanism of this regulation remains to be detd.  Since HIF-1 plays a major role in tumor angiogenesis and since CK2 has been described to be overexpressed in tumor cells, this new pathway of regulation can be one more way for tumor cells to survive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNBUuSy-fVrLVg90H21EOLACvtfcHk0liHy8O506H7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsbbP&md5=3c2c35b3ee77a4bff73e14a34f3fbec0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fijc.21268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21268%26sid%3Dliteratum%253Aachs%26aulast%3DMottet%26aufirst%3DD.%26aulast%3DRuys%26aufirst%3DS.%2BP.%26aulast%3DDemazy%26aufirst%3DC.%26aulast%3DRaes%26aufirst%3DM.%26aulast%3DMichiels%26aufirst%3DC.%26atitle%3DRole%2520for%2520casein%2520kinase%25202%2520in%2520the%2520regulation%2520of%2520HIF-1%2520activity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D117%26issue%3D5%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustolon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertacchini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmiroli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6915</span><span class="NLM_x">–</span> <span class="NLM_lpage">6926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=6915-6926&author=G.+Di+Mairaauthor=F.+Brustolonauthor=J.+Bertacchiniauthor=K.+Tosoniauthor=S.+Marmiroliauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Pharmacological+inhibition+of+protein+kinase+CK2+reverts+the+multidrug+resistance+phenotype+of+a+CEM+cell+line+characterized+by+high+CK2+level"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DBertacchini%26aufirst%3DJ.%26aulast%3DTosoni%26aufirst%3DK.%26aulast%3DMarmiroli%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DPharmacological%2520inhibition%2520of%2520protein%2520kinase%2520CK2%2520reverts%2520the%2520multidrug%2520resistance%2520phenotype%2520of%2520a%2520CEM%2520cell%2520line%2520characterized%2520by%2520high%2520CK2%2520level%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D6915%26epage%3D6926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimelis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span> </span><span class="NLM_article-title">The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">3349</span><span class="NLM_x">–</span> <span class="NLM_lpage">3356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=3349-3356&author=Y.+Xieauthor=K.+Xuauthor=D.+E.+Linnauthor=X.+Yangauthor=Z.+Guoauthor=H.+Shimelisauthor=T.+Nakanishiauthor=D.+D.+Rossauthor=H.+Chenauthor=L.+Fazliauthor=M.+E.+Gleaveauthor=Y.+Qiu&title=The+44-kDa+Pim-1+kinase+phosphorylates+BCRP%2FABCG2+and+thereby+promotes+its+multimerization+and+drug-resistant+activity+in+human+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLinn%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DShimelis%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DFazli%26aufirst%3DL.%26aulast%3DGleave%26aufirst%3DM.%2BE.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DThe%252044-kDa%2520Pim-1%2520kinase%2520phosphorylates%2520BCRP%252FABCG2%2520and%2520thereby%2520promotes%2520its%2520multimerization%2520and%2520drug-resistant%2520activity%2520in%2520human%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D3349%26epage%3D3356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, E. N.</span><span> </span><span class="NLM_article-title">A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=156-166&author=Y.+Zhengauthor=H.+Qinauthor=S.+J.+Frankauthor=L.+Dengauthor=D.+W.+Litchfieldauthor=A.+Tefferiauthor=A.+Pardananiauthor=F.+T.+Linauthor=J.+Liauthor=B.+Shaauthor=E.+N.+Benveniste&title=A+CK2-dependent+mechanism+for+activation+of+the+JAK-STAT+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DF.%2BT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSha%26aufirst%3DB.%26aulast%3DBenveniste%26aufirst%3DE.%2BN.%26atitle%3DA%2520CK2-dependent%2520mechanism%2520for%2520activation%2520of%2520the%2520JAK-STAT%2520signaling%2520pathway%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D156%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Miyata, Y.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11–12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1007%2Fs00018-009-9152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19387550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1840-1849&issue=11%E2%80%9312&author=Y.+Miyata&title=Protein+kinase+CK2+in+health+and+disease%3A+CK2%3A+the+kinase+controlling+the+Hsp90+chaperone+machinery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CK2: the kinase controlling the Hsp90 chaperone machinery</span></div><div class="casAuthors">Miyata, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1840-1849</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells.  Hsp90 is a major mol. chaperone that is required for the folding and function of its client proteins.  A complex contg. Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37.  Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions.  Here, crit. roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described.  CK2 phosphorylates and modulates Hsp90 and its co-chaperones, FKBP52 and Cdc37.  CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases.  The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW2ZhBoll7aLVg90H21EOLACvtfcHk0lijH7Z03LjzPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7o%253D&md5=b4447a54564fde9c88ba6ab0b5b22e90</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9152-0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520health%2520and%2520disease%253A%2520CK2%253A%2520the%2520kinase%2520controlling%2520the%2520Hsp90%2520chaperone%2520machinery%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2580%259312%26spage%3D1840%26epage%3D1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jacobs, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span> </span><span class="NLM_article-title">Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13728</span><span class="NLM_x">–</span> <span class="NLM_lpage">13734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13728-13734&author=M.+D.+Jacobsauthor=J.+Blackauthor=O.+Futerauthor=L.+Swensonauthor=B.+Hareauthor=M.+Flemingauthor=K.+Saxena&title=Pim-1+ligand-bound+structures+reveal+the+mechanism+of+serine%2Fthreonine+kinase+inhibition+by+LY294002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%26aulast%3DFuter%26aufirst%3DO.%26aulast%3DSwenson%26aufirst%3DL.%26aulast%3DHare%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DSaxena%26aufirst%3DK.%26atitle%3DPim-1%2520ligand-bound%2520structures%2520reveal%2520the%2520mechanism%2520of%2520serine%252Fthreonine%2520kinase%2520inhibition%2520by%2520LY294002%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13728%26epage%3D13734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandiyan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span> </span><span class="NLM_article-title">Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2005&pages=183-193&author=A.+Kumarauthor=V.+Mandiyanauthor=Y.+Suzukiauthor=C.+Zhangauthor=J.+Riceauthor=J.+Tsaiauthor=D.+R.+Artisauthor=P.+Ibrahimauthor=R.+Bremer&title=Crystal+structures+of+proto-oncogene+kinase+Pim1%3A+a+target+of+aberrant+somatic+hypermutations+in+diffuse+large+cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DMandiyan%26aufirst%3DV.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DBremer%26aufirst%3DR.%26atitle%3DCrystal%2520structures%2520of%2520proto-oncogene%2520kinase%2520Pim1%253A%2520a%2520target%2520of%2520aberrant%2520somatic%2520hypermutations%2520in%2520diffuse%2520large%2520cell%2520lymphoma%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D348%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptiste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1107%2FS1744309104029963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16508102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=96-99&author=K.+C.+Qianauthor=J.+Studtsauthor=L.+Wangauthor=K.+Barringerauthor=A.+Kronkaitisauthor=C.+Pengauthor=A.+Baptisteauthor=R.+LaFranceauthor=S.+Mischeauthor=B.+Farmer&title=Expression%2C+purification%2C+crystallization+and+preliminary+crystallographic+analysis+of+human+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase</span></div><div class="casAuthors">Qian, Kevin C.; Studts, Joey; Wang, Lian; Barringer, Kevin; Kronkaitis, Anthony; Peng, Charline; Baptiste, Alistair; LaFrance, Roger; Mische, Sheenah; Farmer, Bennett</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">F61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Pim kinases, including Pim-1, Pim-2, and Pim-3, belong to a distinctive serine/threonine protein kinase family.  They are involved in cytokine-induced signal transduction and the development of lymphoid malignancies.  Their kinase domains are highly homologous to one another, but share low sequence identity to other kinases.  Specifically, there are 2 Pro residues in the conserved hinge-region sequence ERPXPX sepd. by a residue that is non-conserved among Pim kinases.  Here, full-length human Pim-1 kinase (1-313) was cloned and expressed in Escherichia coli as a GST-fusion protein and truncated to Pim-1 (14-313) by thrombin digestion during purifn.  The Pim-1 (14-313) protein was purified to high homogeneity and monodispersity.  This protein prepn. yielded small crystals in the initial screening and large crystals after optimization.  The large crystals of apo Pim-1 kinase diffracted to 2.1 Å resoln. and belonged to space group P65, with unit-cell parameters a = b = 95.9, c = 80.0 Å, β = 120° and one mol. per asym. unit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLbLQgcrPUrVg90H21EOLACvtfcHk0lgNqpkhJcmHSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVGnsg%253D%253D&md5=4cfe5a9f248a6699287f9a96c627f4ac</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS1744309104029963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309104029963%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DBaptiste%26aufirst%3DA.%26aulast%3DLaFrance%26aufirst%3DR.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DExpression%252C%2520purification%252C%2520crystallization%2520and%2520preliminary%2520crystallographic%2520analysis%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2005%26volume%3D61%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">6130</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6130-6137&author=K.+C.+Qianauthor=L.+Wangauthor=E.+R.+Hickeyauthor=J.+Studtsauthor=K.+Barringerauthor=C.+Pengauthor=A.+Kronkaitisauthor=J.+Liauthor=A.+Whiteauthor=S.+Mischeauthor=B.+Farmer&title=Structural+basis+of+constitutive+activity+and+a+unique+nucleotide+binding+mode+of+human+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520constitutive%2520activity%2520and%2520a%2520unique%2520nucleotide%2520binding%2520mode%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D6130%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Delft, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7112&issue=10&author=A.+N.+Bullockauthor=S.+Russoauthor=A.+Amosauthor=N.+Paganoauthor=H.+Bregmanauthor=J.+E.+Debreczeniauthor=W.+H.+Leeauthor=F.+von+Delftauthor=E.+Meggersauthor=S.+Knapp&title=Crystal+structure+of+the+PIM2+kinase+in+complex+with+an+organoruthenium+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DAmos%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DN.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3Dvon%2BDelft%26aufirst%3DF.%26aulast%3DMeggers%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520PIM2%2520kinase%2520in%2520complex%2520with%2520an%2520organoruthenium%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magboo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1814</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801242y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1814-1827&issue=7&author=K.+Qianauthor=L.+Wangauthor=C.+L.+Cywinauthor=B.+T.+Farmerauthor=E.+Hickeyauthor=C.+Homonauthor=S.+Jakesauthor=M.+A.+Kashemauthor=G.+Leeauthor=S.+Leonardauthor=J.+Liauthor=R.+Magbooauthor=W.+Maoauthor=E.+Packauthor=C.+Pengauthor=A.+Prokopowiczauthor=M.+Welzelauthor=J.+Wolakauthor=T.+Morwick&title=Hit+to+lead+account+of+the+discovery+of+a+new+class+of+inhibitors+of+Pim+kinases+and+crystallographic+studies+revealing+an+unusual+kinase+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm801242y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801242y%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DFarmer%26aufirst%3DB.%2BT.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DHomon%26aufirst%3DC.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMagboo%26aufirst%3DR.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DPack%26aufirst%3DE.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DProkopowicz%26aufirst%3DA.%26aulast%3DWelzel%26aufirst%3DM.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DHit%2520to%2520lead%2520account%2520of%2520the%2520discovery%2520of%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520Pim%2520kinases%2520and%2520crystallographic%2520studies%2520revealing%2520an%2520unusual%2520kinase%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D7%26spage%3D1814%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3171-3185&author=M.+Lopez-Ramosauthor=R.+Prudentauthor=V.+Moucadelauthor=C.+F.+Sautelauthor=C.+Baretteauthor=L.+Lafanechereauthor=L.+Mouawadauthor=D.+Griersonauthor=F.+Schmidtauthor=J.+C.+Florentauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=S.+Knappauthor=J.+B.+Reiserauthor=C.+Cochet&title=New+potent+dual+inhibitors+of+CK2+and+Pim+kinases%3A+discovery+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DJ.%2BB.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%253A%2520discovery%2520and%2520structural%2520insights%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3171%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3327-3331&author=F.+Pierreauthor=C.+F.+Reganauthor=M.+C.+Chevrelauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=W.+G.+Riceauthor=D.+M.+Ryckman&title=Novel+potent+dual+inhibitors+of+CK2+and+Pim+kinases+with+antiproliferative+activity+against+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DChevrel%26aufirst%3DM.%2BC.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3DNovel%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%2520with%2520antiproliferative%2520activity%2520against%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3327%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtil, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danilenko, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.2174%2F092986710793348554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20939820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=4114-4133&author=F.+Anizonauthor=A.+A.+Shtilauthor=V.+N.+Danilenkoauthor=P.+Moreau&title=Fighting+tumor+cell+survival%3A+advances+in+the+design+and+evaluation+of+Pim+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fighting tumor cell survival: advances in the design and evaluation of pim inhibitors</span></div><div class="casAuthors">Anizon, F.; Shtil, A. A.; Danilenko, V. N.; Moreau, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">4114-4133</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Pim (provirus insertion site of Moloney murine leukemia virus) family of serine/threonine protein kinases possesses the fundamental characteristics crit. for the biol. of eukaryotes, in particular, survival and malignant transformation of cells.  The members of this protein family (Pim-1 to Pim-3) are aberrantly expressed in human tumors, most frequently in prostate cancer and hematol. malignancies.  Therefore, Pim proteins are widely considered as attractive targets in cancer chemotherapy.  Growing knowledge of mechanisms of Pim-mediated anti-apoptosis and transformation, as well as rapid progress in the design of Pim-modulating compds. dictate the need for an in-depth anal. of the chem. of inhibitors and the modes of their interaction with these protein kinases.  This review summarizes recent advances in understanding the mol. events regulated by Pim proteins.  In addn., we focus on the non-patent literature (mostly since 2005) that demonstrates a diversity of chem. classes of small mol. wt. Pim inhibitors.  The X-ray co-crystal structures of complexes Pim:inhibitor provide evidence for SAR data important for the choice of synthetic routes, optimization of lead compds. and testing chem. libraries.  We also discuss a cell-based test system useful for rapid and inexpensive pre-screening of compds. capable of preventing Pim-mediated phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiicnOer8gErVg90H21EOLACvtfcHk0ljExoM4WaIzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgtbbK&md5=7d05b928cf825cfa54b00ba2f015e85d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F092986710793348554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793348554%26sid%3Dliteratum%253Aachs%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DShtil%26aufirst%3DA.%2BA.%26aulast%3DDanilenko%26aufirst%3DV.%2BN.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DFighting%2520tumor%2520cell%2520survival%253A%2520advances%2520in%2520the%2520design%2520and%2520evaluation%2520of%2520Pim%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D4114%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">Pim kinase inhibitors: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1517%2F13543770903496442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20100002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=193-212&issue=2&author=T.+Morwick&title=Pim+kinase+inhibitors%3A+a+survey+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinase inhibitors: a survey of the patent literature</span></div><div class="casAuthors">Morwick, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Pim kinases have recently emerged as targets of interest in oncol. and immune regulation.  Ongoing studies have identified a role for these proteins in cell survival and proliferation, both functionally and mechanistically, and overexpression has been obsd. in a no. of human cancers and inflammatory states.  Areas covered in this review: This report reviews the patent literature for Pim kinase inhibitors identified from a search of the Thomson patent databases from 1970 through July 2009.  Full analyses are provided for publications reporting Pim kinases as primary targets, and a cursory description is given for those disclosing Pim as one of a limited no. of secondary targets.  What the reader will gain: Readers will gain an overview of the various inhibitor series including coverage, potency, selectivity, protein binding features and therapeutic focus, and an appreciation for which scaffolds and structural features have been most highly exploited.  Take home message: A greater understanding of pathol. mechanisms for Pim kinases has stimulated the recent development of a variety of inhibitor classes with one compd. advancing into the clinic earlier this year.  Ongoing studies will help define applications for these inhibitors in the treatment of Pim-assocd. human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qJ9wz2Tau7Vg90H21EOLACvtfcHk0ljExoM4WaIzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D&md5=21d9c3c31b2af04e63bef9ac5adaf549</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F13543770903496442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903496442%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DPim%2520kinase%2520inhibitors%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D193%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tao, Z. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span> </span><span class="NLM_article-title">Discovery of 3<i>H</i>-benzo[4,5]thieno[3,2-<i>d</i>]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900943h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6621-6636&issue=21&author=Z.+F.+Taoauthor=L.+A.+Hasvoldauthor=J.+D.+Leversonauthor=E.+K.+Hanauthor=R.+Guanauthor=E.+F.+Johnsonauthor=V.+S.+Stollauthor=K.+D.+Stewartauthor=G.+Stamperauthor=N.+Soniauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=T.+J.+Sowinauthor=N.+H.+Linauthor=V.+S.+Girandaauthor=S.+H.+Rosenbergauthor=T.+D.+Penning&title=Discovery+of+3H-benzo%5B4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-ones+as+potent%2C+highly+selective%2C+and+orally+bioavailable+inhibitors+of+the+human+protooncogene+proviral+insertion+site+in+moloney+murine+leukemia+virus+%28PIM%29+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm900943h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900943h%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%2BF.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStamper%26aufirst%3DG.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DGiranda%26aufirst%3DV.%2BS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520of%25203H-benzo%255B4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-ones%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520human%2520protooncogene%2520proviral%2520insertion%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520%2528PIM%2529%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D21%26spage%3D6621%26epage%3D6636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V.</span><span> </span><span class="NLM_article-title">Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=4150-4157&author=L.+S.+Chenauthor=S.+Redkarauthor=D.+Bearssauthor=W.+G.+Wierdaauthor=V.+Gandhi&title=Pim+kinase+inhibitor%2C+SGI-1776%2C+induces+apoptosis+in+chronic+lymphocytic+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DPim%2520kinase%2520inhibitor%252C%2520SGI-1776%252C%2520induces%2520apoptosis%2520in%2520chronic%2520lymphocytic%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D4150%26epage%3D4157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mumenthaler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanekal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1158%2F1535-7163.MCT-09-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19825806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2882-2893&author=S.+M.+Mumenthalerauthor=P.+Y.+Ngauthor=A.+Hodgeauthor=D.+Bearssauthor=G.+Berkauthor=S.+Kanekalauthor=S.+Redkarauthor=P.+Tavernaauthor=D.+B.+Agusauthor=A.+Jain&title=Pharmacologic+inhibition+of+Pim+kinases+alters+prostate+cancer+cell+growth+and+resensitizes+chemoresistant+cells+to+taxanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span></div><div class="casAuthors">Mumenthaler, Shannon M.; Ng, Patricia Y. B.; Hodge, Amanda; Bearss, David; Berk, Gregory; Kanekal, Sarath; Redkar, Sanjeev; Taverna, Pietro; Agus, David B.; Jain, Anjali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2882-2893</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine family of Pim kinases function as oncogenes and have been implicated in prostate cancer progression, particularly in hormone-refractory prostate disease, as a result of their antiapoptotic function.  In this study, we used a pharmacol. inhibitor targeting the Pim family members, SGI-1776, to det. whether modulation of Pim kinase activity could alter prostate cancer cell survival and modulate chemotherapy resistance.  Extensive biochem. characterization of SGI-1776 confirmed its specificity for the three isoforms of the Pim family.  Treatment of prostate cancer cells with SGI-1776 resulted in a dose-dependent redn. in phosphorylation of known Pim kinase substrates that are involved in cell cycle progression and apoptosis (p21Cip1/WAF1 and Bad).  Consequently, SGI-1776 compromised overall cell viability by inducing G1 cell cycle arrest and triggering apoptosis.  Overexpression of recombinant Pim-1 markedly increased sensitivity of SGI-1776-mediated prostate cancer cell apoptosis and p21Cip1/WAF1 phosphorylation inhibition, reinforcing the specificity of SGI-1776.  An addnl. cytotoxic effect was obsd. when SGI-1776 was combined with taxane-based chemotherapy agents.  SGI-1776 was able to reduce cell viability in a multidrug resistance 1 protein-based taxane-refractory prostate cancer cell line.  In addn., SGI-1776 treatment was able to resensitize chemoresistant cells to taxane-based therapies by inhibiting multidrug resistance 1 activity and inducing apoptosis.  These findings support the idea that inhibiting Pim kinases, in combination with a chemotherapeutic agent, could play an important role in prostate cancer treatment by targeting the clin. problem of chemoresistance. [Mol Cancer Ther 2009;8(10):2882-93].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGQXKbXm4Y7Vg90H21EOLACvtfcHk0lgQOAaUPsEPiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E&md5=b6353cdc3b367e336a707147e5c99a4c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0293%26sid%3Dliteratum%253Aachs%26aulast%3DMumenthaler%26aufirst%3DS.%2BM.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DHodge%26aufirst%3DA.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DBerk%26aufirst%3DG.%26aulast%3DKanekal%26aufirst%3DS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DJain%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520Pim%2520kinases%2520alters%2520prostate%2520cancer%2520cell%2520growth%2520and%2520resensitizes%2520chemoresistant%2520cells%2520to%2520taxanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2882%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Pogacic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Monard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">Structural analysis identifies imidazo[1,2-<i>b</i>]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6916</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6916-6924&author=V.+Pogacicauthor=A.+N.+Bullockauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=C.+Gasserauthor=A.+Biondiauthor=S.+Meyer-Monardauthor=S.+Knappauthor=J.+Schwaller&title=Structural+analysis+identifies+imidazo%5B1%2C2-b%5Dpyridazines+as+PIM+kinase+inhibitors+with+in+vitro+antileukemic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPogacic%26aufirst%3DV.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBiondi%26aufirst%3DA.%26aulast%3DMeyer-Monard%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DStructural%2520analysis%2520identifies%2520imidazo%255B1%252C2-b%255Dpyridazines%2520as%2520PIM%2520kinase%2520inhibitors%2520with%2520in%2520vitro%2520antileukemic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6916%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Siu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virtanen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongstra, J.</span><span> </span><span class="NLM_article-title">PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1134-1144&author=A.+Siuauthor=C.+Virtanenauthor=J.+Jongstra&title=PIM+kinase+isoform+specific+regulation+of+MIG6+expression+and+EGFR+signaling+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DA.%26aulast%3DVirtanen%26aufirst%3DC.%26aulast%3DJongstra%26aufirst%3DJ.%26atitle%3DPIM%2520kinase%2520isoform%2520specific%2520regulation%2520of%2520MIG6%2520expression%2520and%2520EGFR%2520signaling%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1134%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mahalingam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivel, J. A.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawrocki, S. T.</span><span> </span><span class="NLM_article-title">Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1038%2Fbjc.2011.426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=22015557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=1563-1573&author=D.+Mahalingamauthor=C.+M.+Espitiaauthor=E.+C.+Medinaauthor=J.+A.+Esquivelauthor=K.+R.+Kellyauthor=D.+Bearssauthor=G.+Choyauthor=P.+Tavernaauthor=J.+S.+Carewauthor=F.+J.+Gilesauthor=S.+T.+Nawrocki&title=Targeting+PIM+kinase+enhances+the+activity+of+sunitinib+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma</span></div><div class="casAuthors">Mahalingam, D.; Espitia, C. M.; Medina, E. C.; Esquivel, J. A., II; Kelly, K. R.; Bearss, D.; Choy, G.; Taverna, P.; Carew, J. S.; Giles, F. J.; Nawrocki, S. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1563-1573</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Upregulation of PIM kinase expression has been reported in many malignancies, suggesting that inhibition of PIM kinase activity may be an attractive therapeutic strategy.  We hypothesised that inhibition of PIM kinase activity with SGI-1776, a novel small mol. inhibitor of PIM kinase activity, would reduce the viability of renal cell carcinoma (RCC) cells and enhance the activity of sunitinib.  Methods: Immunoblotting, qRT-PCR, and gene expression arrays were carried out to identify genes modulated by SGI-1776 treatment.  The anticancer activity of SGI-1776 and sunitinib was detd. by viability and apoptosis assays and in tumor xenografts in vivo.  Results: Treatment with SGI-1776 led to a decrease in phosphorylated and total c-Myc levels, which resulted in the modulation of c-Myc target genes.  SGI-1776 in combination with sunitinib induced a further redn. in c-Myc levels, which was assocd. with enhanced anticancer activity. siRNA-mediated knockdown of c-Myc demonstrated that its expression has a key role in regulating the sensitivity to the combination of SGI-1776 and sunitinib.  Importantly, the combination significantly reduced tumor burden in two RCC xenograft models compared with single-agent therapy and was very well tolerated.  Conclusion: These data indicate that targeting PIM kinase signalling is a promising treatment strategy for RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHfOk11dbA8rVg90H21EOLACvtfcHk0liITSJmVz9Hlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGqtrzO&md5=822d95590ce777e0e17efb7615344352</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.426%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DEspitia%26aufirst%3DC.%2BM.%26aulast%3DMedina%26aufirst%3DE.%2BC.%26aulast%3DEsquivel%26aufirst%3DJ.%2BA.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DChoy%26aufirst%3DG.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DNawrocki%26aufirst%3DS.%2BT.%26atitle%3DTargeting%2520PIM%2520kinase%2520enhances%2520the%2520activity%2520of%2520sunitinib%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D1563%26epage%3D1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Chen, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, V.</span><span> </span><span class="NLM_article-title">Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=693-702&author=L.+S.+Chenauthor=S.+Redkarauthor=P.+Tavernaauthor=J.+E.+Cortesauthor=V.+Gandhi&title=Mechanisms+of+cytotoxicity+to+Pim+kinase+inhibitor%2C+SGI-1776%2C+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%2BS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DMechanisms%2520of%2520cytotoxicity%2520to%2520Pim%2520kinase%2520inhibitor%252C%2520SGI-1776%252C%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D693%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hospital, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouscary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamburini, J.</span><span> </span><span class="NLM_article-title">The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1791-1792&author=M.+A.+Hospitalauthor=A.+S.+Greenauthor=C.+Lacombeauthor=P.+Mayeuxauthor=D.+Bouscaryauthor=J.+Tamburini&title=The+FLT3+and+Pim+kinases+inhibitor+SGI-1776+preferentially+target+FLT3-ITD+AML+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHospital%26aufirst%3DM.%2BA.%26aulast%3DGreen%26aufirst%3DA.%2BS.%26aulast%3DLacombe%26aufirst%3DC.%26aulast%3DMayeux%26aufirst%3DP.%26aulast%3DBouscary%26aufirst%3DD.%26aulast%3DTamburini%26aufirst%3DJ.%26atitle%3DThe%2520FLT3%2520and%2520Pim%2520kinases%2520inhibitor%2520SGI-1776%2520preferentially%2520target%2520FLT3-ITD%2520AML%2520cells%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D1791%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baird, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1759-1767&author=K.+T.+Kimauthor=K.+Bairdauthor=J.+Y.+Ahnauthor=P.+Meltzerauthor=M.+Lillyauthor=M.+Levisauthor=D.+Small&title=Pim-1+is+up-regulated+by+constitutively+activated+FLT3+and+plays+a+role+in+FLT3-mediated+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DBaird%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DJ.%2BY.%26aulast%3DMeltzer%26aufirst%3DP.%26aulast%3DLilly%26aufirst%3DM.%26aulast%3DLevis%26aufirst%3DM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DPim-1%2520is%2520up-regulated%2520by%2520constitutively%2520activated%2520FLT3%2520and%2520plays%2520a%2520role%2520in%2520FLT3-mediated%2520cell%2520survival%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D1759%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Constitutively activated FLT3 phosphorylates BAD partially through pim-1</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1111%2Fj.1365-2141.2006.06225.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=16869825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWlu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2006&pages=500-509&author=K.+T.+Kimauthor=M.+Levisauthor=D.+Small&title=Constitutively+activated+FLT3+phosphorylates+BAD+partially+through+pim-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutively activated FLT3 phosphorylates BAD partially through Pim-1</span></div><div class="casAuthors">Kim, Kyu-Tae; Levis, Mark; Small, Donald</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-509</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Constitutively activating internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) play an important role in leukemogenesis and their presence is assocd. with a poor prognosis in acute myeloid leukemia (AML).  Examg. the anti- and pro-apoptotic proteins in constitutively activated FLT3 signaling in BaF3/ITD and MV4-11 cells, we found that the level of Bcl-2 antagonist of cell death (BAD) phosphorylation was greatly decreased in response to FLT3 inhibition.  Both Ser-112 and Ser-136 of BAD are rapidly dephosphorylated after treatment with the FLT3 inhibitor CEP-701 in BaF3/ITD and MV4-11 cells.  In confirmation of the cell line data, BAD was highly phosphorylated in both constitutively activated wild-type and mutant FLT3 primary AML samples, and rapidly dephosphorylated after treatment of the primary samples with CEP-701.  Upstream proteins known to phosphorylate BAD include Akt, extracellular signal-regulated kinase/mitogen-activated protein kinase (Erk/MAPK), Pim-1 and Pim-2.  We and other groups have shown that constitutively activated FLT3 induces multiple signaling pathways, including phosphatidylinositol 3-kinase (PI3K)/Akt, Erk/MAPK and Janus kinase/signal transducers and activators of transcription (Jak/STAT).  Thus, BAD may be a nexus point upon which these multiple signaling pathways converge in FLT3-mediated cell survival.  In support of this, siRNA knockdown of BAD expression in MV4-11 cells conferred resistance to CEP-701-mediated apoptosis.  Our data suggests that Pim-1 is one of the principal kinases mediating the anti-apoptotic function of FLT3/ITD signaling via the phosphorylation of BAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonz5rNZxqqDrVg90H21EOLACvtfcHk0liITSJmVz9Hlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWlu7vO&md5=013ab27ae219a6cf4659e48b1acdc45e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.06225.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.06225.x%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BT.%26aulast%3DLevis%26aufirst%3DM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DConstitutively%2520activated%2520FLT3%2520phosphorylates%2520BAD%2520partially%2520through%2520pim-1%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2006%26volume%3D134%26spage%3D500%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Pastor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajenjo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebria, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albarran, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebrian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrionero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fominaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span> </span><span class="NLM_article-title">Hit to lead evaluation of 1,2,3-triazolo[4,5-<i>b</i>]pyridines as PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1591-1597&author=J.+Pastorauthor=J.+Oyarzabalauthor=G.+Salusteauthor=R.+M.+Alvarezauthor=V.+Riveroauthor=F.+Ramosauthor=E.+Cendonauthor=C.+Blanco-Aparicioauthor=N.+Ajenjoauthor=A.+Cebriaauthor=M.+I.+Albarranauthor=D.+Cebrianauthor=A.+Corrioneroauthor=J.+Fominayaauthor=G.+Montoyaauthor=M.+Mazzorana&title=Hit+to+lead+evaluation+of+1%2C2%2C3-triazolo%5B4%2C5-b%5Dpyridines+as+PIM+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DSaluste%26aufirst%3DG.%26aulast%3DAlvarez%26aufirst%3DR.%2BM.%26aulast%3DRivero%26aufirst%3DV.%26aulast%3DRamos%26aufirst%3DF.%26aulast%3DCendon%26aufirst%3DE.%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DAjenjo%26aufirst%3DN.%26aulast%3DCebria%26aufirst%3DA.%26aulast%3DAlbarran%26aufirst%3DM.%2BI.%26aulast%3DCebrian%26aufirst%3DD.%26aulast%3DCorrionero%26aufirst%3DA.%26aulast%3DFominaya%26aufirst%3DJ.%26aulast%3DMontoya%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26atitle%3DHit%2520to%2520lead%2520evaluation%2520of%25201%252C2%252C3-triazolo%255B4%252C5-b%255Dpyridines%2520as%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1591%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Fathi, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arowojolu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkhowa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmsater, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M.</span><span> </span><span class="NLM_article-title">A potential therapeutic target for FLT3-ITD AML: PIM1 kinase</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.leukres.2011.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21802138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=224-231&author=A.+T.+Fathiauthor=O.+Arowojoluauthor=I.+Swinnenauthor=T.+Satoauthor=T.+Rajkhowaauthor=D.+Smallauthor=F.+Marmsaterauthor=J.+E.+Robinsonauthor=S.+D.+Grossauthor=M.+Martinsonauthor=S.+Allenauthor=N.+C.+Kallanauthor=M.+Levis&title=A+potential+therapeutic+target+for+FLT3-ITD+AML%3A+PIM1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A potential therapeutic target for FLT3-ITD AML: PIM1 kinase</span></div><div class="casAuthors">Fathi, Amir T.; Arowojolu, Omotayo; Swinnen, Ian; Sato, Takashi; Rajkhowa, Trivikram; Small, Donald; Marmsater, Fredrik; Robinson, John E.; Gross, Stefan David; Martinson, Matthew; Allen, Shelley; Kallan, Nicholas C.; Levis, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">224-231</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Patients with acute myeloid leukemia (AML) and a FLT3 internal tandem duplication (ITD) mutation have a poor prognosis, and FLT3 inhibitors are now under clin. investigation.  PIM1, a serine/threonine kinase, is up-regulated in FLT3-ITD AML and may be involved in FLT3-mediated leukemogenesis.  We employed a PIM1 inhibitor, AR00459339 (Array Biopharma Inc.), to investigate the effect of PIM1 inhibition in FLT3-mutant AML.  Like FLT3 inhibitors, AR00459339 was preferentially cytotoxic to FLT3-ITD cells, as demonstrated in the MV4-11, Molm-14, and TF/ITD cell lines, as well as 12 FLT3-ITD primary samples.  Unlike FLT3 inhibitors, AR00459339 did not suppress phosphorylation of FLT3, but did promote the de-phosphorylation of downstream FLT3 targets, STAT5, AKT, and BAD.  Combining AR00459339 with a FLT3 inhibitor resulted in additive to mildly synergistic cytotoxic effects.  AR00459339 was cytotoxic to FLT3-ITD samples from patients with secondary resistance to FLT3 inhibitors, suggesting a novel benefit to combining these agents.  We conclude that PIM1 appears to be closely assocd. with FLT3 signaling, and that inhibition of PIM1 may hold therapeutic promise, either as monotherapy, or by overcoming resistance to FLT3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBBVHeB4yqFbVg90H21EOLACvtfcHk0lg8clum0UhdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVemtQ%253D%253D&md5=e7430db23fe996d45fe6a0a55ec040b3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2011.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2011.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DFathi%26aufirst%3DA.%2BT.%26aulast%3DArowojolu%26aufirst%3DO.%26aulast%3DSwinnen%26aufirst%3DI.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DRajkhowa%26aufirst%3DT.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DMarmsater%26aufirst%3DF.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DS.%2BD.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DA%2520potential%2520therapeutic%2520target%2520for%2520FLT3-ITD%2520AML%253A%2520PIM1%2520kinase%26jtitle%3DLeuk.%2520Res.%26date%3D2012%26volume%3D36%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Xiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmussen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemann, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jancsics, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papoulis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepp, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R. R.</span><span> </span><span class="NLM_article-title">The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3050-3056&author=Y.+Xiangauthor=B.+Hirthauthor=G.+Asmussenauthor=H.+P.+Biemannauthor=K.+A.+Bishopauthor=A.+Goodauthor=M.+Fitzgeraldauthor=T.+Gladyshevaauthor=A.+Jainauthor=K.+Jancsicsauthor=J.+Liuauthor=M.+Metzauthor=A.+Papoulisauthor=R.+Skerljauthor=J.+D.+Steppauthor=R.+R.+Wei&title=The+discovery+of+novel+benzofuran-2-carboxylic+acids+as+potent+Pim-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DAsmussen%26aufirst%3DG.%26aulast%3DBiemann%26aufirst%3DH.%2BP.%26aulast%3DBishop%26aufirst%3DK.%2BA.%26aulast%3DGood%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DJancsics%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DPapoulis%26aufirst%3DA.%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DStepp%26aufirst%3DJ.%2BD.%26aulast%3DWei%26aufirst%3DR.%2BR.%26atitle%3DThe%2520discovery%2520of%2520novel%2520benzofuran-2-carboxylic%2520acids%2520as%2520potent%2520Pim-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3050%26epage%3D3056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span> </span><span class="NLM_article-title">7,8-Dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201286z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=403-413&issue=1&author=K.+Huberauthor=L.+Braultauthor=O.+Fedorovauthor=C.+Gasserauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=D.+Fabbroauthor=J.+Trappeauthor=J.+Schwallerauthor=S.+Knappauthor=F.+Bracher&title=7%2C8-Dichloro-1-oxo-beta-carbolines+as+a+versatile+scaffold+for+the+development+of+potent+and+selective+kinase+inhibitors+with+unusual+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm201286z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201286z%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBracher%26aufirst%3DF.%26atitle%3D7%252C8-Dichloro-1-oxo-beta-carbolines%2520as%2520a%2520versatile%2520scaffold%2520for%2520the%2520development%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520with%2520unusual%2520binding%2520modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D1%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Akue-Gedu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letribot, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saugues, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debiton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anizon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, P.</span><span> </span><span class="NLM_article-title">Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-<i>a</i>]carbazole derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3807</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3807-3809&author=R.+Akue-Geduauthor=B.+Letribotauthor=E.+Sauguesauthor=E.+Debitonauthor=F.+Anizonauthor=P.+Moreau&title=Kinase+inhibitory+potencies+and+in+vitro+antiproliferative+activities+of+N-10+substituted+pyrrolo%5B2%2C3-a%5Dcarbazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkue-Gedu%26aufirst%3DR.%26aulast%3DLetribot%26aufirst%3DB.%26aulast%3DSaugues%26aufirst%3DE.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DKinase%2520inhibitory%2520potencies%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520N-10%2520substituted%2520pyrrolo%255B2%252C3-a%255Dcarbazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3807%26epage%3D3809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Nakano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuganezawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, T.</span><span> </span><span class="NLM_article-title">Rational evolution of a novel type of potent and selective proviral integration site in moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3001289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5151-5164&issue=11&author=H.+Nakanoauthor=N.+Saitoauthor=L.+Parkerauthor=Y.+Tadaauthor=M.+Abeauthor=K.+Tsuganezawaauthor=S.+Yokoyamaauthor=A.+Tanakaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Rational+evolution+of+a+novel+type+of+potent+and+selective+proviral+integration+site+in+moloney+murine+leukemia+virus+kinase+1+%28PIM1%29+inhibitor+from+a+screening-hit+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm3001289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001289%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DSaito%26aufirst%3DN.%26aulast%3DParker%26aufirst%3DL.%26aulast%3DTada%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DTsuganezawa%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DRational%2520evolution%2520of%2520a%2520novel%2520type%2520of%2520potent%2520and%2520selective%2520proviral%2520integration%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520kinase%25201%2520%2528PIM1%2529%2520inhibitor%2520from%2520a%2520screening-hit%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D5151%26epage%3D5164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Tsuhako, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcalas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span> </span><span class="NLM_article-title">The design, synthesis, and biological evaluation of PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3732-3738&author=A.+L.+Tsuhakoauthor=D.+S.+Brownauthor=E.+S.+Koltunauthor=N.+Aayauthor=A.+Arcalasauthor=V.+Chanauthor=H.+Duauthor=S.+Engstauthor=M.+Franziniauthor=A.+Galanauthor=P.+Huangauthor=S.+Johnstonauthor=B.+Kaneauthor=M.+H.+Kimauthor=A.+D.+Lairdauthor=R.+Linauthor=L.+Mockauthor=I.+Nganauthor=M.+Packauthor=G.+Stottauthor=T.+J.+Stoutauthor=P.+Yuauthor=C.+Zahariaauthor=W.+Zhangauthor=P.+Zhouauthor=J.+M.+Nussauthor=P.+C.+Kearneyauthor=W.+Xu&title=The+design%2C+synthesis%2C+and+biological+evaluation+of+PIM+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuhako%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGalan%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DS.%26aulast%3DKane%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DNgan%26aufirst%3DI.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DStott%26aufirst%3DG.%26aulast%3DStout%26aufirst%3DT.%2BJ.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZaharia%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DKearney%26aufirst%3DP.%2BC.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3732%26epage%3D3738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lgI0byylWfcmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaebe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafaelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darjania, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proffitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliesath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitten, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">Discovery of CX-6258. A potent, selective, and orally efficacious pan-Pim kinases inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200259q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=135-139&author=M.+Haddachauthor=J.+Michauxauthor=M.+K.+Schwaebeauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=C.+Borsanauthor=J.+Tranauthor=N.+Rafaelleauthor=S.+Ravulaauthor=D.+Dryginauthor=A.+Siddiqui-Jainauthor=L.+Darjaniaauthor=R.+Stansfieldauthor=C.+Proffittauthor=D.+Macalinoauthor=N.+Streinerauthor=J.+Bliesathauthor=M.+Omoriauthor=J.+P.+Whittenauthor=K.+Anderesauthor=W.+G.+Riceauthor=D.+M.+Ryckman&title=Discovery+of+CX-6258.+A+potent%2C+selective%2C+and+orally+efficacious+pan-Pim+kinases+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fml200259q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200259q%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBorsan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DRafaelle%26aufirst%3DN.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDarjania%26aufirst%3DL.%26aulast%3DStansfield%26aufirst%3DR.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DWhitten%26aufirst%3DJ.%2BP.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3DDiscovery%2520of%2520CX-6258.%2520A%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520pan-Pim%2520kinases%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedellec, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui-Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macalino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckman, D. M.</span><span> </span><span class="NLM_article-title">7-(4<i>H</i>-1,2,4-Triazol-3-yl)benzo[<i>c</i>][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6687</span><span class="NLM_x">–</span> <span class="NLM_lpage">6692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6687-6692&author=F.+Pierreauthor=E.+Stefanauthor=A.+S.+Nedellecauthor=M.+C.+Chevrelauthor=C.+F.+Reganauthor=A.+Siddiqui-Jainauthor=D.+Macalinoauthor=N.+Streinerauthor=D.+Dryginauthor=M.+Haddachauthor=S.+E.+O%E2%80%99Brienauthor=K.+Anderesauthor=D.+M.+Ryckman&title=7-%284H-1%2C2%2C4-Triazol-3-yl%29benzo%5Bc%5D%5B2%2C6%5Dnaphthyridines%3A+a+novel+class+of+Pim+kinase+inhibitors+with+potent+cell+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DStefan%26aufirst%3DE.%26aulast%3DNedellec%26aufirst%3DA.%2BS.%26aulast%3DChevrel%26aufirst%3DM.%2BC.%26aulast%3DRegan%26aufirst%3DC.%2BF.%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DMacalino%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DAnderes%26aufirst%3DK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26atitle%3D7-%25284H-1%252C2%252C4-Triazol-3-yl%2529benzo%255Bc%255D%255B2%252C6%255Dnaphthyridines%253A%2520a%2520novel%2520class%2520of%2520Pim%2520kinase%2520inhibitors%2520with%2520potent%2520cell%2520antiproliferative%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6687%26epage%3D6692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gross, S. D.; Robinson, J. E.; Allen, S.; Cox, A.; DeWolf, W. E.; Galbraith, S.; Lee, P.; Lemieux, C.; Lyssikatos, J. P.; Marmsater, F.; Martinson, M.; Munson, M. C.; Wallace, R. D.; Woessner, R.; Zuzack, J.; Winkler, J.; Koch, K.</span><span> </span><span class="NLM_article-title">Characterization of the Effects of Pim Kinase Inhibition on Multiple Oncogene-Driven Cell Lines</span>. Presented at the 50th Annual Meeting of the American Society of Hematology, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Gross&author=J.+E.+Robinson&author=S.+Allen&author=A.+Cox&author=W.+E.+DeWolf&author=S.+Galbraith&author=P.+Lee&author=C.+Lemieux&author=J.+P.+Lyssikatos&author=F.+Marmsater&author=M.+Martinson&author=M.+C.+Munson&author=R.+D.+Wallace&author=R.+Woessner&author=J.+Zuzack&author=J.+Winkler&author=K.+Koch&title=Characterization+of+the+Effects+of+Pim+Kinase+Inhibition+on+Multiple+Oncogene-Driven+Cell+Lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%2BD.%26atitle%3DCharacterization%2520of%2520the%2520Effects%2520of%2520Pim%2520Kinase%2520Inhibition%2520on%2520Multiple%2520Oncogene-Driven%2520Cell%2520Lines%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ebens, A. J.; Berry, L.; Chen, Y.-H.; Deshumkh, G.; Drummond, G.; Du, C.; Eby, M.; Fitzgerald, K.; Friedman, L. S.; Gould, S. E.; Kenny, J. R.; Maecker, H.; Moffat, J.; Moskalenko, M.; Pacheco, P.; Saadat, A.; Slaga, D.; Sun, L.; Wang, G.; Yang, Y.; Munugalavdla, V.</span><span> </span><span class="NLM_article-title">A Selective PIM Kinase Inhibitor Is Highly Active in Multiple Myeloma: The Biology of Single Agent and PI3K/AKT/mTOR Combination Activity</span>. Presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology, San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+J.+Ebens&author=L.+Berry&author=Y.-H.+Chen&author=G.+Deshumkh&author=G.+Drummond&author=C.+Du&author=M.+Eby&author=K.+Fitzgerald&author=L.+S.+Friedman&author=S.+E.+Gould&author=J.+R.+Kenny&author=H.+Maecker&author=J.+Moffat&author=M.+Moskalenko&author=P.+Pacheco&author=A.+Saadat&author=D.+Slaga&author=L.+Sun&author=G.+Wang&author=Y.+Yang&author=V.+Munugalavdla&title=A+Selective+PIM+Kinase+Inhibitor+Is+Highly+Active+in+Multiple+Myeloma%3A+The+Biology+of+Single+Agent+and+PI3K%2FAKT%2FmTOR+Combination+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEbens%26aufirst%3DA.%2BJ.%26atitle%3DA%2520Selective%2520PIM%2520Kinase%2520Inhibitor%2520Is%2520Highly%2520Active%2520in%2520Multiple%2520Myeloma%253A%2520The%2520Biology%2520of%2520Single%2520Agent%2520and%2520PI3K%252FAKT%252FmTOR%2520Combination%2520Activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Czardybon, W.; Windak, R.; Krawczynska, K.; Zarebski, A.; Dolata, I.; Salwinska, M.; Surawska, M.; Sabiniarz, A.; Szamborska-Gbur, A.; Prymula, K.; Milik, M.; Kosowska-Wardega, A.; Trebacz, E.; Rsymski, T.; Kowalczyk, P.; Brzozka, K.</span><span> </span><span class="NLM_article-title">Development of Selective Pim Kinase Inhibitors for Cancer Treatment</span>. Presented at the 2012 Annual Meeting of the American Association for Cancer Research, Chicago, IL,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+Czardybon&author=R.+Windak&author=K.+Krawczynska&author=A.+Zarebski&author=I.+Dolata&author=M.+Salwinska&author=M.+Surawska&author=A.+Sabiniarz&author=A.+Szamborska-Gbur&author=K.+Prymula&author=M.+Milik&author=A.+Kosowska-Wardega&author=E.+Trebacz&author=T.+Rsymski&author=P.+Kowalczyk&author=K.+Brzozka&title=Development+of+Selective+Pim+Kinase+Inhibitors+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCzardybon%26aufirst%3DW.%26atitle%3DDevelopment%2520of%2520Selective%2520Pim%2520Kinase%2520Inhibitors%2520for%2520Cancer%2520Treatment%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Keeton, E.; McEachem, K.; Alimzhanov, M.; Wang, S.; Cao, Y.; Bao, L.; Palakurthi, S.; Grondine, M.; Chen, Y.; Dillman, K.; Chinnappan, D.; Shen, M.; Dakin, L.; Zheng, X.; Lamb, M.; Wu, A.; Chen, H.; Lyne, P.; Huszar, D.</span><span> </span><span class="NLM_article-title">Efficacy and Biomarker Modulation by AZD1208, a Novel, Potent and Selective Pan-Pim Kinase Inhibitor, in Models of Acute Meloid Leukemia</span>. Presented at the 2012 Annual Meeting of the American Association for Cancer Research, Chicaogo, IL,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=E.+Keeton&author=K.+McEachem&author=M.+Alimzhanov&author=S.+Wang&author=Y.+Cao&author=L.+Bao&author=S.+Palakurthi&author=M.+Grondine&author=Y.+Chen&author=K.+Dillman&author=D.+Chinnappan&author=M.+Shen&author=L.+Dakin&author=X.+Zheng&author=M.+Lamb&author=A.+Wu&author=H.+Chen&author=P.+Lyne&author=D.+Huszar&title=Efficacy+and+Biomarker+Modulation+by+AZD1208%2C+a+Novel%2C+Potent+and+Selective+Pan-Pim+Kinase+Inhibitor%2C+in+Models+of+Acute+Meloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKeeton%26aufirst%3DE.%26atitle%3DEfficacy%2520and%2520Biomarker%2520Modulation%2520by%2520AZD1208%252C%2520a%2520Novel%252C%2520Potent%2520and%2520Selective%2520Pan-Pim%2520Kinase%2520Inhibitor%252C%2520in%2520Models%2520of%2520Acute%2520Meloid%2520Leukemia%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=95-105&issue=Part+1&author=S.+P.+Daviesauthor=H.+Reddyauthor=M.+Caivanoauthor=P.+Cohen&title=Specificity+and+mechanism+of+action+of+some+commonly+used+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DH.%26aulast%3DCaivano%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DSpecificity%2520and%2520mechanism%2520of%2520action%2520of%2520some%2520commonly%2520used%2520protein%2520kinase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26issue%3DPart%25201%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&issue=7&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26issue%3D7%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Why do kinase inhibitors cause cardiotoxicity and what can be done about it?</span> <span class="citation_source-journal">Prog. Cardiovasc. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=114-120&author=H.+Chengauthor=T.+Force&title=Why+do+kinase+inhibitors+cause+cardiotoxicity+and+what+can+be+done+about+it%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DWhy%2520do%2520kinase%2520inhibitors%2520cause%2520cardiotoxicity%2520and%2520what%2520can%2520be%2520done%2520about%2520it%253F%26jtitle%3DProg.%2520Cardiovasc.%2520Dis.%26date%3D2010%26volume%3D53%26spage%3D114%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Hasinoff, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span> </span><span class="NLM_article-title">The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.taap.2010.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=20832415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlentLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=2010&pages=132-139&author=B.+B.+Hasinoffauthor=D.+Patel&title=The+lack+of+target+specificity+of+small+molecule+anticancer+kinase+inhibitors+is+correlated+with+their+ability+to+damage+myocytes+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro</span></div><div class="casAuthors">Hasinoff, Brian B.; Patel, Daywin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Many new targeted small mol. anticancer kinase inhibitors are actively being developed.  However, the clin. use of some kinase inhibitors has been shown to result in cardiotoxicity.  In most cases the mechanisms by which they exert their cardiotoxicity are not well understood.  We have used large scale profiling data on 8 FDA-approved tyrosine kinase inhibitors and 10 other kinase inhibitors to a panel of 317 kinases in order to correlate binding consts. and kinase inhibitor binding selectivity scores with kinase inhibitor-induced damage to neonatal rat cardiac myocytes.  The 18 kinase inhibitors that were the subject of this study were: canertinib, dasatinib, dovitinib, erlotinib, flavopiridol, gefitinib, imatinib, lapatinib, midostaurin, motesanib, pazopanib, sorafenib, staurosporine, sunitinib, tandutinib, tozasertib, vandetanib and vatalanib.  The combined tyrosine kinase and serine-threonine kinase selectivity scores were highly correlated with the myocyte-damaging effects of the kinase inhibitors.  This result suggests that myocyte damage was due to a lack of target selectivity to binding of both tyrosine kinases and serine-threonine kinases, and was not due to binding to either group specifically.  Finally, the strength of kinase inhibitor binding for 290 kinases was examd. for correlations with myocyte damage.  Kinase inhibitor binding was significantly correlated with myocyte damage for 12 kinases.  Thus, myocyte damage may be multifactorial in nature with the inhibition of a no. of kinases involved in producing kinase inhibitor-induced myocyte damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLMB7MMhLiLVg90H21EOLACvtfcHk0lhoNWNR1UaMfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlentLvE&md5=7d79b5cbb2ddf05a33d64235a4bfe37f</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2010.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2010.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26aulast%3DPatel%26aufirst%3DD.%26atitle%3DThe%2520lack%2520of%2520target%2520specificity%2520of%2520small%2520molecule%2520anticancer%2520kinase%2520inhibitors%2520is%2520correlated%2520with%2520their%2520ability%2520to%2520damage%2520myocytes%2520in%2520vitro%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2010%26volume%3D249%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Fischer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottage, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Din, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransioli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, M. A.</span><span> </span><span class="NLM_article-title">Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2009&pages=2077-2087&author=K.+M.+Fischerauthor=C.+T.+Cottageauthor=W.+Wuauthor=S.+Dinauthor=N.+A.+Gudeauthor=D.+Avitabileauthor=P.+Quijadaauthor=B.+L.+Collinsauthor=J.+Fransioliauthor=M.+A.+Sussman&title=Enhancement+of+myocardial+regeneration+through+genetic+engineering+of+cardiac+progenitor+cells+expressing+Pim-1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DK.%2BM.%26aulast%3DCottage%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DDin%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DN.%2BA.%26aulast%3DAvitabile%26aufirst%3DD.%26aulast%3DQuijada%26aufirst%3DP.%26aulast%3DCollins%26aufirst%3DB.%2BL.%26aulast%3DFransioli%26aufirst%3DJ.%26aulast%3DSussman%26aufirst%3DM.%2BA.%26atitle%3DEnhancement%2520of%2520myocardial%2520regeneration%2520through%2520genetic%2520engineering%2520of%2520cardiac%2520progenitor%2520cells%2520expressing%2520Pim-1%2520kinase%26jtitle%3DCirculation%26date%3D2009%26volume%3D120%26spage%3D2077%26epage%3D2087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. X.</span><span> </span><span class="NLM_article-title">Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1016%2Fj.biocel.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=19505587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyntLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=2315-2322&author=D.+Liuauthor=M.+Heauthor=B.+Yiauthor=W.+H.+Guoauthor=A.+L.+Queauthor=J.+X.+Zhang&title=Pim-3+protects+against+cardiomyocyte+apoptosis+in+anoxia%2Freoxygenation+injury+via+p38-mediated+signal+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway</span></div><div class="casAuthors">Liu, Dan; He, Ming; Yi, Bo; Guo, Wu-hua; Que, Ai-ling; Zhang, Ji-xiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2315-2322</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although anoxic preconditioning (APC) in the myocardium has been investigated for many years, its physiol. mechanism is still not completely understood.  Increasing evidence indicates that transiently increased resistance to ischemic damage following APC is dependent on de novo proteins synthesis.  However, the key effector pathway(s) assocd. with APC still remains unclear.  The proto-oncogene Pim kinase belongs to a serine/threonine protein kinase family, consists of Pim-1, Pim-2 and Pim-3 and has been implicated in stimulating cell growth and inhibiting cell apoptosis.  Therefore we assumed that Pim-3 expression might be aberrantly induced in cardiomyocytes that were subjected to anoxia/reoxygenation (A/R) injury and that Pim-3 might also contribute to cardio-protection after APC.  To address this hypothesis, we cloned a Pim-3 expression vector, transfected it into rat cardiomyocytes, and examd. Pim-3 expression in rat cardiomyocytes that were subjected to A/R injury.  Moreover, we studied the role of three major MAPK pathways, e.g. p38 MAPK, JNK, and ERK1/2, in order to evaluate the mol. mechanism underlying Pim-3 up-regulation and A/R induced cardiomyocyte injury.  Our expts. showed that APC induced an up-regulation of Pim-3 and the transfection of Pim-3 gene into the cardiomyocytes attenuated A/R injury.  The inhibition of p38 MAPK by SB203580 abolished both the Pim-3 up-regulation and the cardio-protection provided by APC.  Overall, these results suggest that APC could act to protect the heart from A/R injury with cooperation from the proto-oncogene Pim-3; in addn., it up-regulates Pim-3 expression through a p38 MAPK signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB9h-Mg4eYQbVg90H21EOLACvtfcHk0lhoNWNR1UaMfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyntLvP&md5=84181dc44aac3a4c75f476272160174f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DW.%2BH.%26aulast%3DQue%26aufirst%3DA.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%2BX.%26atitle%3DPim-3%2520protects%2520against%2520cardiomyocyte%2520apoptosis%2520in%2520anoxia%252Freoxygenation%2520injury%2520via%2520p38-mediated%2520signal%2520pathway%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D2315%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span> </span><span class="NLM_article-title">Ischemia–reperfusion injury up-regulates Pim-3 gene expression in myocardial tissue</span> <span class="citation_source-journal">J. Huazhong Univ. Sci. Technol., Med. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=704-708&issue=6&author=L.+Zhaoauthor=Y.+Wangauthor=X.+Minauthor=H.+Yangauthor=P.+Zhangauthor=Q.+Zeng&title=Ischemia%E2%80%93reperfusion+injury+up-regulates+Pim-3+gene+expression+in+myocardial+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DQ.%26atitle%3DIschemia%25E2%2580%2593reperfusion%2520injury%2520up-regulates%2520Pim-3%2520gene%2520expression%2520in%2520myocardial%2520tissue%26jtitle%3DJ.%2520Huazhong%2520Univ.%2520Sci.%2520Technol.%252C%2520Med.%2520Sci.%26date%3D2010%26volume%3D30%26issue%3D6%26spage%3D704%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Kim, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critz, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelech, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. V.</span><span> </span><span class="NLM_article-title">Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3009234&amp;key=10.1139%2Fo99-065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3009234&amp;key=10668633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3009234&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1alsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1999&pages=559-567&issue=6&author=S.+O.+Kimauthor=C.+P.+Bainesauthor=S.+D.+Critzauthor=S.+L.+Pelechauthor=S.+Katzauthor=J.+M.+Downeyauthor=M.+V.+Cohen&title=Ischemia+induced+activation+of+heat+shock+protein+27+kinases+and+casein+kinase+2+in+the+preconditioned+rabbit+heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart</span></div><div class="casAuthors">Kim, Sung O.; Baines, Christopher P.; Critz, Stuart D.; Pelech, Steven L.; Katz, Sidney; Downey, James M.; Cohen, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">559-567</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">Protein kinase C (PKC), p38 MAP kinase, and mitogen-activated protein kinase-activated kinases 2 and 3 (MAPKAPK2 and MAPKAPK3) have been implicated in ischemic preconditioning (PC) of the heart to reduce damage following a myocardial infarct.  This study examd. whether extracellular signal-regulated kinase (Erk) 1, p70 ribosomal S6 kinase (p70 S6K), casein kinase 2 (CK2), and other hsp27 kinases are also activated by PC, and if they are required for protection in rabbit hearts.  CK2 and hsp27 kinase activities declined during global ischemia in control hearts, whereas PC with 5 min ischemia and 10 min reperfusion increased their activities during global ischemia.  Resource Q chromatog. resolved two distinct peaks of hsp27 phosphotransferase activities; the first peak (at 0.36 M NaCl) appeared to correspond to the 55-kDa MAPKAPK2.  Erk1 activity was elevated in both control and PC hearts after post-ischemic reperfusion, but no change was obsd. in p70 S6K activity.  Infarct size (measured by triphenyltetrazolium staining) in isolated rabbit hearts subjected to 30 min regional ischemia and 2 h reperfusion was 31.0% of the risk zone in controls and was 10.3% in PC hearts.  Neither the CK2 inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) nor the Mek1/2 inhibitor PD 98059 infused during ischemia blocked protection by PC.  The activation of CK2 and Erk1 in ischemic preconditioned hearts appear to be epiphenomena and not required for the redn. of infarction from myocardial ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdAYhd9o9SLVg90H21EOLACvtfcHk0lhdhUner5t2rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1alsQ%253D%253D&md5=05a155c6be8d96c498db910f7e6c5103</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1139%2Fo99-065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo99-065%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BO.%26aulast%3DBaines%26aufirst%3DC.%2BP.%26aulast%3DCritz%26aufirst%3DS.%2BD.%26aulast%3DPelech%26aufirst%3DS.%2BL.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DDowney%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DM.%2BV.%26atitle%3DIschemia%2520induced%2520activation%2520of%2520heat%2520shock%2520protein%252027%2520kinases%2520and%2520casein%2520kinase%25202%2520in%2520the%2520preconditioned%2520rabbit%2520heart%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D1999%26volume%3D77%26issue%3D6%26spage%3D559%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Sussman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottage, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Din, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundararaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quijada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstandin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGregor, M.</span><span> </span><span class="NLM_article-title">Myocardial AKT: the omnipresent nexus</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1023-1070&author=M.+A.+Sussmanauthor=M.+Volkersauthor=K.+Fischerauthor=B.+Baileyauthor=C.+T.+Cottageauthor=S.+Dinauthor=N.+Gudeauthor=D.+Avitabileauthor=R.+Alvarezauthor=B.+Sundararamanauthor=P.+Quijadaauthor=M.+Masonauthor=M.+H.+Konstandinauthor=A.+Malhowskiauthor=Z.+Chengauthor=M.+Khanauthor=M.+McGregor&title=Myocardial+AKT%3A+the+omnipresent+nexus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSussman%26aufirst%3DM.%2BA.%26aulast%3DVolkers%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DB.%26aulast%3DCottage%26aufirst%3DC.%2BT.%26aulast%3DDin%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DN.%26aulast%3DAvitabile%26aufirst%3DD.%26aulast%3DAlvarez%26aufirst%3DR.%26aulast%3DSundararaman%26aufirst%3DB.%26aulast%3DQuijada%26aufirst%3DP.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DKonstandin%26aufirst%3DM.%2BH.%26aulast%3DMalhowski%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%26atitle%3DMyocardial%2520AKT%253A%2520the%2520omnipresent%2520nexus%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D1023%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3009234&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-19%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm3009234%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3009234" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677adc7cb84e2308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
